Processing 00000000.tx.1: Identification of cis-Elements Regulating Exon 15Splicing of the Amyloid Precursor Protein Pre-mRNA* Christian Bergsdorf, Krzysztof Paliga, Sylvia Kreger, Colin L. 

Phrase: "Identification of cis-Elements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "Regulating"

Phrase: "Exon 15Splicing of the Amyloid Precursor Protein Pre-mRNA* Christian Bergsdorf,"

Phrase: "Krzysztof Paliga,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3284170:Paliga [Eukaryote]

Phrase: "Sylvia Kreger,"

Phrase: "Colin L."
Processing 00000000.tx.2: Masters, and Konrad Beyreuther From the Center for Molecular Biology Heidelberg (ZMBH), University of Heidelberg, Im Neuenheimer Feld 282,D-69120 Heidelberg, Germany and Department of Pathology, University of Melbourne, Parkville, Victoria 3052,Australia  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Alternative splicing of exon 15of the amyloid precursor protein (APP) pre-mRNA generates two APP isoform groups APPex15 (containing exon 15) and L-APP (without exon 15), which show a cell-specific distribution in non-neuronal cells and neurons of rat. 

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "and"

Phrase: "Konrad Beyreuther From the Center"

Phrase: "for Molecular Biology Heidelberg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0026376:Molecular Biology [Biomedical Occupation or Discipline]

Phrase: "(ZMBH"

Phrase: ")"

Phrase: ","

Phrase: "University of Heidelberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Im Neuenheimer Feld 282,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3539078:IM [Idea or Concept]

Phrase: "D-"

Phrase: "69120 Heidelberg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "and"

Phrase: "Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587487:Pathology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "University of Melbourne,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Parkville,"

Phrase: "Victoria 3052,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042645:Victoria [Geographic Area]
   861   C0997115:Victoria [Plant]

Phrase: "Australia  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alternative splicing of exon 15of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0002345:Alternative Splicing [Genetic Function]
   760   C0035687:Splicing [Genetic Function]
   760   C2610186:splicing [Genetic Function]

Phrase: "the amyloid precursor protein (APP) pre-mRNA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   875   C0026661:precursor mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
           Pre-mRNA
   840   C0035695:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0332152:Pre [Temporal Concept]
   804   C0740175:Pre [Qualitative Concept]
   804   C2257086:PRE [Genetic Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "generates"

Phrase: "two APP isoform"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597298:protein isoform [Amino Acid, Peptide, or Protein]
           Isoform
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "APPex15"

Phrase: "(containing exon 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0332256:Containing [Functional Concept]
   827   C2700400:Containing [Activity]

Phrase: ")"

Phrase: "and"

Phrase: "L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "("

Phrase: "without exon 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a cell-specific distribution in non-neuronal cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "neurons of rat."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.3: Both APP isoforms differ in regard to functional properties like post-translational modification, APP secretion, and proteolytic production of A peptide from APP molecules. 

Phrase: "Both APP isoforms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "differ in regard to functional properties"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0205245:Functional [Functional Concept]
   753   C0542341:Functional [Functional Concept]
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   753   C2700217:Functional [Conceptual Entity]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "like post-translational modification,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0033666:Post-Translational Modification [Molecular Function]
   827   C0392747:Modification [Functional Concept]
   827   C0687676:Post [Temporal Concept]
   827   C1519614:Translational [Genetic Function]
   827   C1554963:modification [Qualitative Concept]
   827   C1704687:Post [Manufactured Object]
   755 E C0040712:Translation [Intellectual Product]
   755 E C0597295:translation [Molecular Function]
   755 E C1514253:Postal [Functional Concept]

Phrase: "APP secretion,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "proteolytic production of A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "from APP molecules."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0567416:molecules [Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   729 E C1521991:Molecular [Qualitative Concept]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.4: Since A generation is an important factor in the development of Alzheimer's disease, one could anticipate that these major APP isoforms might contribute differentially to the mechanisms underlying neurodegeneration in Alzheimer's disease. 

Phrase: "Since"

Phrase: "A generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "is"

Phrase: "an important factor in the development of Alzheimer's disease,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0679238:disease factor [Functional Concept]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "could"

Phrase: "anticipate"

Phrase: "that"

Phrase: "these major APP isoforms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "might"

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "differentially to the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "neurodegeneration in Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.5: In this study, we established an APP minigene system in a murine cell system to identify cis-acting elements controlling exon 15recognition. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "an APP minigene system in a murine cell system to"

Phrase: "identify"

Phrase: "cis-acting elements"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   988   C0599780:cis acting element [Nucleotide Sequence]
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "exon 15recognition."
Processing 00000000.tx.6: A 12.5-kilobase pair genomic fragment of the murine APP gene contained all cis-regulatory elements to reproduce the splicing pattern of the endogenous APP transcripts. 

Phrase: "A 12.5-kilobase pair genomic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "of the murine APP gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Gene [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "all cis-regulatory elements to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Elements [Element, Ion, or Isotope]
   812   C0220905:regulatory [Regulation or Law]
   812   C1704735:Regulatory [Conceptual Entity]
   779 E C1705248:Element [Conceptual Entity]

Phrase: "reproduce"

Phrase: "the splicing pattern of the endogenous APP transcripts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1317658:Protein pattern [Clinical Attribute]
   739   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.7: By using this approach, two intronic cis-elements flanking exon 15were identified that block the inclusion of exon 15in APP transcripts of non-neuronal cells. 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "two intronic cis-elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0013879:Elements [Element, Ion, or Isotope]
   779 E C1705248:Element [Conceptual Entity]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "exon 15were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "that"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the inclusion of exon 15in APP transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1512693:Inclusion [Qualitative Concept]

Phrase: "of non-neuronal cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.8: Point mutation analysis of these intronic regions indicated that pyrimidine-rich sequences are involved in the splice repressor function. 

Phrase: "Point mutation analysis of these intronic regions"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   778   C0796357:mutation analysis [Laboratory Procedure]
   774   C1881250:Intronic Mutation [Genetic Function]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0026882:Mutation [Genetic Function]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1552961:Point [Quantitative Concept]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
   748   C2347617:point [Quantitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that pyrimidine-rich sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "involved in the splice repressor function."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1314939:Involved [Functional Concept]
   753   C1336789:Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1705273:Function [Intellectual Product]
Processing 00000000.tx.9: Finally, grafting experiments demonstrated that these regulatory regions cell-specifically enhance the blockage of a chimeric exon in the non-neuronal splicing system.  

Phrase: "Finally,"

Phrase: "grafting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332835:grafting [Tissue]
  1000   C1527362:grafting [Qualitative Concept]
  1000   C1961139:Grafting [Therapeutic or Preventive Procedure]
   966 E C0181074:{Graft} [Biomedical or Dental Material]

Phrase: "experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "these regulatory regions cell-specifically"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0034987:Regulatory Regions [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0007634:Cell [Cell]
   812   C0220905:regulatory [Regulation or Law]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1704735:Regulatory [Conceptual Entity]
   812   C1948049:Cell [Spatial Concept]
   779   C0017446:Region [Geographic Area]
   779   C0205147:Region [Spatial Concept]
   729 E C0205276:Regional [Spatial Concept]
   729 E C1947913:Regional [Spatial Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the blockage of a chimeric exon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1706968:Blockage [Finding]
   753   C1879887:Blockage [Phenomenon or Process]

Phrase: "in the non-neuronal splicing system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.10: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Amyloid plaques represent characteristic neuropathological lesions in brains of patients with Alzheimer's disease. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "characteristic neuropathological lesions in brains of patients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0221505:Lesion of brain [Disease or Syndrome]
           brain lesions
   748   C0221198:lesions [Finding]
   714 E C1546698:Lesion [Intellectual Product]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.11: These amyloid deposits are mainly composed of a short, highly hydrophobic peptide (40-42 amino acid residues) termed A (1, 2). 

Phrase: "These amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936349:Amyloid Deposits [Acquired Abnormality]
   861   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "mainly"

Phrase: "composed of a short, highly hydrophobic peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0205250:Highly [Qualitative Concept]
   748   C0598629:Hydrophobic [Qualitative Concept]
   748   C1282927:short [Qualitative Concept]
   748   C1806781:Short [Quantitative Concept]
   748   C2350002:Short [Quantitative Concept]

Phrase: "(40-42 amino acid residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "A (1, 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C1825406:A-2 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.12: A is derived by proteolytic processing of the amyloid precursor protein (APP),1 which is expressed abundantly in almost every cell type including neurons (3, 4). 

Phrase: "A"

Phrase: "is"

Phrase: "derived by proteolytic processing of the amyloid precursor protein"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1514570:Proteolytic Processing [Molecular Function]
   762   C0033666:protein processing [Molecular Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0597304:Proteolytic [Molecular Function]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1441547:Derived [Qualitative Concept]
   742   C1709634:Precursor [Idea or Concept]
   742   C1709694:Processing [Activity]
   742   C1947941:proteolytic [Enzyme]
   742   C3245521:derived [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "which"

Phrase: "is"

Phrase: "expressed"

Phrase: "abundantly in almost"

Phrase: "every cell type"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007634:Cell Type [Cell]
           Cell
  1000   C0449475:cell type [Intellectual Product]
   861   C0332307:Type [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1547052:*Type [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.13: The human APP gene is located on chromosome 21(5, 6); 

Phrase: "The human APP gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   897   C0314604:Human gene [Gene or Genome]
   840   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Gene [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "located on chromosome 21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0008664:Chromosome 21 [Cell Component]
   770   C0008633:Chromosome [Cell Component]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.14: it spans ~300 kb, and the coding region is distributed over 18exons (7). 

Phrase: "it"

Phrase: "spans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1711300:Span [Conceptual Entity]
  1000   C2700613:Span [Quantitative Concept]

Phrase: "~300 kb,"

Phrase: "and"

Phrase: "the coding region"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0079941:Coding Region [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   827 E C0805701:Code [Intellectual Product]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "distributed over 18exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704711:Distributed [Functional Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.15: The APP pre-mRNA molecules are targets for post-transcriptional processing by alternative splicing of exons 7(6, 8, 9), 8(9), and 15(10) generating eight different isoforms of a type I transmembrane glycoprotein ranging in length from 677to 770amino acids. 

Phrase: "The APP pre-mRNA molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0567416:molecules [Substance]
   716 E C1521991:Molecular [Qualitative Concept]

Phrase: "are"

Phrase: "targets for post-transcriptional processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1521840:Target [Functional Concept]
   726   C2986546:TARGET [Diagnostic Procedure]

Phrase: "by alternative splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002345:Alternative Splicing [Genetic Function]
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "of exons 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(6,"

Phrase: "8,"

Phrase: "9"

Phrase: ")"

Phrase: ","

Phrase: "8"

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "15"

Phrase: "(10"

Phrase: ")"

Phrase: "generating eight different isoforms of a type I transmembrane glycoprotein ranging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "in length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]

Phrase: "from 677to 770amino acids."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.16: Alternative splicing of APP exon 15was first discovered in peripheral mononuclear leukocytes and activated microglial cells (10). 

Phrase: "Alternative splicing of APP exon 15was first"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0002345:Alternative Splicing [Genetic Function]
   762   C0376437:Protein Splicing [Genetic Function]
   742   C0035687:Splicing [Genetic Function]
   742   C2610186:splicing [Genetic Function]

Phrase: "discovered in peripheral mononuclear leukocytes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0023517:Leukocytes, Mononuclear [Cell]
   760   C0023516:Leukocytes [Cell]
   760   C0205100:Peripheral [Spatial Concept]
   760   C1513475:Mononuclear [Clinical Attribute]
   726   C1880355:Discover [Activity]

Phrase: "and"

Phrase: "activated microglial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   988   C0001280:Activated microglial cell [Cell]
   884   C0206116:Microglial cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.17: Therefore, isoforms lacking exon 15were denoted as leukocyte-derived APP (L-APP). 

Phrase: "Therefore,"

Phrase: "isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "exon 15were"

Phrase: "denoted as leukocyte-derived APP"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0682634:Leukocyte precursor [Cell]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0023516:Leucocyte [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1441547:Derived [Qualitative Concept]
   748   C1709634:Precursor [Idea or Concept]
   748   C3245521:derived [Idea or Concept]

Phrase: "(L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.18: Detailed expression studies revealed a ubiquitous distribution of L-APP transcripts in rat tissues (11). 

Phrase: "Detailed expression studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a ubiquitous distribution of L-APP transcripts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0872250:protein distribution [Cell Function]
   742   C0520511:distribution [Idea or Concept]
   742   C1704711:Distribution [Functional Concept]

Phrase: "in rat tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.19: In peripheral tissues L-APP mRNA molecules constitute between 25and 72% of total APP transcripts. 

Phrase: "In peripheral tissues L-APP mRNA molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0567416:molecules [Substance]
   710 E C1521991:Molecular [Qualitative Concept]

Phrase: "constitute between 25and 72% of total APP transcripts."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0439177:Protein.total [Quantitative Concept]
   757   C0555903:Total protein [Laboratory Procedure]
   757   C1261360:total protein [Laboratory or Test Result]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0439175:% total [Quantitative Concept]
   739   C0439810:Total [Qualitative Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.20: In contrast, the expression levels of L-APP in the central nervous system, including hippocampus, cerebellum, and cerebral cortex, is low (<10%), and no significant L-APP amounts were detected in cultured primary rat neurons. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the expression levels of L-APP"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   767   C1171362:expression protein [Genetic Function]
   750   C0428479:Protein level [Laboratory or Test Result]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Levels [Qualitative Concept]
   737   C3244092:expression level [Idea or Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the central nervous system,"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "cerebellum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "and"

Phrase: "cerebral cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "is"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "("

Phrase: "<10%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "no significant L-APP amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "detected in cultured primary rat neurons."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0027882:Neurons [Cell]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.21: These findings suggested that exon 15is recognized by a cell type-specific mechanism in rat. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that exon 15is"

Phrase: "recognized by a cell type-specific mechanism"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0007634:Cell Type [Cell]
           Cell
   778   C0449475:cell type [Intellectual Product]
   748   C0205369:Specific [Qualitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0441712:Mechanism [Functional Concept]
   748   C1269647:Cell [Cell]
   748   C1547052:*Type [Quantitative Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1704653:Cell [Medical Device]
   748   C1706376:Mechanism [Manufactured Object]
   748   C1948049:Cell [Spatial Concept]

Phrase: "in rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]
Processing 00000000.tx.22: Exclusion of 18amino acids encoded by exon 15has important consequences for the functional properties of the corresponding APP isoforms. 

Phrase: "Exclusion of 18amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0680251:EXCLUSION [Functional Concept]
   770   C2828389:Exclusion [Activity]

Phrase: "encoded by exon 15has important consequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0679058:encoded [Mental Process]
   753   C0686907:consequences [Functional Concept]
   753   C2700640:Encoded [Activity]

Phrase: "for the functional properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "of the corresponding APP isoforms."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.23: Fusion of exon 14with exon 16creates a new post-translational modification motif ENEGSG. 

Phrase: "Fusion of exon 14with exon 16creates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332466:Fusion [Functional Concept]
   753   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "a new post-translational modification motif ENEGSG."
Processing 00000000.tx.24: This motif is recognized by xylosyltransferase that attaches a chondroitin sulfate glycosaminoglycan chain via xylose to the serine residue of the ENEGSG sequence. 

Phrase: "This motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514562:Motif [Amino Acid Sequence]

Phrase: "is"

Phrase: "recognized by xylosyltransferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0149066:xylosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "attaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231441:Attach [Finding]
  1000   C1314972:ATTACH [Intellectual Product]

Phrase: "a chondroitin sulfate glycosaminoglycan chain via xylose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0337112:Chain [Manufactured Object]
   748   C1524075:Chain [Idea or Concept]

Phrase: "to the serine residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "of the ENEGSG sequence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.25: Chondroitin sulfate glycosaminoglycan chain-modified L-APP is denoted as appican (12, 13). 

Phrase: "Chondroitin sulfate glycosaminoglycan chain-modified L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   827   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   817   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   807   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0011560:Amyloid [Pathologic Function]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "denoted as appican"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0297349:appican [Amino Acid, Peptide, or Protein]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.26: The biological function of appican is not known, but it may be similar to the function of other chondroitin sulfate proteoglycans in biological processes as wound healing, cell adhesion, neurite outgrowth, and axon guidance (14-16). 

Phrase: "The biological function of appican"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0031845:Biological function, NOS [Physiologic Function]
   760   C0005532:Biological [Biomedical Occupation or Discipline]
   760   C0031843:function [Physiologic Function]
   760   C0205460:biological [Qualitative Concept]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "similar to the function of other chondroitin sulfate proteoglycans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2348205:Similar [Qualitative Concept]

Phrase: "in biological processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031845:Biological Processes [Physiologic Function]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "as wound healing,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "cell adhesion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007577:Cell Adhesion [Cell Function]
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "neurite outgrowth,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]

Phrase: "and"

Phrase: "axon guidance"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2984268:Axon guidance [Cell Function]
   964 E C0598948:axonal guidance [Cell Function]
   861   C0150600:Guidance [Health Care Activity]
   861   C1959633:Guidance [Clinical Attribute]

Phrase: "(14-16"

Phrase: ")."
Processing 00000000.tx.27: Evidence for appican function in mediating cell adhesion came from expression studies on appican in rat C6 glioma cells. 

Phrase: "Evidence for appican function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "in"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "cell adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007577:Cell Adhesion [Cell Function]
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "came from expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "studies on appican"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0297349:appican [Amino Acid, Peptide, or Protein]
   790   C0557651:Study [Manufactured Object]
   790   C0947630:studies [Laboratory Procedure]
   790   C2603343:Study [Research Activity]

Phrase: "in rat C6 glioma cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0007634:Cells [Cell]
   812   C0017638:Glioma [Neoplastic Process]
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
   812   C0555198:[M]Glioma NOS [Neoplastic Process]
   812   C2984291:Glioma [Functional Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.28: Appican-expressing cells attach more avidly to substrate surface than untransfected cells (17). 

Phrase: "Appican-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "attach"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231441:Attach [Finding]
  1000   C1314972:ATTACH [Intellectual Product]

Phrase: "more avidly to substrate surface"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205148:Surface [Spatial Concept]
   760   C0205172:More [Functional Concept]
   760   C1710236:Substrate [Manufactured Object]

Phrase: "than untransfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.29: In former cells appican is enriched in the extracellular matrix and displays adhesion-promoting properties for neuronal cells (17). 

Phrase: "In former cells appican"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0297349:appican [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "enriched in the extracellular matrix"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0015350:Extracellular Matrix [Tissue]
   760   C0359583:enriched [Food]
   760   C0521119:Extracellular [Cell Component]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "adhesion-promoting properties for neuronal cells"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.30: Furthermore, alternative splicing of exon 15regulates the basolateral and apical secretion of APP and L-APP isoforms in polarized Madin-Darby canine kidney II cells by either creating a new apical or destroying a basolateral sorting signal in L-APP molecules, respectively (18). 

Phrase: "Furthermore,"

Phrase: "alternative splicing of exon 15regulates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0002345:Alternative Splicing [Genetic Function]
   760   C0035687:Splicing [Genetic Function]
   760   C2610186:splicing [Genetic Function]

Phrase: "the basolateral"

Phrase: "and"

Phrase: "apical secretion of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "L-APP isoforms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "in polarized Madin-Darby canine kidney II cells"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   911   C0598829:Madin Darby Canine Kidney Cells [Cell]
   876   C0598102:polarized cell [Cell]
   813   C0553257:kidney cell [Cell]
   795   C0007634:Cells [Cell]
   795   C0012984:Canine, NOS [Mammal]
   795   C0022646:Kidney [Body Part, Organ, or Organ Component]
   795   C0227665:kidney [Body Part, Organ, or Organ Component]
   795   C1278978:Kidney [Body Part, Organ, or Organ Component]
   795   C1280551:Canine [Mammal]
   795   C1514845:KIDNEY [Tissue]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]
   703 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "by either"

Phrase: "creating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706214:Create [Activity]
   966   C3244320:create [Functional Concept]

Phrase: "a new apical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205111:Apical [Spatial Concept]

Phrase: "or"

Phrase: "destroying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Destroy [Idea or Concept]

Phrase: "a basolateral sorting signal in L-APP molecules,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   782   C1522688:Basolateral Sorting Signal [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   777   C0887827:Sorting Signal, Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1710082:Signal [Phenomenon or Process]

Phrase: "respectively"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.31: In context of Alzheimer's disease pathogenesis it is relevant that exclusion of the region encoded by exon 15from the mature APP also affects its processing to the A peptide by decreasing the relative amount of generated A (18). 

Phrase: "In context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of Alzheimer's disease pathogenesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0543483:pathogenesis [Functional Concept]
   827   C0699748:Pathogenesis [Pathologic Function]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "it"

Phrase: "is"

Phrase: "relevant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347946:Relevant [Qualitative Concept]

Phrase: "that exclusion of the region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0680251:EXCLUSION [Functional Concept]
   760   C2828389:Exclusion [Activity]

Phrase: "encoded by exon 15from"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0679058:encoded [Mental Process]
   770   C2700640:Encoded [Activity]

Phrase: "the mature APP also"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "its processing to the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709694:Processing [Activity]

Phrase: "A peptide by decreasing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "the relative amount of generated A (18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.32: In order to get some insight into the splicing regulation of exon 15,in the present study we performed a molecular analysis of this splicing process. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "get"

Phrase: "some insight into the splicing regulation of exon 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0233820:Insight [Mental Process]

Phrase: "in the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a molecular analysis of this splicing process."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1513380:Molecular Analysis [Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.33: We demonstrate that the cell type-specific recognition of exon 15in non-neuronal and neuronal cells is conserved between mouse and rat. 

Phrase: "We"

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the cell type-specific recognition of exon 15in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0678836:cell recognition [Cell Function]
   744   C0524637:Recognition [Mental Process]

Phrase: "non-neuronal"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518422:Non [Functional Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "neuronal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "conserved between mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]
Processing 00000000.tx.34: To characterize the regulatory requirements for the cell type-specific usage of exon 15,an APP minigene expression system was established in murine cell lines NIH3T3 and P19. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "the regulatory requirements for the cell type-specific usage of exon 15,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1553903:regulatory requirement [Idea or Concept]
   703   C1514873:Requirement [Functional Concept]

Phrase: "an APP minigene expression system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "was"

Phrase: "established in murine cell lines NIH3T3"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   804   C0598089:established cell line [Cell]
   790   C0007600:Cell lines [Cell]
   783   C1257739:Cell, NIH-3T3 [Cell]
           NIH/3T3
   753   C0007634:Cell [Cell]
   753   C0026809:Murine [Mammal]
   753   C0205132:lines [Spatial Concept]
   753   C0443211:Established [Qualitative Concept]
   753   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   753   C1269647:Cell [Cell]
   753   C1272684:Established [Qualitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "P19."
Processing 00000000.tx.35: By using this approach we were able to identify two intronic regions flanking exon 15,which we refer to as "upstream control region" (UCR) and "downstream control region" (DCR). 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "identify"

Phrase: "two intronic regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "exon 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "we"

Phrase: "refer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205543:refer [Functional Concept]

Phrase: "to as ""upstream control region"" (UCR)"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   853   C1883644:Upstream Region [Nucleotide Sequence]
   804   C0017446:Region [Geographic Area]
   804   C0205147:Region [Spatial Concept]
   733 E C0205276:Regional [Spatial Concept]
   733 E C1947913:Regional [Spatial Concept]

Phrase: "and """

Phrase: "downstream control region"" (DCR)."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.36: Finally, we present evidence that both intronic regions play a key role for the cell type-specific exclusion of exon 15in APP mRNA molecules in non-neuronal cells.  

Phrase: "Finally,"

Phrase: "we"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "both intronic regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a key role for the cell type-specific exclusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "of exon 15in APP mRNA molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0567416:molecules [Substance]
   712 E C1521991:Molecular [Qualitative Concept]

Phrase: "in non-neuronal cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.37: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Animals and Tissue Preparation-- All tissues were prepared from 2-to 3-month-old female NMRI mice, provided by the animal facility of Center for Molecular Biology, Heidelberg, Germany. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "Tissue Preparation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0200728:Tissue Preparation [Laboratory Procedure]
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "All tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "prepared from 2-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: "to 3-month-old female NMRI mice,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0024485:NMRI [Diagnostic Procedure]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   799   C1513846:NMRI [Mammal]
           NMRI Mouse

Phrase: "provided by the animal facility of Center"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0872329:animal facility [Manufactured Object]
   748   C0003062:Animal [Animal]
   748   C0205099:Center [Spatial Concept]
   748   C1547538:Facility [Idea or Concept]
   748   C1999230:Provided [Activity]

Phrase: "for Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Heidelberg,"

Phrase: "Germany."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]
Processing 00000000.tx.38: The animals were killed by cervical dislocation, and the tissues were immediately removed, washed in ice-cold phosphate-buffered saline, and quickly frozen in liquid nitrogen. 

Phrase: "The animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "killed by cervical dislocation,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C2983594:Cervical Dislocation [Research Activity]
   770   C0012691:Dislocation [Injury or Poisoning]
   770   C0027530:Cervical [Body Location or Region]
   770   C0162388:killed [Social Behavior]
   770   C0205064:Cervical [Spatial Concept]
   737 E C0681205:Kill [Idea or Concept]
   737 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "the tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "washed in ice-cold phosphate-buffered saline,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0456963:Ice cold [Qualitative Concept]
   774   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0020746:Ice [Inorganic Chemical]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0036082:Saline [Substance]
   748   C0234192:Cold [Physiologic Function]
   748   C1548982:Washed [Idea or Concept]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   714 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "quickly"

Phrase: "frozen in liquid nitrogen."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]
Processing 00000000.tx.39: Cell Culture Conditions-- The following murine cell lines NIH3T3, P19, N2a, and AtT20 were cultured in Dulbecco's modified Eagle's medium plus 10% fetal calf serum (Sigma and Boehringer Ingelheim) as adherent monolayers on 10-cm tissue culture dishes at 37C under 5% CO2 atmosphere. 

Phrase: "Cell Culture Conditions"
Meta Candidates (Total=21; Excluded=9; Pruned=0; Remaining=12)
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   771 E C0040607:Training [Educational Activity]
   771 E C0220931:Training [Educational Activity]
   771 E C0336809:Train [Manufactured Object]
   771 E C1552514:Train [Manufactured Object]
   771 E C2673163:training [Qualitative Concept]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "-"

Phrase: "-"

Phrase: "The following murine cell lines NIH3T3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1257739:NIH/3T3 [Cell]

Phrase: "P19,"

Phrase: "N2a,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445079:N2a [Finding]

Phrase: "and"

Phrase: "AtT20"

Phrase: "were"

Phrase: "cultured in Dulbecco's modified Eagle's medium plus 10% fetal calf serum"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   738   C0009458:Medium [Intellectual Product]
   738   C0015965:Fetal [Embryonic Structure]
   738   C0229671:Serum [Body Substance]
   738   C0230445:Calf [Body Location or Region]
   738   C0325564:Eagle [Bird]
   738   C0332287:Plus [Qualitative Concept]
   738   C0392747:Modified [Functional Concept]
   738   C0439536:Medium [Quantitative Concept]
   738   C0521457:Fetal [Functional Concept]
   738   C1305418:Calf [Body Part, Organ, or Organ Component]
   738   C1546774:Serum [Intellectual Product]
   738   C1550100:Serum [Body Substance]
   738   C1551720:Eagle [Population Group]
   738   C1705217:Medium [Substance]
   738   C3244283:medium [Intellectual Product]
   737   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   704   C0010453:Culture [Idea or Concept]
   704   C0220814:culture [Functional Concept]
   704   C0430400:Culture [Laboratory Procedure]
   704   C2242979:Culture [Laboratory Procedure]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "and"

Phrase: "Boehringer Ingelheim"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331792:Boehringer Ingelheim [Health Care Related Organization]

Phrase: ")"

Phrase: "as adherent monolayers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872351:monolayers [Clinical Drug]

Phrase: "on 10-cm tissue culture dishes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C0492792:DISH, TISSUE CULTURE [Medical Device]
   771   C0020498:DISH [Disease or Syndrome]

Phrase: "at 37C"

Phrase: "under 5% CO2 atmosphere."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0004178:Atmosphere [Natural Phenomenon or Process]
   827   C0678214:atmosphere [Quantitative Concept]
Processing 00000000.tx.40: Isolation of Genomic Clones-- The genomic APP clone L12 (Fig. 2A) was isolated from a Lambda Fix II 129SVJ mouse genomic library (Stratagene) using an -32P-labeled human APP cDNA probe encoding exons 14-17. 

Phrase: "Isolation of Genomic Clones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0204727:Isolation [Therapeutic or Preventive Procedure]
   770   C0205409:Isolation [Functional Concept]
   770   C0220862:isolation [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "The genomic APP clone L12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1419629:L12 [Gene or Genome]
   799   C1539707:L12 [Gene or Genome]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "was"

Phrase: "isolated from a Lambda Fix II 129SVJ mouse genomic library"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   760   C0017430:Genomic Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0017428:Genomic [Gene or Genome]
   739   C0023621:Library [Manufactured Object,Organization]
   739   C0025914:Mouse [Mammal]
   739   C0025929:mouse [Mammal]
   739   C0026809:Mouse [Mammal]
   739   C0205409:Isolated [Functional Concept]
   739   C0231441:Fix [Finding]
   739   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0887950:genomic [Biomedical Occupation or Discipline]
   739   C0926407:Lambda [Body Location or Region]
   739   C1548221:Isolated [Idea or Concept]
   739   C1706314:Lambda [Idea or Concept]
   739   C1720314:Lambda [Intellectual Product]
   739   C3539736:LAMBDA [Spatial Concept]
   706 E C0370215:Isolate [Substance]
   706 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(Stratagene"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an -32P-labeled human APP cDNA probe encoding exons 14-17."
Meta Candidates (Total=23; Excluded=2; Pruned=0; Remaining=21)
   816   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   812   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   807   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   787   C0011560:Amyloid [Pathologic Function]
   787   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   787   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0086418:Human [Human]
   787   C0182400:Probe [Medical Device]
   787   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C1547699:Encoding [Idea or Concept]
   787   C1553631:32p [Medical Device]
   787   C1704681:Probe [Gene or Genome]
   787   C1708632:Labeled [Qualitative Concept]
   787   C1709634:Precursor [Idea or Concept]
   787   C2347609:Probe [Chemical Viewed Functionally]
   787   C2700640:Encoding [Activity]
   787   C3536729:Probe [Manufactured Object]
   754 E C0181496:Label [Manufactured Object]
   754 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.41: Minigene Constructs-- All clones were created by using standard methods (19). 

Phrase: "Minigene Constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "-"

Phrase: "-"

Phrase: "All clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "created by"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1707531:Created By [Qualitative Concept]
   833   C1706214:Created [Activity]
   799 E C3244320:create [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.42: For cloning the APP minigene MG1, two DNA fragments of the genomic APP clone L12 were used (Fig. 2A) as follows: fragment I, SacI site of exon 14to XbaI site of intron 14(~5.5 kb), and fragment II, XbaI site of intron 14to EcoRI site of exon 16(~6.9 kb) (Fig. 2A). 

Phrase: "For cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "the APP minigene MG1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1417498:MG1 [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "two DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "fragments of the genomic APP clone L12"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0009013:Clone [Cell]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0017428:Genomic [Gene or Genome]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0332255:fragment [Functional Concept]
   742   C0486805:Fragments [Body Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0887950:genomic [Biomedical Occupation or Discipline]
   742   C1419629:L12 [Gene or Genome]
   742   C1522642:Clone [Tissue]
   742   C1539707:L12 [Gene or Genome]
   742   C1708096:Fragment [Qualitative Concept]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "fragment I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "SacI site of exon 14to XbaI site of intron 14"

Phrase: "(~5.5 kb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0450380:5/5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "fragment II,"

Phrase: "XbaI site of intron 14to EcoRI site of exon 16"

Phrase: "(~6.9 kb) (Fig. 2A"

Phrase: ")."
Processing 00000000.tx.43: The recipient vector pSKE1416X for fragment I and II was created by inserting a mouse APP cDNA fragment (exons 14-16) that was amplified by PCR using the primer pair sE14EcoRV (5'-ACGATTGATATCATGAGCTGCTTCAGAAGGAGC-3') and aE16XhoI (5'-AGCACCCTCGAGCAGTTTTTGATGGCGGACTTC-5'; 

Phrase: "The recipient vector pSKE1416X for fragment I"

Phrase: "and"

Phrase: "II"

Phrase: "was"

Phrase: "created by inserting"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C1707531:Created By [Qualitative Concept]
   790   C1706214:Created [Activity]
   756   C0441587:Insert [Health Care Activity]
   756   C1743766:Insert [Medical Device]
   756   C1883719:Insert [Functional Concept]
   756 E C3244320:create [Functional Concept]

Phrase: "a mouse APP cDNA fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "(exons 14-16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "that"

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the primer pair sE14EcoRV"

Phrase: "(5'-ACGATTGATATCATGAGCTGCTTCAGAAGGAGC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "aE16XhoI"

Phrase: "(5'-AGCACCCTCGAGCAGTTTTTGATGGCGGACTTC-5'"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0450380:5/5 [Quantitative Concept]
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.44: boldface nucleotides indicate restriction sites) in the EcoRV and XhoI site of a Bluescript (SK+) plasmid. 

Phrase: "boldface nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "indicate"

Phrase: "restriction sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   966   C1882940:Restriction Site [Nucleotide Sequence]
   861   C0205145:Sites [Spatial Concept]
   861   C0443288:Restriction [Functional Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: "in the EcoRV"

Phrase: "and"

Phrase: "XhoI site of a Bluescript"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2945843:Site of [Qualitative Concept]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "(SK+) plasmid."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.45: Finally, an XbaI polylinker was introduced between the SacI (exon 14) and EcoRI (exon 16) sites of the APP cDNA fragment. 

Phrase: "Finally,"

Phrase: "an XbaI polylinker"

Phrase: "was"

Phrase: "introduced between the SacI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1519179:SACI [Health Care Related Organization]
   770   C1854580:SACI [Gene or Genome]
   737   C1292748:introduce [Functional Concept]

Phrase: "(exon 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "and"

Phrase: "EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(exon 16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "sites of the APP cDNA fragment."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   754   C2945843:Site of [Qualitative Concept]
   744   C0205145:Sites [Spatial Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.46: Fragment II was introduced into the EcoRI and XbaI site of pSKE1416X generating the pSK1516X plasmid. 

Phrase: "Fragment II"

Phrase: "was"

Phrase: "introduced into the EcoRI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   737   C1292748:introduce [Functional Concept]

Phrase: "and"

Phrase: "XbaI site of pSKE1416X"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2945843:Site of [Qualitative Concept]
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C2825164:Site [Spatial Concept]

Phrase: "generating"

Phrase: "the pSK1516X plasmid."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.47: Afterward fragment I was inserted into SacI and XbaI site of pSK1516X producing the APP minigene pSKMG1. 

Phrase: "Afterward fragment I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "inserted into SacI"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0441587:Inserted [Health Care Activity]
   790   C1519179:SACI [Health Care Related Organization]
   790   C1854580:SACI [Gene or Genome]
   756 E C1743766:Insert [Medical Device]
   756 E C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "XbaI site of pSK1516X"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2945843:Site of [Qualitative Concept]
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C2825164:Site [Spatial Concept]

Phrase: "producing"

Phrase: "the APP minigene pSKMG1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.48: The EcoRV/XhoI fragment of pSKMG1 was inserted into the ScaI/XhoI site of the mammalian expression vector pZeoSV (Invitrogen) generating the APP minigene MG1. 

Phrase: "The EcoRV/XhoI fragment of pSKMG1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "inserted into the ScaI/XhoI site of the mammalian expression vector pZeoSV"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   753   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C2945843:Site of [Qualitative Concept]
   736   C0024660:Mammalian [Mammal]
   736   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
   736   C0205145:Site [Spatial Concept]
   736   C0441587:Inserted [Health Care Activity]
   736   C0442335:Vector [Spatial Concept]
   736   C1515974:Site [Body Location or Region]
   736   C1538353:SCAI [Gene or Genome]
   736   C1705099:Vector [Idea or Concept]
   736   C2825164:Site [Spatial Concept]
   734   C1705686:Insert Site [Nucleotide Sequence]
   703 E C1743766:Insert [Medical Device]
   703 E C1883719:Insert [Functional Concept]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "generating"

Phrase: "the APP minigene MG1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1417498:MG1 [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.49: All cloning steps were controlled by DNA sequencing. 

Phrase: "All cloning steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "were"

Phrase: "controlled by DNA sequencing."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C0162326:DNA sequencing [Nucleotide Sequence]
   833   C0332298:Controlled by [Functional Concept]
   833   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   770   C2587213:Controlled [Functional Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C1550141:Control [Substance]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]
Processing 00000000.tx.50: MG2 was constructed by deleting a 2.8-kb NcoI DNA fragment from pSK1516X, followed by a religation and exchanging the wild type XbaI/XhoI fragment of MG1 against the shortened one of pSK1516X. 

Phrase: "MG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "constructed by deleting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1880274:Delete [Activity]
   756   C2827421:Construct [Classification]

Phrase: "a 2.8-kb NcoI DNA fragment from pSK1516X,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332255:fragment [Functional Concept]
   742   C1708096:Fragment [Qualitative Concept]

Phrase: "followed by a religation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "exchanging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678640:exchanging [Social Behavior]

Phrase: "the wild type XbaI/XhoI fragment of MG1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "against the shortened one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "of pSK1516X."
Processing 00000000.tx.51: Deletions constructs A1 to A6 and B1 to B8 were generated by PCR cloning, amplifying 5'- or 3'-truncated PacI/AflII fragments (Figs. 4 and 5). 

Phrase: "Deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880274:Deletions [Activity]
   966 E C1442161:Deletion [Cell or Molecular Dysfunction]
   966 E C1511760:Deletion [Genetic Function]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "A1 to A6"

Phrase: "and"

Phrase: "B1 to B8"

Phrase: "were"

Phrase: "generated by PCR cloning,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0009015:Cloning [Research Activity]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C3146294:Generated [Activity]

Phrase: "amplifying"

Phrase: "5'-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "or"

Phrase: "3'-truncated PacI/AflII fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0332255:fragments [Functional Concept]
   804   C0486805:Fragments [Body Substance]
   771 E C1708096:Fragment [Qualitative Concept]

Phrase: "(Figs. 4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.52: Minigene constructs UCR, DCR, dUCR, dDCR, UCR1, DCR1, RCU, RCD, M2, and PM34.1 were produced by using a recombinant PCR approach. 

Phrase: "Minigene"

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "UCR,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "DCR,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "dUCR,"

Phrase: "dDCR,"

Phrase: "UCR1,"

Phrase: "DCR1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1333218:DCR1 [Gene or Genome]
  1000   C1420803:DCR1 [Gene or Genome]
  1000   C1720962:DcR1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C3539668:DCR1 [Gene or Genome]

Phrase: "RCU,"

Phrase: "RCD,"

Phrase: "M2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: "and"

Phrase: "PM34.1"

Phrase: "were"

Phrase: "produced by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a recombinant PCR approach."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.53: Mutagenized PacI/AflII fragments of the genomic APP region were inserted in the parental APP minigene MG2. 

Phrase: "Mutagenized PacI/AflII"

Phrase: "fragments of the genomic APP region"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1514562:Protein Region [Amino Acid Sequence]
   767   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0017428:Genomic [Gene or Genome]
   744   C0017446:Region [Geographic Area]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205147:Region [Spatial Concept]
   744   C0332255:fragment [Functional Concept]
   744   C0486805:Fragments [Body Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0887950:genomic [Biomedical Occupation or Discipline]
   744   C1708096:Fragment [Qualitative Concept]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "were"

Phrase: "inserted in the parental APP minigene MG2."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0030551:Parental [Family Group]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0441587:Inserted [Health Care Activity]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1417500:MG2 [Gene or Genome]
   742   C1709634:Precursor [Idea or Concept]
   742   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   708 E C1743766:Insert [Medical Device]
   708 E C1883719:Insert [Functional Concept]
Processing 00000000.tx.54: Point mutations PM13, PM14, PM15, PM23, PM25, PM26, and PM35 were introduced in the PacI/AflII fragment of MG2 by a modified protocol of the megaprimer PCR method (20). 

Phrase: "Point mutations PM13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0162735:Point Mutations [Cell or Molecular Dysfunction]

Phrase: "PM14,"

Phrase: "PM15,"

Phrase: "PM23,"

Phrase: "PM25,"

Phrase: "PM26,"

Phrase: "and"

Phrase: "PM35"

Phrase: "were"

Phrase: "introduced in the PacI/AflII fragment of MG2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0332255:fragment [Functional Concept]
   744   C1165245:paci [Immunologic Factor,Pharmacologic Substance]
   744   C1417500:MG2 [Gene or Genome]
   744   C1708096:Fragment [Qualitative Concept]
   744   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   711   C1292748:introduce [Functional Concept]

Phrase: "by a modified protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "of the megaprimer PCR method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.55: Instead of Taq DNA polymerase we used Pfu DNA polymerase (Stratagene), and therefore no Klenow treatment of newly synthesized megaprimer was necessary. 

Phrase: "Instead of Taq DNA polymerase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0075813:Taq DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           Taq Polymerase
  1000   C2257065:Taq DNA polymerase [Genetic Function]
   901   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Pfu DNA polymerase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0136227:Pfu DNA polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           Pfu polymerase
   901   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Stratagene"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "therefore"

Phrase: "no Klenow treatment of newly synthesized megaprimer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0746919:NO TREATMENT [Finding]
   774   C3275118:NO TREATMENT [Finding]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "was"

Phrase: "necessary."
Processing 00000000.tx.56: All introduced mutations were confirmed by sequencing. 

Phrase: "All introduced mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "confirmed by sequencing."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.57: MG4 was generated by PCR using the primer pair sxE15EcoRV (5'-ACGATTGATATCGTGAATGCGTCTGTTCCA-3'), axE17XhoI (5'-AGCACCCTCGAGTCAGGGTCGTTCCTCCAG-3'; 

Phrase: "MG4"

Phrase: "was"

Phrase: "generated by PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the primer pair sxE15EcoRV"

Phrase: "(5'-ACGATTGATATCGTGAATGCGTCTGTTCCA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "axE17XhoI"

Phrase: "(5'-AGCACCCTCGAGTCAGGGTCGTTCCTCCAG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.58: bold-face nucleotides mark restriction sites), and a human genomic DNA preparation as template. 

Phrase: "bold-face nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "mark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "restriction sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   966   C1882940:Restriction Site [Nucleotide Sequence]
   861   C0205145:Sites [Spatial Concept]
   861   C0443288:Restriction [Functional Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a human genomic DNA preparation as template."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0455052:Preparation [Health Care Activity]
   748   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.59: The PCR product was inserted into the ScaI/XhoI sites of the pZeoSV vector. 

Phrase: "The PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "inserted into the ScaI/XhoI sites of the pZeoSV vector."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   743   C2945843:Site of [Qualitative Concept]
   739   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205145:Sites [Spatial Concept]
   739   C0441587:Inserted [Health Care Activity]
   739   C0442335:Vector [Spatial Concept]
   739   C1538353:SCAI [Gene or Genome]
   739   C1705099:Vector [Idea or Concept]
   724   C1705686:Insert Site [Nucleotide Sequence]
   706 E C1515974:Site [Body Location or Region]
   706 E C1743766:Insert [Medical Device]
   706 E C1883719:Insert [Functional Concept]
   706 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.60: E1690 was produced by deleting a 90-bp DNA fragment in exon 16of MG4 by recombinant PCR. 

Phrase: "E1690"

Phrase: "was"

Phrase: "produced by deleting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1880274:Delete [Activity]

Phrase: "a 90-bp DNA fragment in exon 16of MG4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332255:fragment [Functional Concept]
   742   C1708096:Fragment [Qualitative Concept]

Phrase: "by recombinant PCR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]
Processing 00000000.tx.61: For creating the chimeric constructs C1 and C2, the genomic APP DNA fragments shown in Fig. 

Phrase: "For creating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706214:Create [Activity]
   966   C3244320:create [Functional Concept]

Phrase: "the chimeric constructs C1"

Phrase: "and"

Phrase: "C2,"

Phrase: "the genomic APP DNA fragments"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0684192:DNA fragments [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   822   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   766 E C1708096:Fragment [Qualitative Concept]
   709   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.62: 8A were fused by recombinant PCR to construct E1690. 

Phrase: "8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553640:8a [Medical Device]

Phrase: "were"

Phrase: "fused by recombinant PCR to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0677874:pCR [Finding]
   760   C0699952:Fused [Functional Concept]
   760   C1514798:recombinant [Organism]
   726 E C1414861:FUSE [Gene or Genome]
   726 E C1708111:Fuse [Manufactured Object]

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "E1690."
Processing 00000000.tx.63: Detailed PCR strategies and oligonucleotide sequences are available on request. 

Phrase: "Detailed PCR strategies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategies [Mental Process]

Phrase: "and"

Phrase: "oligonucleotide sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "available on request."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]
Processing 00000000.tx.64: DNA Transfection and Total RNA Preparation-- The P19 and NIH3T3 cells were transfected by the calcium phosphate coprecipitation method. 

Phrase: "DNA Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "Total RNA Preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The P19"

Phrase: "and"

Phrase: "NIH3T3 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected by the calcium phosphate coprecipitation method."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0006711:calcium phosphate [Inorganic Chemical,Pharmacologic Substance]
   778   C0006712:Calcium/Phosphate [Inorganic Chemical,Pharmacologic Substance]
   778   C1161320:calcium phosphate [Pharmacologic Substance]
   748   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0006726:Calcium [Inorganic Chemical]
   748   C0025663:Method [Intellectual Product]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0301915:Coprecipitation [Molecular Function]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   748   C2936886:Calcium [Pharmacologic Substance]
Processing 00000000.tx.65: One 10-cm dish of 15% confluent cells was transfected with 10g of plasmid DNA. 

Phrase: "One 10-cm dish of 15% confluent cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C2347576:Cells/dish [Quantitative Concept]
   744   C0020498:DISH [Disease or Syndrome]

Phrase: "was"

Phrase: "transfected with 10g of plasmid DNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.66: Each transfection was performed at duplication. 

Phrase: "Each transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "performed at duplication."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332597:Duplication [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C1705960:Duplication [Cell or Molecular Dysfunction]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.67: 48h after transfection cells were washed three times with ice-cold phosphate-buffered saline and harvested. 

Phrase: "48h after transfection cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1442464:48H [Temporal Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with ice-cold phosphate-buffered saline"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0040223:times [Temporal Concept]
   744   C1632851:Times [Quantitative Concept]
   711 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "harvested."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]
Processing 00000000.tx.68: The total RNA was isolated by using RNeasy columns (Qiagen) or High Pure total RNA Isolation columns (Roche Molecular Biochemicals) according to the manufacturer's protocol. 

Phrase: "The total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated by"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0205409:Isolated [Functional Concept]
   833   C1548221:Isolated [Idea or Concept]
   799 E C0370215:Isolate [Substance]
   799 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RNeasy columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "(Qiagen"

Phrase: ")"

Phrase: "or"

Phrase: "High Pure total RNA Isolation columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C1185738:Column [Body Part, Organ, or Organ Component]
   766   C1706132:Column [Idea or Concept]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: "according to the manufacturer's protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.69: Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)-- In general for first-strand cDNA synthesis 2g of total RNA preparations were reverse-transcribed with 200units of SuperScriptTM (Life Technologies, Inc.) and 50pmol of oligo(dT)17 in a total reaction volume of 20l under the conditions provided by the manufacturer's protocol. 

Phrase: "Reverse Transcriptase-Polymerase Chain Reaction"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]
   804   C2257077:transcriptase [Genetic Function]

Phrase: "(RT-PCR)-- In general"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]

Phrase: "for first-strand cDNA synthesis 2g"

Phrase: "of total RNA preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "reverse-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed with 200units of SuperScriptTM"

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "and"

Phrase: "50pmol of oligo(dT)17"

Phrase: "in a total reaction volume"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0449468:Total Volume [Quantitative Concept]
           *Volume
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: "of 20l"

Phrase: "under the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "provided by the manufacturer's protocol."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0442711:Protocol [Intellectual Product]
   760   C0947322:Manufacturer [Intellectual Product]
   760   C1507394:Protocol [Intellectual Product]
   760   C1522729:Protocol [Intellectual Product]
   760   C1705426:Manufacturer [Population Group]
   760   C1999230:Provided [Activity]
   760   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.70: To verify the endogenous APP mRNA splicing pattern, a PCR reaction with the primer pair sm1805 (5'-AGGAGATTCAAGATGAAGTCG-3', last 21nt of exon 13) and am2225 (5'-CCCACATCTTCAGCAAAGAAC-3', first 21nt of exon 17) was performed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "the endogenous APP mRNA splicing pattern,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C1317658:Protein pattern [Clinical Attribute]
   795   C0449774:Pattern [Spatial Concept]

Phrase: "a PCR reaction with the primer pair sm1805"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]

Phrase: "(5'-AGGAGATTCAAGATGAAGTCG-3',"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "last 21nt of exon 13"

Phrase: ")"

Phrase: "and"

Phrase: "am2225"

Phrase: "(5'-CCCACATCTTCAGCAAAGAAC-3',"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "first 21nt of exon 17"

Phrase: ")"

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.71: To measure the level of minigene-derived mRNA isoforms, the primer pair spZEO1 (5'-AGCTATTCCAGAAGTAGTGAG-3') and apZEO2 (5'-GACACTATAGAACAGCTGATC-3') was used, recognizing unique sequences in the pZeoSV vector. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the level of minigene-derived mRNA isoforms,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "the primer pair spZEO1"

Phrase: "(5'-AGCTATTCCAGAAGTAGTGAG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "apZEO2"

Phrase: "(5'-GACACTATAGAACAGCTGATC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "recognizing"

Phrase: "unique sequences in the pZeoSV vector."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0162326:Sequences [Nucleotide Sequence]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]
Processing 00000000.tx.72: In a standard quantitative PCR reaction one-hundredth of a cDNA preparation was amplified in a Perkin-Elmer thermocycler 9600using the following reaction conditions: 200nM sense primer, 50nM 33P-end-labeled and 150nM unlabeled antisense primer, 0.2mM dNTP, 1.5mM MgCl2, and 2.5units of Taq DNA polymerase (Life Technologies, Inc.) with the supplied PCR buffer in a final reaction volume of 50l. 

Phrase: "In a standard quantitative PCR reaction one-hundredth"

Phrase: "of a cDNA preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "was"

Phrase: "amplified in a Perkin-Elmer thermocycler 9600using"

Phrase: "the following reaction conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: ":"

Phrase: "200nM sense primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "50nM 33P-end-"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0444930:End [Spatial Concept]
   827   C2746065:End [Temporal Concept]
   771 E C0205088:Terminal [Temporal Concept]
   771 E C1705314:Terminal [Manufactured Object]
   771 E C1705315:Terminal [Spatial Concept]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "150nM unlabeled antisense primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "0.2mM dNTP,"

Phrase: "1.5mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "2.5units of Taq DNA polymerase"

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.) with the supplied PCR buffer"

Phrase: "in a final reaction volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: "of 50l."
Processing 00000000.tx.73: Since pilot experiments showed that the PCR amplification rates of the endogenous APP transcripts and of the minigene-derived APP transcripts were linear between the 22nd and 28th cycle, we used the following cycle parameters in our quantitative RT-PCR assay: 94C 10s, 60C 15s, 72C 40s for 24cycles (endogenous APPex15/L-APP) and 26cycles (MG-APPex15/MG-L-APP) plus a final extension of 7min at 72C. 

Phrase: "Since"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711239:Since [Temporal Concept]

Phrase: "pilot"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0473169:Pilot [Professional or Occupational Group]
  1000   C1414316:PILOT [Gene or Genome]

Phrase: "experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the PCR amplification rates of the endogenous APP transcripts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   704   C0871208:Rate [Activity]
   704   C1521828:Rate [Quantitative Concept]

Phrase: "and of the minigene-derived APP transcripts"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1441547:Derived [Qualitative Concept]
   742   C1515981:And [Idea or Concept]
   742   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C1709634:Precursor [Idea or Concept]
   742   C3245521:derived [Idea or Concept]

Phrase: "were"

Phrase: "linear between the 22nd"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205132:Linear [Spatial Concept]

Phrase: "and"

Phrase: "28th cycle,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511572:Cycle [Temporal Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following cycle parameters in our quantitative RT-PCR assay"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C0449381:Parameters [Finding]
   706 E C0549193:Parameter [Spatial Concept]
   706 E C1704769:Parameter [Conceptual Entity]
   706 E C2350001:Parameter [Quantitative Concept]

Phrase: ":"

Phrase: "94C 10s,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552124:10s [Body Part, Organ, or Organ Component]

Phrase: "60C 15s,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552129:15s [Body Part, Organ, or Organ Component]

Phrase: "72C 40s for 24cycles"

Phrase: "(endogenous APPex15/L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "26cycles"

Phrase: "(MG-APPex15/MG-L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   845   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   845   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   829   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0011560:Amyloid [Pathologic Function]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "plus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332287:Plus [Qualitative Concept]

Phrase: "a final extension of 7min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231448:Extension [Functional Concept]
   760   C1880641:Extension [Conceptual Entity]

Phrase: "at 72C."
Processing 00000000.tx.74: Since the signals for MG-L-APP PCR product were very weak in the P19 cells, one-twenty-fifth of a cDNA preparation was amplified with spZEO1 and apZEO2 (pilot experiments showed that the amount of cDNA template did not change the ratio of both PCR products). 

Phrase: "Since"

Phrase: "the signals for MG-L-APP PCR product"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "very weak in the P19 cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004093:Weak [Sign or Symptom]
   753   C1762617:Weak [Qualitative Concept]

Phrase: "one-twenty-fifth of a cDNA preparation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205439:Fifth [Quantitative Concept]

Phrase: "was"

Phrase: "amplified with spZEO1"

Phrase: "and"

Phrase: "apZEO2"

Phrase: "(pilot experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the amount of cDNA template"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the ratio of both PCR products"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.75: Generated PCR products were separated electrophoretically on a 6% denaturing urea-polyacrylamide gel, and the dried gels were exposed to x-ray films (Kodak X-Omat AR) at room temperature between 2days and 2weeks. 

Phrase: "Generated PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "electrophoretically on a 6% denaturing urea-polyacrylamide gel,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   744   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   744   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "the dried gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "exposed to x-ray films"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   862   C0043303:X-Ray Films [Medical Device]
   806   C0034571:X-ray [Functional Concept]
   806   C0043299:X-ray, NOS [Diagnostic Procedure]
   806   C0043309:X-ray [Natural Phenomenon or Process]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   806   C1306645:X-ray [Diagnostic Procedure]
   806   C1962945:X-ray [Diagnostic Procedure]
   760   C0086296:Films [Manufactured Object]
   760   C0086894:ray [Fish]
   760   C0851346:ray [Natural Phenomenon or Process]
   760   C2314876:ray [Fish]
   726 E C1561571:film [Biomedical or Dental Material]
   726 E C1561572:film [Substance]

Phrase: "(Kodak X-Omat"

Phrase: "AR) at room temperature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986463:AR+ [Finding]

Phrase: "between 2days"

Phrase: "and"

Phrase: "2weeks."
Processing 00000000.tx.76: The amount of incorporated radioactivity was determined for each band by using a PhosphorImager (Molecular Dynamics) and the quant modus of the computer program Mac BAS 1.0.

Phrase: "The amount of incorporated radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "determined for each band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0175723:Band [Medical Device]
   770   C0439645:Band [Spatial Concept]
   770   C1521913:band [Cell Component]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PhosphorImager"

Phrase: "(Molecular Dynamics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: ")"

Phrase: "and"

Phrase: "the quant modus of the computer program Mac BAS 1.0."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1449955:Modus [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.77: For quantification each band was corrected by a corresponding background value, and the relative amount of both isoforms with (APPex15) and without exon 15(L-APP) was calculated to total APP (L-APP +APPex15).  

Phrase: "For quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantification [Quantitative Concept]

Phrase: "each band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "corrected by a corresponding background value,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0205202:Corrected [Qualitative Concept]
   753   C1522609:Value [Quantitative Concept]
   753   C1706907:Background [Conceptual Entity]
   719 E C2349182:Correct [Qualitative Concept]

Phrase: "and"

Phrase: "the relative amount of both isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "with"

Phrase: "(APPex15"

Phrase: ")"

Phrase: "and without exon 15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1515981:And [Idea or Concept]

Phrase: "(L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "calculated to total APP"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0439177:Protein.total [Quantitative Concept]
   783   C0555903:Total protein [Laboratory Procedure]
   783   C1261360:total protein [Laboratory or Test Result]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0444686:Calculated [Functional Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "(L-APP +APPex15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.78: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES APP mRNA Isoforms without Exon 15(L-APP) Are Ubiquitously Expressed in Murine Tissues, Including Brain, but Not in Neurons-- A previous report on the APP expression established the ubiquitous distribution of L-APP in rat tissues with the exception of primary cultured neurons (11). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "APP mRNA Isoforms without Exon 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C3178793:mRNA Isoforms [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   767   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms

Phrase: "(L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "Are"

Phrase: "Ubiquitously"

Phrase: "Expressed in Murine Tissues,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0026809:Murine [Mammal]
   770   C0040300:Tissues [Tissue]
   770   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "Including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "Not in Neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C1518422:Not [Functional Concept]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "-"

Phrase: "-"

Phrase: "A previous report on the APP expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0684224:Report [Intellectual Product]
   742   C0700287:Report [Health Care Activity]
   742   C3273238:Report [Intellectual Product]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "the ubiquitous distribution of L-APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0872250:protein distribution [Cell Function]
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "in rat tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of primary cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.79: Since in the present study we used the mouse system to identify cis-acting elements involved in the splicing regulation of exon 15,we first examined the expression pattern of exon 15-containing (APPex15) and lacking (L-APP) APP mRNA isoforms in a number of organs of three adult female mice. 

Phrase: "Since in the present study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1711239:Since [Temporal Concept]
   760   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the mouse system to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "identify"

Phrase: "cis-acting elements"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   988   C0599780:cis acting element [Nucleotide Sequence]
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "involved in the splicing regulation of exon 15,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0035687:Splicing [Genetic Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1314939:Involved [Functional Concept]
   744   C1327622:Regulation [Biologic Function]
   744   C2610186:splicing [Genetic Function]

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the expression pattern of exon 15-containing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Pattern [Spatial Concept]

Phrase: "(APPex15"

Phrase: ")"

Phrase: "and"

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "(L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "APP mRNA isoforms in a number of organs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C3178793:mRNA Isoforms [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   757   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms

Phrase: "of three adult female mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.80: To assay the relative amounts of APPex15 and L-APP in these murine tissues, cDNA was prepared and served as a template in a radioactive PCR using a primer pair flanking exon 15(Fig. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "the relative amounts of APPex15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "L-APP in these murine tissues,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "served as a template"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0728990:TEMPLATE [Medical Device]
   770   C1514575:Template [Conceptual Entity]
   770   C1705542:Template [Idea or Concept]

Phrase: "in a radioactive PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a primer pair flanking exon 15"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0230171:flanking [Body Location or Region]
   804   C1709450:Pair [Qualitative Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.81: 1A). 

Phrase: "1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.82: After separation of the radioactively labeled PCR products by denaturing polyacrylamide gel electrophoresis, two major bands of 420and 366bp were visible in the autoradiogram (Fig. 1B), corresponding to APPex15 and L-APP, respectively. 

Phrase: "After separation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036679:Separation [Pathologic Function]
  1000   C0237868:Separation [Social Behavior]
  1000   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "of the radioactively labeled PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "by denaturing polyacrylamide gel electrophoresis,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   861   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   812   C1382104:Gel [Substance]

Phrase: "two major bands of 420and 366bp"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0175723:Bands [Medical Device]
   719 E C0439645:Band [Spatial Concept]
   719 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "visible in the autoradiogram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205379:Visible [Qualitative Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "corresponding to APPex15"

Phrase: "and"

Phrase: "L-APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "respectively."
Processing 00000000.tx.83: The identity of these bands was confirmed by comparison with the mobility of DNA fragments amplified from corresponding plasmid standards and sequencing (data not shown). 

Phrase: "The identity of these bands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0424215:Identity [Mental Process]
   760   C2003939:Identity [Finding]

Phrase: "was"

Phrase: "confirmed by comparison with the mobility of DNA fragments"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   764   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   764   C0684192:DNA fragments [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0332255:fragments [Functional Concept]
   742   C0425245:Mobility [Finding]
   742   C0449580:Mobility [Qualitative Concept]
   742   C0486805:Fragments [Body Substance]
   742   C0750484:Confirmed [Idea or Concept]
   742   C1707455:Comparison [Activity]
   726   C0178868:mobile DNA [Gene or Genome]
   708 E C1456348:Confirm [Qualitative Concept]
   708 E C1708096:Fragment [Qualitative Concept]

Phrase: "amplified from corresponding plasmid standards"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0038137:standards [Intellectual Product]
   760   C0175675:Standards [Qualitative Concept]
   726 E C1442989:Standard [Qualitative Concept]
   726 E C2828392:Standard [Intellectual Product]

Phrase: "and"

Phrase: "sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.84: APPex15 and L-APP were present in all tested tissues (Fig. 1B, lanes 1-14). 

Phrase: "APPex15"

Phrase: "and"

Phrase: "L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "were"

Phrase: "present in all tested tissues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "lanes 1-14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.85: A quantitative determination of the relative L-APP amounts by phosphorimaging revealed that the relative L-APP portions in the non-neuronal tissues varied between 45% (adrenal gland) and 65% (lung) with the mean value of 55% (Table I). 

Phrase: "A quantitative determination of the relative L-APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1148554:determination [Laboratory Procedure]

Phrase: "amounts by phosphorimaging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1265611:Amount [Quantitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the relative L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "portions in the non-neuronal tissues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0040300:Tissues [Tissue]
   753   C0449719:Portion [Spatial Concept]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C1518422:Non [Functional Concept]
   719 E C1547928:Tissue [Intellectual Product]

Phrase: "varied between 45%"

Phrase: "(adrenal gland"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001625:Adrenal gland [Body Part, Organ, or Organ Component]
  1000   C1268989:Adrenal gland [Body Part, Organ, or Organ Component]
  1000   C1515890:GLAND, ADRENAL [Tissue]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "and"

Phrase: "65%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "(lung"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: ")"

Phrase: "with the mean value"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0444504:Mean [Quantitative Concept]
   861   C1522609:Value [Quantitative Concept]
   861   C2347634:Mean [Quantitative Concept]
   861   C2348143:Mean [Quantitative Concept]

Phrase: "of 55%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.86: In contrast, the relative intensities of the L-APP bands in cDNA preparations from cerebellum or cortex were markedly weaker (Fig. 1B, lanes 13and 14; Table I) consisting of 7or 8%, respectively, and suggesting a predominant production of APPex15 isoforms in the central nervous system. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the relative intensities of the L-APP bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0522510:intensities [Qualitative Concept]

Phrase: "in cDNA preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "from cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "or"

Phrase: "cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "were"

Phrase: "markedly weaker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0004093:Weak [Sign or Symptom]
   827   C1762617:Weak [Qualitative Concept]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "lanes 13and 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "; Table I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "consisting of 7or 8%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0332529:CONSIST [Qualitative Concept]

Phrase: "respectively,"

Phrase: "and"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a predominant production of APPex15 isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "in the central nervous system."
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.87: To clarify which cell types in the central nervous system contribute to L-APP production, primary cultures of embryonic mouse neurons (embryonal day 11) and primary cultures of microglial cells derived from newborn mice were cultured, and the relative APPex15 and L-APP amounts were measured by the quantitative RT-PCR assay described above. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "which cell types in the central nervous system"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   793   C0027882:nervous system cell [Cell]
           Nerve cell
   770   C0449475:Cell types [Intellectual Product]
   744   C0007634:Cell [Cell]
       E   Cell Type
   744   C0332307:Types [Qualitative Concept]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711 E C1547052:*Type [Quantitative Concept]

Phrase: "contribute to L-APP production,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033268:production [Occupational Activity]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]
   748   C1880177:Contribute [Activity]

Phrase: "primary cultures of embryonic mouse neurons"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0010453:Cultures [Idea or Concept]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "(embryonal day 11"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332173:/day [Temporal Concept]
   827   C0439228:day [Temporal Concept]
   827   C0439505:/day [Temporal Concept]
   727   C0013935:Embryonic [Embryonic Structure]

Phrase: ")"

Phrase: "and"

Phrase: "primary cultures of microglial cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   824   C1449562:Primary Cell Cultures [Laboratory Procedure]
   797   C0007585:cells cultures [Laboratory Procedure]
   760   C0010453:Cultures [Idea or Concept]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "derived from newborn mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0021289:Newborn [Age Group]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1441547:Derived [Qualitative Concept]
   770   C2239178:Newborn, NOS [Finding]
   770   C2939425:Newborn, NOS [Temporal Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: ","

Phrase: "and"

Phrase: "the relative APPex15"

Phrase: "and"

Phrase: "L-APP amounts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1265611:amounts [Quantitative Concept]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "were"

Phrase: "measured by the quantitative RT-PCR assay"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   814   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0243073:assay [Qualitative Concept]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0677874:pCR [Finding]
   748   C1510438:Assay [Laboratory Procedure]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.88: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.89: 1C, murine primary neurons do not synthesize detectable amounts of L-APP, whereas in microglial cells both APPex15 and L-APP are expressed, the latter accounting for more than a half of the total APP mRNA (Table I; Fig. 1C, compare lanes 16and 17). 

Phrase: "1C,"

Phrase: "murine primary neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "synthesize"

Phrase: "detectable amounts of L-APP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:amounts [Quantitative Concept]

Phrase: "whereas in microglial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   816   C0206116:Microglial cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0521398:Microglial [Body Location or Region]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "both APPex15"

Phrase: "and"

Phrase: "L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "are"

Phrase: "expressed"

Phrase: ","

Phrase: "the latter accounting for more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0000938:Accounting [Occupational Activity]

Phrase: "than a half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825407:Half [Quantitative Concept]

Phrase: "of the total APP mRNA (Table I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0021966:I- [Inorganic Chemical]
   795   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "; Fig. 1C,"

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 16and 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.90: Thus, L-APP is produced in murine brain exclusively by cells of non-neuronal origin, and skipping of exon 15appears to be a very rare event during post-transcriptional processing of APP pre-mRNA transcripts in neurons. 

Phrase: "Thus,"

Phrase: "L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "produced in murine brain exclusively"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0026809:Murine [Mammal]
   760   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "by cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "of non-neuronal origin,"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   827   C0079946:origin [Classification]
   827   C0439659:Origin [Temporal Concept]
   827   C1550512:origin [Intellectual Product]
   771 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   771 E C0314603:Genetic [Functional Concept]
   755 E C0205313:Original [Idea or Concept]
   755 E C2347409:Original [Occupational Activity]
   743 E C0005615:Birth [Organism Function]
   743 E C0035150:Reproduction [Organism Function]
   743 E C1550722:birth [Idea or Concept]
   743 E C3245487:birth [Intellectual Product]
   727 E C0454729:Natal [Geographic Area]
   727 E C0559522:Genital [Body System]
   727 E C0598240:originality [Mental Process]
   727 E C1546649:Genital [Intellectual Product]
   727 E C1550642:Genital [Body Substance]

Phrase: "and"

Phrase: "skipping of exon 15appears to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0560435:skipping [Finding]

Phrase: "be"

Phrase: "a very rare event during post-transcriptional processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1546087:post {event} [Clinical Attribute]
   744   C0441471:Event [Event]

Phrase: "of APP pre-mRNA transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.91: These results are consistent with the data reported by Sandbrink et al. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "reported by Sandbrink et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.92: (11) for rat tissues and suggest that exon 15splicing is regulated in a cell type-specific manner. 

Phrase: "(11"

Phrase: ")"

Phrase: "for rat tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that exon 15splicing"

Phrase: "is"

Phrase: "regulated in a cell type-specific manner."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0007634:Cell Type [Cell]
           Cell
   778   C0449475:cell type [Intellectual Product]
   748   C0205369:Specific [Qualitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0851285:Regulated [Governmental or Regulatory Activity]
   748   C1269647:Cell [Cell]
   748   C1547052:*Type [Quantitative Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.93: View larger version (22K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.94: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.95: RT-PCR analysis of APP mRNA isoforms in murine tissues, primary brain cell cultures, and murine cell lines. 

Phrase: "RT-PCR analysis of APP mRNA isoforms"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0200931:PCR analysis [Laboratory Procedure]
   764   C0599161:RT-PCR [Molecular Biology Research Technique]
   762   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0677874:pCR [Finding]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "in murine tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "primary brain cell cultures,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   923   C1449562:Primary Cell Cultures [Laboratory Procedure]
   861   C0007585:Cell Cultures [Laboratory Procedure]
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "murine cell lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.96: A, exon structure of the full-length APP 770transcript is shown. 

Phrase: "A,"

Phrase: "exon structure of the full-length APP 770transcript"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0175168:protein structure [Amino Acid, Peptide, or Protein]
   757   C1510464:Protein Structure [Amino Acid, Peptide, or Protein]
   739   C0678594:Structure [Spatial Concept]
   722 E C0582263:Structural protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.97: Alternatively spliced exons 7,8,and 15are indicated by black boxes. 

Phrase: "Alternatively spliced exons 7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "8,"

Phrase: "and"

Phrase: "15are"

Phrase: "indicated by black boxes."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0005680:Black [Population Group]
   770   C0027567:Black [Population Group]
   770   C0085756:Black [Population Group]
   770   C0179400:boxes [Manufactured Object]
   770   C0439541:Black [Qualitative Concept]
   770   C1444656:Indicated [Finding]
   770   C1638312:Boxes [Quantitative Concept]
   737 E C1533124:Box [Medical Device]
Processing 00000000.tx.98: A is marked in gray. 

Phrase: "A"

Phrase: "is"

Phrase: "marked in gray."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0522501:Marked [Qualitative Concept]
   790   C0556636:gray [Quantitative Concept]
   790   C1269776:Gray [Qualitative Concept]
   790   C1706089:Marked [Qualitative Concept]
Processing 00000000.tx.99: TM, transmembrane domain. 

Phrase: "TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
  1000   C3540468:TM [Gene or Genome]

Phrase: "transmembrane domain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1519623:Transmembrane Domain [Amino Acid Sequence]
   861   C1167322:transmembrane [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C2752508:transmembrane [Cell Component]
   861   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.100: Below, location of the primer pair sm1805 and am2225 (arrowheads) and the size of the amplified PCR-products (APPex15 and L-APP) are illustrated. 

Phrase: "Below,"

Phrase: "location of the primer pair sm1805"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0450429:Location [Spatial Concept]
   753   C1515974:Location [Body Location or Region]

Phrase: "and"

Phrase: "am2225"

Phrase: "(arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")"

Phrase: "and"

Phrase: "the size of the amplified PCR-products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0456389:size [Spatial Concept]

Phrase: "(APPex15"

Phrase: "and"

Phrase: "L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "are"

Phrase: "illustrated."
Processing 00000000.tx.101: B-D, autoradiograms of APPex15 and L-APP splicing pattern in 14examined mouse tissues (lanes 1-14), two primary brain cell cultures (lanes 16and 17), and four murine cell lines (lanes 19-22) are shown. 

Phrase: "B-D,"

Phrase: "autoradiograms of APPex15"

Phrase: "and"

Phrase: "L-APP splicing pattern in 14examined mouse tissues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0439719:L-pattern [Spatial Concept]
   757   C1317658:Protein pattern [Clinical Attribute]
   739   C0449774:Pattern [Spatial Concept]

Phrase: "(lanes 1-14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "two primary brain cell cultures"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   888   C1449562:Primary Cell Cultures [Laboratory Procedure]
   840   C0007585:Cell Cultures [Laboratory Procedure]
   804   C0010453:Cultures [Idea or Concept]
   771 E C0220814:culture [Functional Concept]
   771 E C0430400:Culture [Laboratory Procedure]
   771 E C2242979:Culture [Laboratory Procedure]

Phrase: "(lanes 16and 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "four murine cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "(lanes 19-22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.102: 2g of total RNA of each tissue sample and the complete total RNA preparation of primary cell cultures were subjected to a reverse transcription reaction, and resulting cDNAs were amplified for 24cycles in a PCR reaction using the primer pair sm1805 and am2225 (33P-labeled). 

Phrase: "2g of total RNA of each tissue sample"

Phrase: "and"

Phrase: "the complete total RNA preparation of primary cell cultures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0920433:cell preparation [Laboratory Procedure]
   742   C0455052:Preparation [Health Care Activity]
   742   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "subjected to a reverse transcription reaction,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0035380:Reverse Transcription [Genetic Function]
   753   C0040649:Transcription [Genetic Function]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1555029:Reverse [Idea or Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "resulting cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "amplified for 24cycles"

Phrase: "in a PCR reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the primer pair sm1805"

Phrase: "and"

Phrase: "am2225"

Phrase: "(33P-labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1708632:Labeled [Qualitative Concept]
   827 E C0181496:Label [Manufactured Object]
   827 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: ")."
Processing 00000000.tx.103: To check the specificity of amplified PCR signals, 2g of total RNA of one tissue or the half of a RNA preparation from a primary cell culture sample were reverse-transcribed without SuperScriptTM and subjected to the RT-PCR assay (lanes 15and 18).  

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "check"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1283174:Check [Activity]

Phrase: "the specificity of amplified PCR signals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "2g of total RNA of one tissue"

Phrase: "or"

Phrase: "the half of a RNA preparation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2825407:Half [Quantitative Concept]

Phrase: "from a primary cell culture sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0370003:Sample [Substance]
   812   C2347026:Sample [Conceptual Entity]
   756   C1449562:Primary Cell Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "reverse-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed without SuperScriptTM"

Phrase: "and"

Phrase: "subjected to the RT-PCR assay"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0599161:RT-PCR [Molecular Biology Research Technique]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0243073:assay [Qualitative Concept]
   753   C0677874:pCR [Finding]
   753   C1510438:Assay [Laboratory Procedure]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "(lanes 15and 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.104: View this table: [in this window] [in a new window]  Table I Quantification of APPex15 and L-APP mRNA isoforms in peripheral tissues, neuronal tissues, primary cultured brain cells, and cell lines of mouse Radiolabeled RT-PCR products were analyzed by using a PhosphorImager. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I Quantification of APPex15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "and"

Phrase: "L-APP mRNA isoforms in peripheral tissues,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C3178793:mRNA Isoforms [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   762   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms

Phrase: "neuronal tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "primary cultured brain cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   875   C0007600:cultured cells [Cell]
   875   C0007635:Cultured Cells [Cell]
   875   C3282338:Cells, Cultured [Cell]
   861   C0596208:brain cells [Cell]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cell lines of mouse"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   865   C1513528:Mouse Cell Line [Cell]
   833   C0007600:Cell lines [Cell]
   770   C0007634:Cell [Cell]
   770   C0205132:lines [Spatial Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "Radiolabeled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527121:Radiolabeled [Qualitative Concept]
   966 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "RT-PCR products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]
   734   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "were"

Phrase: "analyzed by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PhosphorImager."
Processing 00000000.tx.105: Each band was corrected by a corresponding background value. 

Phrase: "Each band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "corrected by a corresponding background value."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0205202:Corrected [Qualitative Concept]
   753   C1522609:Value [Quantitative Concept]
   753   C1706907:Background [Conceptual Entity]
   719 E C2349182:Correct [Qualitative Concept]
Processing 00000000.tx.106: Relative amounts of both mRNA isoforms were determined in percent using the following calculations: %L-APP=(APPex15+L-APP)/100L-APP; 

Phrase: "Relative amounts of both mRNA isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "determined in percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439165:Percent [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1441506:Calculation [Activity]

Phrase: ":"

Phrase: "%L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "="

Phrase: "(APPex15+L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "/100L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.107: %APPex15=(APPex15+L-APP)/100APPex15. 

Phrase: "%APPex15"

Phrase: "="

Phrase: "(APPex15+L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "/100APPex15."
Processing 00000000.tx.108: By using our quantitative RT-PCR assays, we next searched for a murine cell culture model that mimics the in vivo non-neuronal and neuronal L-APP expression pattern. 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "our quantitative RT-PCR assays,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   861   C0599161:RT-PCR [Molecular Biology Research Technique]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0392762:Quantitative [Quantitative Concept]
   812   C0677874:pCR [Finding]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "searched for a murine cell culture model"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   778   C0007585:Cell Culture [Laboratory Procedure]
   748   C0007634:Cell [Cell]
   748   C0010453:Culture [Idea or Concept]
   748   C0026809:Murine [Mammal]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1706202:Searched [Activity]
   748   C1948049:Cell [Spatial Concept]
   748   C2242979:Culture [Laboratory Procedure]
   748   C3161035:Model [Intellectual Product]
   714 E C1552603:search [Intellectual Product]

Phrase: "that"

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "the in vivo non-neuronal"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0521390:Neuronal [Immunologic Factor]
   812   C1518422:Non [Functional Concept]
   741 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "neuronal L-APP expression pattern."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   829   C1317658:Protein pattern [Clinical Attribute]
   795   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.109: For this, we chose the following murine cell lines: NIH3T3 (fibroblastoma), AtT20 (pituitary gland), N2a (neuroblastoma), and P19 (embryonic carcinoma). 

Phrase: "For this,"

Phrase: "we"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "the following murine cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: ":"

Phrase: "NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257739:NIH/3T3 [Cell]

Phrase: "(fibroblastoma"

Phrase: ")"

Phrase: ","

Phrase: "AtT20"

Phrase: "(pituitary gland"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032005:Pituitary Gland [Body Part, Organ, or Organ Component]
           Pituitary, NOS
  1000   C1278880:Pituitary gland [Body Part, Organ, or Organ Component]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: ","

Phrase: "N2a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445079:N2a [Finding]

Phrase: "(neuroblastoma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027819:Neuroblastoma [Neoplastic Process]
  1000   C0700095:neuroblastoma [Neoplastic Process]
  1000   C3540583:Neuroblastoma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "P19"

Phrase: "(embryonic carcinoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   950   C0206659:Embryonal Carcinoma [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]

Phrase: ")."
Processing 00000000.tx.110: Analysis of the APP splicing pattern by phosphorimaging revealed that APPex15 isoforms were expressed by all cell lines tested and constituted between 43(NIH3T3) and 99% (P19) of the total APP message (Fig. 1D, lanes 19-22; Table I). 

Phrase: "Analysis of the APP splicing pattern"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1514534:Protein Analysis [Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "by phosphorimaging"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that APPex15 isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "expressed by all cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "constituted between 43"

Phrase: "(NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257739:NIH/3T3 [Cell]

Phrase: ")"

Phrase: "and"

Phrase: "99%"

Phrase: "(P19"

Phrase: ")"

Phrase: "of the total APP message"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0470166:Message [Intellectual Product]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C0555903:Total protein [Laboratory Procedure]
   708   C1261360:total protein [Laboratory or Test Result]

Phrase: "(Fig. 1D, lanes 19-22"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0349966:Fig [Food]
   804   C1337208:FIG [Food]
   804   C1416886:1D [Gene or Genome]
   804   C1442449:1D [Temporal Concept]
   771   C1708639:Lane [Spatial Concept]

Phrase: "; Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.111: Conversely, L-APP constituted 14or 57% in the non-neuronal cell lines AtT20 or NIH3T3, respectively, whereas only minor amounts of these APP isoforms were expressed in the two cell lines N2a (<5%) and P19 (<1%). 

Phrase: "Conversely,"

Phrase: "L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "constituted"

Phrase: "14or 57% in the non-neuronal cell lines AtT20"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0027836:Non-neuronal cell [Cell]
   764   C0007600:Cell lines [Cell]
   742   C0007634:Cell [Cell]
   742   C0205132:lines [Spatial Concept]
   742   C0521390:Neuronal [Immunologic Factor]
   742   C1269647:Cell [Cell]
   742   C1518422:Non [Functional Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   708 E C1550648:Line [Substance]
   708 E C1552960:Line [Quantitative Concept]

Phrase: "or"

Phrase: "NIH3T3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257739:NIH/3T3 [Cell]

Phrase: "respectively,"

Phrase: "whereas"

Phrase: "only minor amounts of these APP isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "expressed in the two cell lines N2a"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0007600:Cell lines [Cell]
   748   C0007634:Cell [Cell]
   748   C0205132:lines [Spatial Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0445079:N2a [Finding]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C1550648:Line [Substance]
   714 E C1552960:Line [Quantitative Concept]

Phrase: "("

Phrase: "<5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "P19"

Phrase: "("

Phrase: "<1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.112: Thus, the P19 cell line appeared to be most suitable for studying exon 15splicing in a neuronal context since the very low or absent L-APP expression is a characteristic feature of neurons. 

Phrase: "Thus,"

Phrase: "the P19 cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "most suitable for studying exon 15splicing"

Phrase: "in a neuronal context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449255:Context [Finding]
   861   C0542559:Context [Functional Concept]

Phrase: "since"

Phrase: "the very low"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442811:Very low [Finding]
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "or"

Phrase: "absent L-APP expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1171362:protein expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a characteristic feature of neurons."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1521970:Feature [Qualitative Concept]
   760   C1706388:Feature [Conceptual Entity]
   760   C2346469:Feature [Qualitative Concept]
   760   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.113: The NIH3T3 cell line was chosen for the following experiments as representative for cells with the non-neuronal L-APP splicing pattern. 

Phrase: "The NIH3T3 cell line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007600:Cell Line [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   734   C1257739:Cell, NIH-3T3 [Cell]

Phrase: "was"

Phrase: "chosen for the following experiments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0681814:Experiments [Research Activity]
   760   C1707391:Chosen [Activity]
   726   C0332283:follow [Temporal Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726   C1719822:Follow [Intellectual Product]

Phrase: "as representative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Representative [Activity]

Phrase: "for cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "with the non-neuronal L-APP splicing pattern."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   822   C1317658:Protein pattern [Clinical Attribute]
   793   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.114: A Minigene Spanning APP Exons 14-16 Mimics the Alternative Splicing Pattern of APP Exon 15in NIH3T3 and P19 Cells-- To examine the regulation of the alternative splicing of APP exon 15in more detail, a minigene construct encompassing the exons 14-16 of the murine APP gene was generated. 

Phrase: "A Minigene Spanning APP Exons 14-16"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   835   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   835   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   822   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0011560:Amyloid [Pathologic Function]
   793   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1709634:Precursor [Idea or Concept]
   760   C1711300:Span [Conceptual Entity]
   760   C2700613:Span [Quantitative Concept]

Phrase: "Mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "the Alternative Splicing Pattern of APP Exon 15in NIH3T3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C1317658:Protein pattern [Clinical Attribute]
   738   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "P19 Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the regulation of the alternative splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "of APP exon 15in more detail,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1522508:Detail [Qualitative Concept]
   795   C1561567:detail [Functional Concept]

Phrase: "a minigene construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "encompassing"

Phrase: "the exons 14-16 of the murine APP gene"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0017337:Gene [Gene or Genome]
   738   C0026809:Murine [Mammal]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "generated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]
Processing 00000000.tx.115: For this, a mouse genomic library was screened with a fragment of the human APP cDNA (exons 14-17). 

Phrase: "For this,"

Phrase: "a mouse genomic library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017430:Genomic Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0023621:Library [Manufactured Object,Organization]
   827   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "screened with a fragment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0332255:fragment [Functional Concept]
   770   C1708096:Fragment [Qualitative Concept]
   737   C0220908:screen [Health Care Activity]
   737   C1305399:screen [Functional Concept]
   737   C1705053:Screen [Medical Device]

Phrase: "of the human APP cDNA (exons 14-17"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   836   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   835   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   835   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   822   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0011560:Amyloid [Pathologic Function]
   793   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0086418:Human [Human]
   793   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1709634:Precursor [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.116: A hybridizing clone termed L12 contained a genomic fragment of ~18 kb including the exons 14-17 of the murine APP gene (Fig. 2A). 

Phrase: "A hybridizing clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "L12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419629:L12 [Gene or Genome]
  1000   C1539707:L12 [Gene or Genome]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a genomic fragment of ~18 kb"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the exons 14-17 of the murine APP gene"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0017337:Gene [Gene or Genome]
   738   C0026809:Murine [Mammal]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1709634:Precursor [Idea or Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.117: Since cis-acting elements involved in the regulation of alternative splicing are often located in intronic sequences proximal to an alternatively used exon or in regions of upstream and downstream exons of neighboring sequences (21-24), the genomic regions adjacent to exons 14-16 were determined and compared with the corresponding regions in the human APP gene (Fig. 2B). 

Phrase: "Since"

Phrase: "cis-acting elements"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   988   C0599780:cis acting element [Nucleotide Sequence]
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "involved in the regulation of alternative splicing"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0002345:Alternative Splicing [Genetic Function]
   748   C0035687:Splicing [Genetic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1314939:Involved [Functional Concept]
   748   C1327622:Regulation [Biologic Function]
   748   C1523987:Alternative [Conceptual Entity]
   748   C2610186:splicing [Genetic Function]

Phrase: "are"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "located in intronic sequences"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0162326:Sequences [Nucleotide Sequence]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "proximal to an alternatively used exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205107:Proximal [Spatial Concept]

Phrase: "or in regions of upstream"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1883644:Upstream Region [Nucleotide Sequence]
   760   C0522505:Upstream [Spatial Concept]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "downstream exons of neighboring sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(21-24"

Phrase: ")"

Phrase: ","

Phrase: "the genomic regions"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "adjacent to exons 14-16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "were"

Phrase: "determined"

Phrase: "and"

Phrase: "compared with the corresponding regions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1707455:Compared [Activity]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "in the human APP gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   897   C0314604:Human gene [Gene or Genome]
   840   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Gene [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.118: The sequence alignment revealed a high degree of conservation in the intronic areas upstream and downstream of exon 15(80or 60% similarity, respectively), suggesting the presence of functionally important regulatory cis-elements. 

Phrase: "The sequence alignment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0080143:Sequence Alignment [Molecular Biology Research Technique]
   861   C1706765:Alignment [Quantitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a high degree of conservation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "in the intronic areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "upstream"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522505:Upstream [Spatial Concept]

Phrase: "and downstream of exon 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0522506:Downstream [Spatial Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "(80or 60% similarity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2348205:Similarity [Qualitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of functionally important regulatory cis-elements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.119: View larger version (36K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.120: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.121: Organization of the genomic region exons 14-17 of mouse APP locus. 

Phrase: "Organization of the genomic region exons 14-17"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0029237:Organisation [Physiologic Function]
   744   C0029246:Organization [Organization]
   744   C0220885:organization [Qualitative Concept]
   744   C1300196:Organization [Functional Concept]
   744   C1522486:Organization [Professional or Occupational Group]

Phrase: "of mouse APP locus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1708726:Locus [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.122: A, maps of the murine APP locus and the APP minigene MG1. 

Phrase: "A,"

Phrase: "maps of the murine APP locus"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0024779:Map [Manufactured Object]
   744   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0026809:Murine [Mammal]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1706473:Map [Conceptual Entity]
   744   C1708726:Locus [Gene or Genome]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "the APP minigene MG1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1417498:MG1 [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.123: On top the genomic clone L12, containing an ~18-kb APP DNA fragment, is shown (constitutive exons, open boxes; alternatively spliced exon 15,gray; introns, black solid lines). 

Phrase: "On top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "the genomic clone L12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419629:L12 [Gene or Genome]
   827   C1539707:L12 [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an ~18-kb APP DNA fragment,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   795   C0332255:fragment [Functional Concept]
   795   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(constitutive exons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "open boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]

Phrase: "; alternatively spliced exon 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "gray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: "; introns,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021920:Introns [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "black solid lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.124: Only restriction sites involved in cloning of APP minigenes are indicated (compare "Materials and Methods") and are not necessarily unique. 

Phrase: "Only restriction sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   867   C1882940:Restriction Site [Nucleotide Sequence]
   827   C0205145:Sites [Spatial Concept]
   827   C0443288:Restriction [Functional Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "involved in cloning of APP minigenes"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0009015:Cloning [Research Activity]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1314939:Involved [Functional Concept]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "are"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: """Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "are"

Phrase: "not necessarily unique."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710548:Unique [Qualitative Concept]
Processing 00000000.tx.125: The approximate scale is given by the 1-kb bar on the top. 

Phrase: "The approximate scale"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0175659:Scale [Medical Device]
   861   C0349674:Scale [Intellectual Product]
   861   C1947916:Scale [Activity]
   861   C3536777:Scale [Manufactured Object]
   789 E C1710017:Scalar [Qualitative Concept]
   777 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "given by the 1-kb bar"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C1442162:GIVEN [Conceptual Entity]
   753   C1550718:given [Idea or Concept]
   753   C3244317:given [Intellectual Product]
   719 E C1947971:Give [Functional Concept]

Phrase: "on the top."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.126: In MG1, the genomic fragment spanning exons 14-16 (~12.5 kb), marked by the connecting solid lines between L12 and MG1, was set under the control of a SV40 early promotor (SV40 prom, black box) and an SV40 polyadenylation signal (SV40 pA, black box) of the mammalian expression vector pZeo SV (Invitrogen). 

Phrase: "In MG1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417498:MG1 [Gene or Genome]

Phrase: "the genomic fragment spanning exons 14-16"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0017428:Genomic [Gene or Genome]
   799   C0332255:fragment [Functional Concept]
   799   C0887950:genomic [Biomedical Occupation or Discipline]
   799   C1708096:Fragment [Qualitative Concept]
   766   C1711300:Span [Conceptual Entity]
   766   C2700613:Span [Quantitative Concept]

Phrase: "(~12.5 kb"

Phrase: ")"

Phrase: ","

Phrase: "marked by the connecting solid lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0205132:lines [Spatial Concept]
   753   C0205208:Solid [Qualitative Concept]
   753   C0302909:Solid [Substance]
   753   C0522501:Marked [Qualitative Concept]
   753   C1378566:Solid [Biomedical or Dental Material]
   753   C1706089:Marked [Qualitative Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]
   719   C2986575:Connect [Activity]

Phrase: "between L12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419629:L12 [Gene or Genome]
  1000   C1539707:L12 [Gene or Genome]

Phrase: "and"

Phrase: "MG1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417498:MG1 [Gene or Genome]

Phrase: "was"

Phrase: "set under the control of a SV40 early promotor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   742   C0036849:Set [Mental Process]
   742   C0038975:SV 40 [Virus]
   742   C0086860:promotor [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0243148:control [Qualitative Concept]
   742   C1279919:Early [Temporal Concept]
   742   C1442518:Set [Functional Concept]
   742   C1550141:Control [Substance]
   742   C1705195:Set [Conceptual Entity]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]

Phrase: "(SV40 prom,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0015944:PROM [Pathologic Function]
   861   C0079991:PROM [Organ or Tissue Function]
   861   C1709700:PROM [Manufactured Object]

Phrase: "black box"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "an SV40 polyadenylation signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "(SV40 pA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "black box"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: ")"

Phrase: "of the mammalian expression vector pZeo SV (Invitrogen"

Phrase: ")."
Processing 00000000.tx.127: Vector sequences are not drawn in scale. 

Phrase: "Vector sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "drawn in scale."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0175659:Scale [Medical Device]
   790   C0349674:Scale [Intellectual Product]
   790   C1947916:Scale [Activity]
   790   C3536777:Scale [Manufactured Object]
   756   C0013113:Draw [Intellectual Product]
   718 E C1710017:Scalar [Qualitative Concept]
   706 E C0222045:Scales [Body Part, Organ, or Organ Component]
Processing 00000000.tx.128: Small black arrows show the localization of the minigene-specific primer pair spZEO1 and apZEO2 used in the quantitative RT-PCR assay to determine the splicing pattern of the minigene-derived mRNA molecules. 

Phrase: "Small black arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0336721:arrows [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the localization of the minigene-specific primer pair spZEO1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "apZEO2"

Phrase: "used in the quantitative RT-PCR assay to"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   800   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   770   C0599161:RT-PCR [Molecular Biology Research Technique]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0243073:assay [Qualitative Concept]
   744   C0392762:Quantitative [Quantitative Concept]
   744   C0677874:pCR [Finding]
   744   C1273517:used [Finding]
   744   C1510438:Assay [Laboratory Procedure]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]

Phrase: "determine"

Phrase: "the splicing pattern of the minigene-derived mRNA molecules."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.129: Below, expected minigene splicing pattern in non-neuronal and neuronal cells is diagrammed (vector-specific sequences, black; constitutive exons, white; and alternative exon, gray), showing the two amplified PCR products either skipping (MG-L-APP) or including exon 15(MG-APPex15). 

Phrase: "Below,"

Phrase: "expected minigene splicing pattern in non-neuronal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "neuronal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "diagrammed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681494:Diagram [Intellectual Product]

Phrase: "(vector-specific sequences,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "black"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "; constitutive exons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "white"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: ";"

Phrase: "and"

Phrase: "alternative exon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "gray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the two amplified PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "either skipping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0560435:skipping [Finding]

Phrase: "(MG-L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "exon 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(MG-APPex15"

Phrase: ")."
Processing 00000000.tx.130: B, alignment of genomic sequences flanking the mouse and human exon 15(exonic sequence, capital letters; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "alignment of genomic sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0080143:Sequence Alignment [Molecular Biology Research Technique]
   770   C1706765:Alignment [Quantitative Concept]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "human exon 15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0086418:Human [Human]

Phrase: "(exonic sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "capital letters"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   983   C2827599:Capital Letter [Qualitative Concept]
   861   C0282413:letters [Intellectual Product]
   827 E C1096774:Letter [Intellectual Product]
   827 E C2360551:Letter [Clinical Attribute]
   789 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   768 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.131: intronic sequence, small letters; 

Phrase: "intronic sequence,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "small letters"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0282413:letters [Intellectual Product]
   827 E C1096774:Letter [Intellectual Product]
   827 E C2360551:Letter [Clinical Attribute]
   789 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   768 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.132: exon 15,gray box; 

Phrase: "exon 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "gray box"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: ";"
Processing 00000000.tx.133: identical nucleotides, vertical bars). 

Phrase: "identical nucleotides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "vertical bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.134: The depicted sequences were aligned by using the method of J.Hein (Lasergene 2.0). 

Phrase: "The depicted sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "aligned by"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1706765:Aligned [Quantitative Concept]
   799 E C2369992:Align [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the method of J.Hein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]

Phrase: "(Lasergene 2.0"

Phrase: ")."
Processing 00000000.tx.135: Constitutive splicing signals: 3'-SS, 3'-splice site; 

Phrase: "Constitutive splicing signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: ":"

Phrase: "3'-SS,"

Phrase: "3'-splice site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0887918:3' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.136: 5'-SS; 

Phrase: "5'-SS"

Phrase: ";"
Processing 00000000.tx.137: 5'-splice site; 

Phrase: "5'-splice site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0887917:5' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.138: *, putative branch points sharing four or more nucleotides with branch site consensus sequence. 

Phrase: "*,"

Phrase: "putative branch points"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1253959:Branch [Body Part, Organ, or Organ Component]
   827   C1881507:Branch [Chemical Viewed Structurally]
   827   C2700383:Branch [Plant]
   827   C2826234:BRANCH [Intellectual Product]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]

Phrase: "sharing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Sharing [Social Behavior]

Phrase: "four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "or"

Phrase: "more nucleotides with branch site consensus sequence."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0004793:Nucleotide Sequence [Nucleotide Sequence]
   748   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.139: The intronic sequences of murine APP gene has been submitted to the GenBankTM Data Bank with accession numbers AF199003, AF199004, and AF199005. 

Phrase: "The intronic sequences of murine APP gene"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   762   C0002518:protein sequences [Amino Acid Sequence]
   742   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0162326:Sequences [Nucleotide Sequence]
   726   C1171311:Protein Intron [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708 E C0004793:Sequence [Nucleotide Sequence]
   708 E C0162327:Sequence [Nucleotide Sequence]
   708 E C1519249:Sequence [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "submitted to the GenBankTM Data Bank"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0242356:Data Bank [Intellectual Product]
   753   C0442598:Bank [Manufactured Object]
   753   C0872261:Bank [Manufactured Object]
   753   C1511726:Data [Idea or Concept]
   753   C1515023:Submitted [Functional Concept]
   753   C3245479:data [Medical Device]

Phrase: "with accession numbers AF199003,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   701   C1510755:Accession Number [Intellectual Product]

Phrase: "AF199004,"

Phrase: "and"

Phrase: "AF199005."
Processing 00000000.tx.140: To generate an APP minigene vector a 12.5-kb fragment spanning exons 14-16 was inserted into the multiple cloning site of the mammalian expression vector pZeoSV as described under "Materials and Methods" (Fig. 2A). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "an APP minigene vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "a 12.5-kb fragment spanning exons 14-16"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0332255:fragment [Functional Concept]
   793   C1708096:Fragment [Qualitative Concept]
   760   C1711300:Span [Conceptual Entity]
   760   C2700613:Span [Quantitative Concept]

Phrase: "was"

Phrase: "inserted into the multiple cloning site of the mammalian expression vector pZeoSV"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   753   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1705686:Cloning Site [Nucleotide Sequence]
           Insert Site
   753   C2945843:Site of [Qualitative Concept]
   751   C0086022:Cloning Vector [Nucleic Acid, Nucleoside, or Nucleotide]
           Vector
   751   C0599958:expression cloning [Molecular Biology Research Technique]
   736   C0009015:Cloning [Research Activity]
   736   C0024660:Mammalian [Mammal]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
   736   C0205145:Site [Spatial Concept]
   736   C0439064:Multiple [Quantitative Concept]
   736   C0441587:Inserted [Health Care Activity]
   736   C0442335:Vector [Spatial Concept]
   736   C1515974:Site [Body Location or Region]
   736   C1705099:Vector [Idea or Concept]
   736   C2825164:Site [Spatial Concept]
   703 E C0009013:Clone [Cell]
   703 E C1522642:Clone [Tissue]
   703 E C1743766:Insert [Medical Device]
   703 E C1883719:Insert [Functional Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.141: To examine whether the minigene-derived mRNA can be efficiently expressed in cells and whether the minigene-encoded exon 15undergoes alternative splicing, the APP minigene MG1 was ectopically expressed in NIH3T3 (non-neuronal splicing system) and P19 cells (neuronal splicing system). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "the minigene-derived mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "can"

Phrase: "be"

Phrase: "efficiently"

Phrase: "expressed in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "whether"

Phrase: "the minigene-encoded exon 15undergoes alternative splicing,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002345:Alternative Splicing [Genetic Function]
   799   C0035687:Splicing [Genetic Function]
   799   C2610186:splicing [Genetic Function]

Phrase: "the APP minigene MG1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1417498:MG1 [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "was"

Phrase: "ectopically"

Phrase: "expressed in NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1257739:NIH/3T3 [Cell]

Phrase: "(non-neuronal splicing system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "P19 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(neuronal splicing system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: ")."
Processing 00000000.tx.142: The minigene splicing pattern was monitored by a quantitative RT-PCR assay, using vector-specific primers in a PCR reaction with 26cycles (Fig. 2A). 

Phrase: "The minigene splicing pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "monitored by a quantitative RT-PCR assay,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0243073:assay [Qualitative Concept]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0677874:pCR [Finding]
   748   C1510438:Assay [Laboratory Procedure]
   714   C0030695:monitor [Health Care Activity]
   714   C0150369:monitor [Health Care Activity]
   714   C0181904:Monitor [Medical Device]
   714   C0596972:Monitor [Medical Device]
   714   C1521743:Monitor [Professional or Occupational Group]
   714   C1704646:Monitor [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "vector-specific primers in a PCR reaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with 26cycles"

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.143: Concomitantly, the endogenously produced APP transcripts were detected by using the quantitative RT-PCR assay described in Fig. 

Phrase: "Concomitantly,"

Phrase: "the endogenously produced APP transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "detected by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0442726:Detected [Finding]
   833   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the quantitative RT-PCR assay"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   861   C0599161:RT-PCR [Molecular Biology Research Technique]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0243073:assay [Qualitative Concept]
   812   C0392762:Quantitative [Quantitative Concept]
   812   C0677874:pCR [Finding]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.144: 1A. 

Phrase: "1A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]
Processing 00000000.tx.145: By using both primer pairs in two separate RT-PCRs, we thus were able to monitor and discriminate between the endogenously and the ectopically expressed APP isoforms. 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "pairs in two separate RT-PCRs,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0599161:RT-PCR [Molecular Biology Research Technique]
   753   C0205448:Two [Quantitative Concept]
   753   C0443299:Separate [Spatial Concept]
   753   C1709450:Pair [Qualitative Concept]
   719   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   719   C0677874:pCR [Finding]

Phrase: "we thus"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "and"

Phrase: "discriminate between the endogenously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205235:Discriminate [Qualitative Concept]

Phrase: "and"

Phrase: "the ectopically expressed APP isoforms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
Processing 00000000.tx.146: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.147: 3A, in addition to the endogenous APP mRNA fragments, two minigene-derived splice products were visible as bands of 447and 501bp, and these bands were not present in cDNA preparations from "mock"-transfected control cells (Fig. 3A, lanes 1and 4versus 3and 6). 

Phrase: "3A,"

Phrase: "in addition to the endogenous APP mRNA fragments,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   822   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "two minigene-derived splice products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1514468:Products [Entity]
   771 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "visible as bands of 447and 501bp,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205379:Visible [Qualitative Concept]

Phrase: "and"

Phrase: "these bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present in cDNA preparations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   737   C0455052:Preparation [Health Care Activity]
   737   C1521827:Preparation [Functional Concept]

Phrase: "from """

Phrase: "mock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: """-transfected control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0007634:Cells [Cell]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3A,"

Phrase: "lanes 1and 4versus 3and 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.148: In analogy to the APP mRNA isoforms generated from the endogenous APP gene, we refer to the 447-bp fragment as MG-L-APP (minigene-derived APP mRNA isoforms without exon 15) and to the 501-bp fragment as MG-APPex15 (minigene-derived APP mRNA isoforms with exon 15). 

Phrase: "In analogy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679213:analogy [Idea or Concept]
   900 E C0243071:Analog [Chemical Viewed Structurally]

Phrase: "to the APP mRNA isoforms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   840   C3178793:mRNA Isoforms [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "generated from the endogenous APP gene,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0017337:Gene [Gene or Genome]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205227:Endogenous [Functional Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   744   C3146294:Generated [Activity]

Phrase: "we"

Phrase: "refer to the 447-bp fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205543:refer [Functional Concept]
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "as MG-L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "(minigene-derived APP mRNA isoforms without exon 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C3178793:mRNA Isoforms [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   757   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms

Phrase: ")"

Phrase: "and to the 501-bp fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332255:fragment [Functional Concept]
   753   C1515981:And [Idea or Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "as MG-APPex15"

Phrase: "(minigene-derived APP mRNA isoforms with exon 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C3178793:mRNA Isoforms [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   757   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms

Phrase: ")."
Processing 00000000.tx.149: The identity of the bands representing MG-L-APP and MG-APPex15 was confirmed by comparison of their electrophoretical mobilities with those of corresponding bands derived by PCR amplification of a plasmid standard (Fig. 3A, lanes 1and 4versus 7) and by sequencing (data not shown). 

Phrase: "The identity of the bands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0424215:Identity [Mental Process]
   760   C2003939:Identity [Finding]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "MG-L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "MG-APPex15"

Phrase: "was"

Phrase: "confirmed by comparison of their electrophoretical mobilities"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   748   C0449580:mobilities [Qualitative Concept]
   748   C0750484:Confirmed [Idea or Concept]
   748   C1707455:Comparison [Activity]
   714 E C0425245:Mobility [Finding]
   714 E C1456348:Confirm [Qualitative Concept]

Phrase: "with those"

Phrase: "of corresponding bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "derived by PCR amplification of a plasmid standard"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0677874:pCR [Finding]
   744   C1441547:Derived [Qualitative Concept]
   744   C1442989:Standard [Qualitative Concept]
   744   C1517480:Amplification [Molecular Biology Research Technique]
   744   C1521871:Amplification [Phenomenon or Process]
   744   C1705759:Amplification [Cell or Molecular Dysfunction]
   744   C2828392:Standard [Intellectual Product]
   744   C3245521:derived [Idea or Concept]

Phrase: "(Fig. 3A,"

Phrase: "lanes 1and 4versus 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and by sequencing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1515981:And [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.150: A quantitative analysis of the minigene-derived PCR products demonstrated that exon 15inclusion occurred to 413% (n=11) in NIH3T3 cells and to 865% (n=11) in P19 cells (Fig. 3B). 

Phrase: "A quantitative analysis of the minigene-derived PCR products"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C2733022:Quantitative PCR analysis [Laboratory Procedure]
   762   C0200931:PCR analysis [Laboratory Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0392762:Quantitative [Quantitative Concept]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "demonstrated"

Phrase: "that exon 15inclusion"

Phrase: "occurred to 413%"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "(n=11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in NIH3T3 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and to 865%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "(n=11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in P19 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.151: The ectopic expression of the APP minigene did not influence the processing of the endogenous APP mRNA as revealed by a quantitative analysis of endogenous APP mRNA levels in transfected and non-transfected cells (Fig. 3B). 

Phrase: "The ectopic expression of the APP minigene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1512167:Ectopic Expression [Genetic Function]
   762   C1171362:expression protein [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "the processing of the endogenous APP mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0033666:protein processing [Molecular Function]
   762   C1749524:mRNA processing [Genetic Function]
   742   C1709694:Processing [Activity]

Phrase: "as"

Phrase: "revealed by a quantitative analysis of endogenous APP mRNA levels"
Meta Candidates (Total=28; Excluded=3; Pruned=0; Remaining=25)
   770   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   770   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   766   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   766   C0002723:Amyloid A Precursor [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Amyloid A
   755   C1960892:Amyloid A level [Laboratory Procedure]
   753   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C0026661:mRNA Precursor [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   751   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   751   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   751   C1514534:Protein Analysis [Molecular Biology Research Technique]
   736   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0011560:Amyloid [Pathologic Function]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0205227:Endogenous [Functional Concept]
   736   C0392762:Quantitative [Quantitative Concept]
   736   C0441889:Levels [Qualitative Concept]
   736   C0443289:Revealed [Qualitative Concept]
   736   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0936012:Analysis [Research Activity]
   736   C1524024:analysis [Functional Concept]
   736   C1709634:Precursor [Idea or Concept]
   734   C0428479:Protein level [Laboratory or Test Result]
   703 E C0456079:Level [Classification]
   703 E C1547707:Level [Geographic Area]
   703 E C2946261:Level [Pharmacologic Substance]

Phrase: "in transfected"

Phrase: "and"

Phrase: "non-transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.152: This has also been confirmed for NIH3T3 and P19 cells stably transfected with the APP minigene (data not shown). 

Phrase: "This"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "confirmed for NIH3T3"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0521093:confirmed [Qualitative Concept]
   790   C0750484:Confirmed [Idea or Concept]
   790   C1257739:NIH/3T3 [Cell]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "P19 cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the APP minigene"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.153: Further control experiments were performed to exclude effects on the splicing regulation due to different transfection efficiencies. 

Phrase: "Further control experiments"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009932:control experiments [Group]
   827   C0243148:control [Qualitative Concept]
   827   C0681814:Experiments [Research Activity]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "effects on the splicing regulation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "due to different transfection efficiencies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0013682:efficiencies [Quantitative Concept]
   827   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   743 E C0442799:Efficient [Qualitative Concept]
Processing 00000000.tx.154: Control transfections with a pZeogal reporter construct and subsequent staining of fixed cells with 5-bromo-4-chloro-3-indolyl -D-galactopyranoside (X-gal) confirmed similar transfection rates in NIH3T3 and P19 cells (data not shown). 

Phrase: "Control transfections with a pZeogal reporter construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "subsequent staining of fixed cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "with 5-bromo-4-chloro-3-indolyl -"

Phrase: "D-"

Phrase: "galactopyranoside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016945:Galactopyranoside [Biologically Active Substance,Carbohydrate]

Phrase: "(X-gal)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0049081:X-gal [Carbohydrate]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "similar transfection rates in NIH3T3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "P19 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.155: In summary, the genomic APP sequence spanning exons 14-16 contained all cis-acting elements necessary for cell type-specific recognition of exon 15in the minigene pre-mRNA molecules. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "the genomic APP sequence spanning exons 14-16"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   827   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   827   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   817   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   807   C0002518:Protein Sequence [Amino Acid Sequence]
   807   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0004793:Sequence [Nucleotide Sequence]
   791   C0011560:Amyloid [Pathologic Function]
   791   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   791   C0017428:Genomic [Gene or Genome]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0162326:Sequence [Nucleotide Sequence]
   791   C0162327:Sequence [Nucleotide Sequence]
   791   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0887950:genomic [Biomedical Occupation or Discipline]
   791   C1519249:Sequence [Functional Concept]
   791   C1709634:Precursor [Idea or Concept]
   758   C1711300:Span [Conceptual Entity]
   758   C2700613:Span [Quantitative Concept]
   720 E C1548958:Sequential [Idea or Concept]
   720 E C1705294:Sequential [Qualitative Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "all cis-acting elements"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   988   C0599780:cis acting element [Nucleotide Sequence]
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "necessary for cell type-specific recognition of exon 15in"

Phrase: "the minigene pre-mRNA molecules."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:molecules [Substance]
   729 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.156: Since the removal of a 2.8-kb fragment in intron 15of the APP minigene did not affect the regulation of exon 15splicing, we used this shortened minigene version, denoted as MG2, as parental construct in all subsequent experiments. 

Phrase: "Since"

Phrase: "the removal of a 2.8-kb fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015252:Removal [Therapeutic or Preventive Procedure]
   744   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "in intron 15of"

Phrase: "the APP minigene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the regulation of exon 15splicing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this shortened minigene version,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: "denoted as MG2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1417500:MG2 [Gene or Genome]
   790   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "as"

Phrase: "parental construct in all subsequent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2827421:Construct [Classification]
Processing 00000000.tx.157: View larger version (25K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.158: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.159: Quantitation of endogenous and minigene-derived APP mRNA isoforms by RT-PCR. 

Phrase: "Quantitation of endogenous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709793:Quantitation [Quantitative Concept]

Phrase: "and"

Phrase: "minigene-derived APP mRNA isoforms by RT-PCR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C3178793:mRNA Isoforms [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   757   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
Processing 00000000.tx.160: A, an autoradiogram of the endogenous and minigene-derived APP splicing pattern in NIH3T3 and P19 cells transiently transfected with minigene MG1 and pZeo SV is shown. 

Phrase: "A,"

Phrase: "an autoradiogram of the endogenous"

Phrase: "and"

Phrase: "minigene-derived APP splicing pattern in NIH3T3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1317658:Protein pattern [Clinical Attribute]
   742   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "P19 cells transiently"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with minigene MG1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1417498:MG1 [Gene or Genome]

Phrase: "and"

Phrase: "pZeo SV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0013754:SV [Geographic Area]
   861   C0560132:Sv [Quantitative Concept]
   861   C1704677:SV [Idea or Concept]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.161: 48h after transfection the mRNA splicing pattern of endogenous and minigene-derived APP was analyzed by RT-PCR. 

Phrase: "48h after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442464:48H [Temporal Concept]

Phrase: "the mRNA splicing pattern of endogenous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "minigene-derived APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "analyzed by RT-PCR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.162: Amplified PCR products are indicated: MG-APPex15 (minigene-derived APP with exon 15), MG-L-APP (minigene-derived APP without exon 15), APPex15 (endogenous APP with exon 15), and L-APP (endogenous APP without exon 15). 

Phrase: "Amplified PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "are"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ":"

Phrase: "MG-APPex15"

Phrase: "(minigene-derived APP with exon 15"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "MG-L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "(minigene-derived APP without exon 15"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "APPex15"

Phrase: "(endogenous APP with exon 15"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "(endogenous APP without exon 15"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.163: On top of each lane the analyzed splicing pattern and the transfected construct are depicted: APP-PCR, endogenous APP transcripts; 

Phrase: "On top of each lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "the analyzed splicing pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "the transfected construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "are"

Phrase: "depicted"

Phrase: ":"

Phrase: "APP-PCR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "endogenous APP transcripts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.164: MG-APP, minigene-derived APP mRNA molecules; 

Phrase: "MG-APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "minigene-derived APP mRNA molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0567416:molecules [Substance]
   712 E C1521991:Molecular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.165: MG1, APP minigene; 

Phrase: "MG1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417498:MG1 [Gene or Genome]

Phrase: "APP minigene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.166: m, mock control; 

Phrase: "m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "mock control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.167: K, RT control. 

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "RT control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.168: S, PCR-standard. 

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "PCR-standard."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.169: On buttons of the autoradiogram cell lines are indicated, NIH3T3 (lanes 1-3), P19 (lanes 4-6), and PCR standard (lane 7). 

Phrase: "On buttons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0453985:Button [Manufactured Object]

Phrase: "of the autoradiogram cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "are"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257739:NIH/3T3 [Cell]

Phrase: "(lanes 1-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "P19"

Phrase: "(lanes 4-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "PCR standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: "(lane 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.170: B, quantitation of exon 15-containing isoforms. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantitation of exon 15-containing isoforms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709793:Quantitation [Quantitative Concept]
Processing 00000000.tx.171: Percent exon 15inclusion was analyzed by a PhosphorImager using the following calculation ((counts in exon 15including product)+(counts in exon 15excluding product))/100%(counts in exon 15including product). 

Phrase: "Percent exon 15inclusion"

Phrase: "was"

Phrase: "analyzed by a PhosphorImager"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following calculation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1441506:Calculation [Activity]

Phrase: "("

Phrase: "(counts in exon 15including product"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0439157:counts [Quantitative Concept]
   726 E C0750480:Count [Activity]
   726 E C1705566:Count [Quantitative Concept]

Phrase: ")"

Phrase: "+"

Phrase: "(counts in exon 15excluding product"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0439157:counts [Quantitative Concept]
   726 E C0750480:Count [Activity]
   726 E C1705566:Count [Quantitative Concept]

Phrase: ")"

Phrase: ")"

Phrase: "/100%"

Phrase: "(counts in exon 15including product"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0439157:counts [Quantitative Concept]
   726 E C0750480:Count [Activity]
   726 E C1705566:Count [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.172: White, gray, and dark gray bars represent the meanS.E. of at least three independent experiments (each transfection was performed in duplicate). 

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "gray,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: "and"

Phrase: "dark gray bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1707156:BARS [Gene or Genome]
   827   C3274014:BARS [Intellectual Product]
   827   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanS.E."

Phrase: "of"

Phrase: "at least three independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "("

Phrase: "each transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "performed in duplicate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.173: Identification of an Inhibitory cis-Element, Located 69nt Upstream of the Exon 153'-splice site, Denoted as Upstream Control Region (UCR)-- Alignment of human and mouse intronic sequences flanking exon 15of the APP gene revealed the highest level of conservation in the 3'-terminal region of intron 14.

Phrase: "Identification of an Inhibitory cis-Element,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "Located 69nt Upstream of the Exon 153'-splice site,"

Phrase: "Denoted as Upstream Control Region"

Phrase: "(UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: ")"

Phrase: "--"

Phrase: "Alignment of human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1706765:Alignment [Quantitative Concept]

Phrase: "and"

Phrase: "mouse intronic sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "exon 15of"

Phrase: "the APP gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the highest level of conservation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in the 3'-terminal region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:3' Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of intron 14."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.174: This was reflected by 80% nucleotide sequence similarity within ~500 bp upstream of exon 153'-splice site (3'-SS) and suggested the presence of conserved cis-acting elements. 

Phrase: "This"

Phrase: "was"

Phrase: "reflected by 80% nucleotide sequence similarity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   790   C1710052:Sequence Similarity [Quantitative Concept]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0558058:reflected [Mental Process]
   753   C1519249:Sequence [Functional Concept]
   753   C2348205:Similarity [Qualitative Concept]

Phrase: "within ~500 bp"

Phrase: "upstream of exon 153'-splice site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "(3'-SS)"

Phrase: "and"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of conserved cis-acting elements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.175: To examine this more precisely, deletions increasing in length (between 65and 371bp) were introduced in this intronic area, and the splicing pattern of these mutagenized APP minigenes was determined in NIH3T3 and P19 cells (Fig. 4A, A1-A6). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "this more precisely,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880274:Deletions [Activity]
   966 E C1442161:Deletion [Cell or Molecular Dysfunction]
   966 E C1511760:Deletion [Genetic Function]

Phrase: "increasing in length"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0442808:Increasing [Functional Concept]
   790   C1444754:Length [Quantitative Concept]
   790   C1706316:LENGTH [Research Activity]
   756 E C0442805:Increase [Functional Concept]
   718 E C0205166:Long [Qualitative Concept]
   718 E C1517378:Gain [Quantitative Concept]
   718 E C1522425:Longest [Qualitative Concept]
   718 E C1706317:Long [Qualitative Concept]

Phrase: "("

Phrase: "between 65and 371bp"

Phrase: ")"

Phrase: "were"

Phrase: "introduced in this intronic area,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017446:Area [Geographic Area]
   760   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205146:Area [Spatial Concept]
   726   C1292748:introduce [Functional Concept]

Phrase: "and"

Phrase: "the splicing pattern of these mutagenized APP minigenes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1317658:Protein pattern [Clinical Attribute]
   739   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "determined in NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1257739:NIH/3T3 [Cell]

Phrase: "and"

Phrase: "P19 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "A1-A6"

Phrase: ")."
Processing 00000000.tx.176: Removal of up to 303bp led to a moderate increase of the relative MG-APPex15 level between 563and 652% in NIH3T3 cells (Fig. 4A, A1-A4). 

Phrase: "Removal of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0015252:Removal [Therapeutic or Preventive Procedure]
   833   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "up to 303bp"

Phrase: "led to a moderate increase of the relative MG-APPex15 level"
Meta Candidates (Total=21; Excluded=5; Pruned=0; Remaining=16)
   738   C0080103:Relative [Family Group]
   738   C0205081:Moderate [Qualitative Concept]
   738   C0205345:Relative [Qualitative Concept]
   738   C0439269:mg% [Quantitative Concept]
   738   C0441889:Level [Qualitative Concept]
   738   C0442805:Increase [Functional Concept]
   738   C0456079:Level [Classification]
   738   C1547039:*Relative [Quantitative Concept]
   738   C1547707:Level [Geographic Area]
   738   C1708698:LED [Manufactured Object]
   738   C1881878:Moderate [Qualitative Concept]
   738   C1960952:mg % [Quantitative Concept]
   738   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   738   C2946261:Level [Pharmacologic Substance]
   737   C0428255:lead level [Laboratory or Test Result]
   737   C0524167:Lead level [Laboratory Procedure]
   704 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   704 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   704 E C1522538:Lead [Functional Concept]
   704 E C2348269:Lead [Element, Ion, or Isotope]
   704 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "between 563and 652%"

Phrase: "in NIH3T3 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "A1-A4"

Phrase: ")."
Processing 00000000.tx.177: In contrast, the largest deletions present in minigenes A5 and A6 caused a drastic increase of the relative MG-APPex15 amounts to 904(n=5) and 842% (n=6), respectively, compared with 526% (n=6) MG-APPex15 in control cells expressing the intact APP-minigene MG2 (Fig. 4A). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the largest deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1880274:Deletions [Activity]
   827 E C1442161:Deletion [Cell or Molecular Dysfunction]
   827 E C1511760:Deletion [Genetic Function]

Phrase: "present in minigenes A5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "A6"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a drastic increase of the relative MG-APPex15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "amounts to 904"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1265611:Amount [Quantitative Concept]

Phrase: "(n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "842%"

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "respectively,"

Phrase: "compared with 526%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "MG-APPex15 in control cells"

Phrase: "expressing"

Phrase: "the intact APP-minigene MG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1417500:MG2 [Gene or Genome]
   799   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.178: None of the 3'-terminal deletions in intron 14significantly influenced the recognition of exon 15in P19 cells (Fig. 4A). 

Phrase: "None of the 3'-terminal deletions"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0205088:Terminal [Temporal Concept]
   753   C0456148:None [Quantitative Concept]
   753   C0549184:None [Quantitative Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C1880274:Deletions [Activity]
   719 E C1442161:Deletion [Cell or Molecular Dysfunction]
   719 E C1511760:Deletion [Genetic Function]

Phrase: "in intron 14significantly"

Phrase: "influenced"

Phrase: "the recognition of exon 15in P19 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0678836:cell recognition [Cell Function]
   748   C0524637:Recognition [Mental Process]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.179: To confirm the specificity of this effect, the potential regulatory region located 69-135 nt upstream of exon 153'SS was removed (Fig. 4B, UCR), or the orientation of this area was turned around (Fig. 4B, RCU). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the specificity of this effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "the potential regulatory region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "located"

Phrase: "69-135 nt upstream of exon 153'SS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332126:NT [Qualitative Concept]
   744   C1449832:NT [Diagnostic Procedure]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "(Fig. 4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "the orientation of this area"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0029266:Orientation [Mental Process]
   760   C1704322:orientation [Spatial Concept]
   760   C1704972:Orientation [Spatial Concept]
   760   C3539923:Orientation [Intellectual Product]

Phrase: "was"

Phrase: "turned around"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0541749:turned [Finding]
   799 E C1709743:Turn [Spatial Concept]

Phrase: "(Fig. 4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "RCU"

Phrase: ")."
Processing 00000000.tx.180: Expression of both constructs in NIH3T3 cells resulted in significantly elevated MG-APPex15 levels (Fig. 4B, UCR, 793%, n=16,lane 2; RCU, 851%, n=7,lane 1) in comparison to wild type-transfected control cells (Fig. 4B, MG2, 525%, n=15,lane 3). 

Phrase: "Expression of both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "constructs in NIH3T3 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   770   C0007634:Cells [Cell]
   770   C2827421:Construct [Classification]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "resulted in significantly elevated MG-APPex15 levels"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   748   C0205250:Elevated [Qualitative Concept]
   748   C0439269:mg% [Quantitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C3163633:Elevated [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714 E C1547707:Level [Geographic Area]
   714   C2825142:Result [Finding]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "UCR,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "793%,"

Phrase: "n=16,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "; RCU,"

Phrase: "851%,"

Phrase: "n=7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "in comparison to wild type-transfected control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   858   C0449475:type cell [Intellectual Product]
   804   C0007634:Cells [Cell]
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "MG2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "525%,"

Phrase: "n=15,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.181: In contrast, destruction or misorientation of this potential regulatory region did not give rise to a markedly altered minigene splicing pattern in the neuronal splicing system (Fig. 4B, UCR, 953%, n=13,lane 5; RCU, 943%, n=8,lane 4; MG2, 927%, n=15,lane 6). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "destruction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1261381:Destruction [Therapeutic or Preventive Procedure]
  1000   C1948029:Destruction [Activity]

Phrase: "or"

Phrase: "misorientation of this potential regulatory region"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to a markedly altered minigene splicing pattern"

Phrase: "in the neuronal splicing system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Fig. 4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "UCR,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "953%,"

Phrase: "n=13,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "; RCU,"

Phrase: "943%,"

Phrase: "n=8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "; MG2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "927%,"

Phrase: "n=15,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.182: From this analysis, we concluded that the intronic sequence located in the region 69 to 135 relative to the intron 14/exon 15border contains cis-acting element(s) controlling the recognition of the alternatively spliced exon in a cell type-specific manner. 

Phrase: "From this analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the intronic sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "located in the region 69"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0450388:69 [Intellectual Product]

Phrase: "to 135 relative"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "to the intron 14/exon 15border"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "cis-acting element"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599780:cis acting element [Nucleotide Sequence]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C1705248:Element [Conceptual Entity]

Phrase: "("

Phrase: "s)"

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "the recognition of the alternatively spliced exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0524637:Recognition [Mental Process]

Phrase: "in a cell type-specific manner."
Processing 00000000.tx.183: Therefore, this region of 67nt was denoted as UCR. 

Phrase: "Therefore,"

Phrase: "this region of 67nt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]

Phrase: "was"

Phrase: "denoted as UCR."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   797   C1883644:Upstream Region [Nucleotide Sequence]
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0243148:control [Qualitative Concept]
   760   C0522505:Upstream [Spatial Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.184: View larger version (21K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.185: 4.  

Phrase: "4."
Processing 00000000.tx.186: Mapping of the "upstream control region." 

Phrase: "Mapping of the ""upstream control region."""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1283195:Mapping [Activity]
Processing 00000000.tx.187: A, left panel, structure of wild type and truncated minigenes. 

Phrase: "A,"

Phrase: "left panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "structure of wild type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "truncated minigenes."
Processing 00000000.tx.188: On top the genomic map of wild type minigene MG2, carrying a 2.8-kb deletion between the indicated NcoI sites, is shown. 

Phrase: "On top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "the genomic map of wild type minigene MG2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0024779:Map [Manufactured Object]
   744   C1706473:Map [Conceptual Entity]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "a 2.8-kb deletion between the indicated NcoI sites,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C1442161:Deletion [Cell or Molecular Dysfunction]
   739   C1511760:Deletion [Genetic Function]
   739   C1880274:Deletion [Activity]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.189: Below the genomic region of MG2 spanning exon 15(gray box) to the PacI (418nt upstream) is enlarged. 

Phrase: "Below the genomic region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0017428:Genomic [Gene or Genome]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   861   C0887950:genomic [Biomedical Occupation or Discipline]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of MG2 spanning exon 15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1417500:MG2 [Gene or Genome]
   812   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   779   C1711300:Span [Conceptual Entity]
   779   C2700613:Span [Quantitative Concept]

Phrase: "(gray box"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: ")"

Phrase: "to the PacI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1165245:paci [Immunologic Factor,Pharmacologic Substance]

Phrase: "(418nt"

Phrase: "upstream"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522505:Upstream [Spatial Concept]

Phrase: ")"

Phrase: "is"

Phrase: "enlarged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442800:Enlarged [Qualitative Concept]
  1000   C1293134:Enlarged [Therapeutic or Preventive Procedure]
Processing 00000000.tx.190: The numbers at the 5'-end of the truncated clones A1-A6 mark the beginning of the deletion. 

Phrase: "The numbers at the 5'-end"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "of the truncated clones A1-A6"

Phrase: "mark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "the beginning of the deletion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439659:Beginning [Temporal Concept]
Processing 00000000.tx.191: Right panel, quantitative analysis of minigene splicing pattern in NIH3T3 (dark gray) and P19 cells (gray) using RT-PCR, followed by a PhosphorImager analysis (bars, meanS.E. of percent exon 15inclusion), measured in two independent transfection experiments with double or triple samples. 

Phrase: "Right panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "quantitative analysis of minigene splicing pattern"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0392762:Quantitative [Quantitative Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257739:NIH/3T3 [Cell]

Phrase: "(dark gray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0556636:gray [Quantitative Concept]
   861   C1269776:Gray [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "P19 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(gray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RT-PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "followed by a PhosphorImager analysis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "(bars,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "meanS.E."

Phrase: "of percent exon 15inclusion"

Phrase: ")"

Phrase: ","

Phrase: "measured in two independent transfection experiments"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   753   C0085862:Independent [Idea or Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C0681814:Experiments [Research Activity]
   753   C1299583:Independent [Finding]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "with double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "or"

Phrase: "triple samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.192: The two vertical dashed lines mark the degree of exon 15inclusion in NIH3T3 and P19 cells, observed for the wild type minigene MG2. 

Phrase: "The two vertical dashed lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "mark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "the degree of exon 15inclusion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "in NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257739:NIH/3T3 [Cell]

Phrase: "and"

Phrase: "P19 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "observed for the wild type minigene MG2."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1417500:MG2 [Gene or Genome]
   748   C1441672:Observed [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.193: The p values of mutant constructs versus the parental minigene MG2 were determined by Student's t test; 

Phrase: "The p values of mutant constructs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1709380:P-Value [Quantitative Concept]
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "versus"

Phrase: "the parental minigene MG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1417500:MG2 [Gene or Genome]
   827   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "were"

Phrase: "determined by Student's t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.194: *, p<0.05; 

Phrase: "*,"

Phrase: "p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.195: **, p<0.01; 

Phrase: "*"

Phrase: "*,"

Phrase: "p<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.196: and ***, p<0.001.B, left panel, maps of minigenes to analyze sequence-specific effects. 

Phrase: "and **"

Phrase: "*,"

Phrase: "p<0.001.B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C1539794:P-B [Gene or Genome]

Phrase: "left panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "maps of minigenes to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0024779:Map [Manufactured Object]
   770   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1706473:Map [Conceptual Entity]

Phrase: "analyze"

Phrase: "sequence-specific effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.197: UCR contains a total deletion of nucleotides 135 to 69. 

Phrase: "UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a total deletion of nucleotides 135"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "to 69."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]
Processing 00000000.tx.198: RCU has an inverted copy of nucleotides 135 to 69 (black box with white arrow). 

Phrase: "RCU"

Phrase: "has"

Phrase: "an inverted copy of nucleotides 135"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1948062:Copy [Manufactured Object]

Phrase: "to 69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "(black box with white arrow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0179400:Box [Manufactured Object]
   760   C1533124:Box [Medical Device]

Phrase: ")."
Processing 00000000.tx.199: Right panel, quantitative determination of percent exon 15inclusion in minigene-derived transcripts. 

Phrase: "Right panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "quantitative determination of percent exon 15inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]

Phrase: "in minigene-derived transcripts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.200: At least three independent experiments in duplicate were performed and analyzed by PhosphorImager. 

Phrase: "At least three independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "in duplicate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205173:Duplicate [Functional Concept]
  1000   C3539942:Duplicate [Intellectual Product]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "analyzed by PhosphorImager."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.201: In the case of UCR all measured values (NIH3T3, n=16; P19, n=13) during this study were included in this diagram. 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "all measured values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "(NIH3T3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257739:NIH/3T3 [Cell]

Phrase: "n=16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; P19,"

Phrase: "n=13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "during this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "included in this diagram."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0332257:included [Functional Concept]
   770   C0681494:Diagram [Intellectual Product]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.202: For the control construct MG2, the corresponding values that were determined in one experiment together with UCR and/or RCU were used in this graphical blot. 

Phrase: "For the control construct MG2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1417500:MG2 [Gene or Genome]
   827   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "the corresponding values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "determined in one experiment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205447:One [Quantitative Concept]
   770   C0681814:Experiment [Research Activity]
   770   C1706386:Experiment [Conceptual Entity]

Phrase: "together with UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and/or"

Phrase: "RCU"

Phrase: "were"

Phrase: "used in this graphical blot."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.203: The symbols in this diagram are the same as used in A.Below two autoradiograms of representative gels are depicted, showing the splicing pattern of the minigenes marked above. 

Phrase: "The symbols in this diagram"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0679214:symbols [Idea or Concept]
   726 E C1698987:symbol [Intellectual Product]

Phrase: "are"

Phrase: "the same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "as"

Phrase: "used in A."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "Below two autoradiograms"

Phrase: "of representative gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "are"

Phrase: "depicted"

Phrase: ","

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the splicing pattern of the minigenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.204: Defining a Potential Regulatory Region Downstream of Exon 15,Named DCR-- Since the sequence downstream of exon 15is also conserved (63% similarity between human and mouse sequence within ~500 bp downstream of exon 15), a deletion scan of the 5'-terminal portion of intron 15,extending from the 5'-splice site (5'-SS) of exon 15to the NcoI restriction site of intron 15,was performed (Fig. 5A). 

Phrase: "Defining"

Phrase: "a Potential Regulatory Region Downstream of Exon 15,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   767   C1883633:Downstream Region [Nucleotide Sequence]
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]
   744   C0220905:regulatory [Regulation or Law]
   744   C1704735:Regulatory [Conceptual Entity]

Phrase: "Named"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027365:named [Intellectual Product]
   966 E C1547383:Name [Intellectual Product]

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "Since"

Phrase: "the sequence downstream of exon 15is also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "conserved"

Phrase: "(63% similarity between human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similarity [Qualitative Concept]

Phrase: "and"

Phrase: "mouse sequence within ~500 bp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "downstream of exon 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "a deletion scan of the 5'-terminal portion of intron 15,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0034606:Scan [Diagnostic Procedure]
   738   C0441633:Scan [Diagnostic Procedure]
   738   C2826292:SCAN [Finding]

Phrase: "extending from the 5'-splice site"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0205145:Site [Spatial Concept]
   753   C0439792:Extending [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
   719 E C0231448:Extend [Functional Concept]

Phrase: "(5'-SS) of exon 15to"

Phrase: "the NcoI restriction site of intron 15,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1882940:Restriction Site [Nucleotide Sequence]
   778   C2945843:Site of [Qualitative Concept]
   748   C0205145:Site [Spatial Concept]
   748   C0443288:Restriction [Functional Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.205: For this purpose, a set of deletion constructs was generated by removing stepwise fragments of ~400 to 1300bp length in the 5'-portion of intron 15(Fig. 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "a set of deletion constructs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]

Phrase: "was"

Phrase: "generated by removing stepwise fragments of ~400"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0332255:fragments [Functional Concept]
   748   C0486805:Fragments [Body Substance]
   748   C3146294:Generated [Activity]
   714   C0849355:remove [Qualitative Concept]
   714 E C1708096:Fragment [Qualitative Concept]
   714   C1883720:Remove [Activity]
   714   C3244314:remove [Functional Concept]

Phrase: "to 1300bp length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "in the 5'-portion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449719:Portion [Spatial Concept]

Phrase: "of intron 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.206: 5A, B1-B8). 

Phrase: "5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553637:5a [Medical Device]

Phrase: "B1-B8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0507118:B8 [Body Part, Organ, or Organ Component]
   861   C1417622:B8 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.207: Splicing pattern analysis of these minigenes in NIH3T3 cells showed that the removal of large parts in the 5'-terminal sequences of intron 15only caused a moderate increase of the relative MG-APPex15 amount between 603and 633% in comparison to 522% MG-APPex15 wild type-transfected cells (Fig. 5A, B1-B6 versus MG2). 

Phrase: "Splicing pattern analysis of these minigenes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in NIH3T3 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the removal of large parts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015252:Removal [Therapeutic or Preventive Procedure]
   760   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "in the 5'-terminal sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "of intron 15only"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a moderate increase of the relative MG-APPex15 amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "between 603and 633%"

Phrase: "in comparison to 522% MG-APPex15 wild type-transfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   813   C0449475:type cell [Intellectual Product]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "B1-B6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0507115:B6 [Body Part, Organ, or Organ Component]
   861   C1521751:B6 [Mammal]

Phrase: "versus"

Phrase: "MG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.208: In contrast, deletions of approximately 1.1or 1.2kb, respectively, led to an activation of exon 15splicing in NIH3T3 cells that was mirrored by a strong increase of the relative MG-APPex15 level to 742% (n=5) and to 812% (n=5) in comparison to 524% (n=6) in NIH3T3 cells expressing the wild type APP-minigene (Fig. 5A, B7 and B8 versus MG2). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "deletions of approximately 1.1or 1.2kb,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C1880274:Deletions [Activity]
   714 E C1442161:Deletion [Cell or Molecular Dysfunction]
   714 E C1511760:Deletion [Genetic Function]

Phrase: "respectively,"

Phrase: "led to an activation of exon 15splicing"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1708698:LED [Manufactured Object]
   748   C1879547:Activation [Activity]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in NIH3T3 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "was"

Phrase: "mirrored by a strong increase of the relative MG-APPex15 level"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   738   C0080103:Relative [Family Group]
   738   C0181868:mirrored [Manufactured Object]
   738   C0205345:Relative [Qualitative Concept]
   738   C0439269:mg% [Quantitative Concept]
   738   C0441889:Level [Qualitative Concept]
   738   C0442805:Increase [Functional Concept]
   738   C0442821:Strong [Qualitative Concept]
   738   C0456079:Level [Classification]
   738   C1547039:*Relative [Quantitative Concept]
   738   C1547707:Level [Geographic Area]
   738   C1960952:mg % [Quantitative Concept]
   738   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   738   C2946261:Level [Pharmacologic Substance]
   704 E C1706183:Mirror [Manufactured Object]

Phrase: "to 742%"

Phrase: "(n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and to 812%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "(n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in comparison to 524%"

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in NIH3T3 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the wild type APP-minigene"

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "B7"

Phrase: "and"

Phrase: "B8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0507118:B8 [Body Part, Organ, or Organ Component]
  1000   C1417622:B8 [Gene or Genome]

Phrase: "versus"

Phrase: "MG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.209: None of the truncated APP minigenes influenced the inclusion of exon 15in the minigene-derived mRNA transcripts of P19 cells (Fig. 5A). 

Phrase: "None of the truncated APP minigenes"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0456148:None [Quantitative Concept]
   744   C0549184:None [Quantitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "influenced"

Phrase: "the inclusion of exon 15in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1512693:Inclusion [Qualitative Concept]

Phrase: "the minigene-derived mRNA transcripts of P19 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.210: One possible explanation of this result is that the enhancement of exon 15recognition observed in NIH3T3 cells transfected with the constructs B7 and B8 is due to the removal of a splice repressor sequence. 

Phrase: "One possible explanation of this result"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that"

Phrase: "the enhancement of exon 15recognition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "observed in NIH3T3 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   770   C0007634:Cells [Cell]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the constructs B7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "B8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0507118:B8 [Body Part, Organ, or Organ Component]
  1000   C1417622:B8 [Gene or Genome]

Phrase: "is due to the removal of a splice repressor sequence."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0678226:Due to [Functional Concept]
           due
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0015252:Removal [Therapeutic or Preventive Procedure]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0728940:Removal [Therapeutic or Preventive Procedure]
   739   C1336789:Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1519249:Sequence [Functional Concept]
   739   C3146286:Due [Idea or Concept]
Processing 00000000.tx.211: Alternatively, the activating effect could solely depend on the size of the deleted intronic area. 

Phrase: "Alternatively,"

Phrase: "the activating effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "could"

Phrase: "solely"

Phrase: "depend on the size of the deleted intronic area."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0017446:Area [Geographic Area]
   742   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205146:Area [Spatial Concept]
   742   C0456389:size [Spatial Concept]
   742   C0725813:depend [Medical Device]
   742   C1880274:Deleted [Activity]
Processing 00000000.tx.212: To discriminate between these two possibilities, the potential regulatory region in intron 15(position +21 to +158) was deleted (Fig. 5B, DCR), or the removed intronic fragment was reintroduced in the opposite direction (Fig. 5B, RCD). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "discriminate between these two possibilities,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205235:Discriminate [Qualitative Concept]
   760   C0205448:Two [Quantitative Concept]

Phrase: "the potential regulatory region in intron 15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C0220905:regulatory [Regulation or Law]
   748   C1704735:Regulatory [Conceptual Entity]

Phrase: "(position +21 to +158"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0733755:Position [Spatial Concept]
   741 E C0240795:POSITIONAL [Finding]

Phrase: ")"

Phrase: "was"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "(Fig. 5B,"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "the removed intronic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "reintroduced in the opposite direction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449738:Direction [Spatial Concept]
   760   C1521805:Opposite [Spatial Concept]

Phrase: "(Fig. 5B,"

Phrase: "RCD"

Phrase: ")."
Processing 00000000.tx.213: These mutations significantly improved the recognition of exon 15in NIH3T3 cells (Fig. 5B, lanes 1and 2versus 3) resulting in an increase of the relative MG-APPex15 levels to 788% (n=13,DCR) and to 733% (n=6,RCD) compared with 508% MG-APPex15 (n=13) in control cells transfected with the wild type minigene MG2. 

Phrase: "These mutations significantly"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "the recognition of exon 15in NIH3T3 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0678836:cell recognition [Cell Function]
   748   C0524637:Recognition [Mental Process]

Phrase: "(Fig. 5B,"

Phrase: "lanes 1and 2versus 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "resulting in an increase of the relative MG-APPex15 levels"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
   760   C0332294:Resulting in [Functional Concept]
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C0439269:mg% [Quantitative Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C0442805:Increase [Functional Concept]
   739   C0678226:resulting [Functional Concept]
   739   C1547039:*Relative [Quantitative Concept]
   739   C1960952:mg % [Quantitative Concept]
   739   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   706 E C0456079:Level [Classification]
   706 E C1274040:Result [Functional Concept]
   706 E C1546471:Result [Idea or Concept]
   706 E C1547707:Level [Geographic Area]
   706 E C2825142:Result [Finding]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "to 788%"

Phrase: "(n=13,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: ")"

Phrase: "and to 733%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "(n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "RCD)"

Phrase: "compared with 508% MG-APPex15"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439269:mg% [Quantitative Concept]
   760   C1707455:Compared [Activity]
   760   C1960952:mg % [Quantitative Concept]
   760   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(n=13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the wild type minigene MG2."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1417500:MG2 [Gene or Genome]
   748   C1547052:*Type [Quantitative Concept]
   748   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.214: In P19 cells only the deletion present in the DCR construct slightly increased the relative MG-APPex15 amount from 934% (n=11) to 982% (n=11), whereas the usage of exon 15was not enhanced in cells transfected with the RCD vector (Fig. 5B, lanes 4and 5versus 6). 

Phrase: "In P19 cells only"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "the deletion present in the DCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the relative MG-APPex15 amount from 934%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "(n=11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "to 982%"

Phrase: "(n=11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the usage of exon 15was"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0457083:Usage [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enhanced in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C2349975:Enhanced [Activity]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the RCD vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]

Phrase: "(Fig. 5B,"

Phrase: "lanes 4and 5versus 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.215: In summary, these data suggested the presence of regulatory sequence elements located in intron 15(position +21 to +158) that block the inclusion of exon 15in NIH3T3 cells. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of regulatory sequence elements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "located in intron 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(position +21 to +158"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0733755:Position [Spatial Concept]
   741 E C0240795:POSITIONAL [Finding]

Phrase: ")"

Phrase: "that"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the inclusion of exon 15in NIH3T3 cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0205708:cells inclusion [Cell Component]
   748   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.216: This region was therefore designated DCR. 

Phrase: "This region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "was"

Phrase: "therefore"

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "DCR."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.217: View larger version (24K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.218: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.219: Identification of the "downstream control region." 

Phrase: "Identification of the ""downstream control region."""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]
Processing 00000000.tx.220: A, left panel, structure of the wild type and the truncated minigenes. 

Phrase: "A,"

Phrase: "left panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "structure of the wild type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "the truncated minigenes."
Processing 00000000.tx.221: On top the genomic map of MG2 is depicted. 

Phrase: "On top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "the genomic map of MG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0024779:Map [Manufactured Object]
   760   C1706473:Map [Conceptual Entity]

Phrase: "is"

Phrase: "depicted."
Processing 00000000.tx.222: Below the genomic area of MG2, spanning exon 15to the NcoI site (~1, 3kb downstream of exon 15), is enlarged (exon 15,gray box; intronic sequences, black solid line). 

Phrase: "Below the genomic area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "of MG2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "exon 15to"

Phrase: "the NcoI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "(~1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3kb downstream of exon 15"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "enlarged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442800:Enlarged [Qualitative Concept]
  1000   C1293134:Enlarged [Therapeutic or Preventive Procedure]

Phrase: "(exon 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "gray box"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "; intronic sequences,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "black solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.223: Numbers at the 3'-end of constructs B1-B8 indicate the beginning of deleted DNA fragments. 

Phrase: "Numbers at the 3'-end of constructs B1-B8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]

Phrase: "indicate"

Phrase: "the beginning of deleted DNA fragments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439659:Beginning [Temporal Concept]
Processing 00000000.tx.224: Right panel, quantification of percent exon 15inclusion in these minigene-derived transcripts using RT-PCR and PhosphorImager analysis. 

Phrase: "Right panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "quantification of percent exon 15inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "in these minigene-derived transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "PhosphorImager analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.225: Results of two independent experiments with triple samples are graphically illustrated, representing the meanS.E. by the gray (P19) and dark gray (NIH3T3) bars. 

Phrase: "Results of two independent experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C2825142:Experimental Result [Finding]
           Result
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]

Phrase: "with triple samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "are"

Phrase: "graphically"

Phrase: "illustrated"

Phrase: ","

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "the meanS.E."

Phrase: "by the gray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: "(P19"

Phrase: ")"

Phrase: "and"

Phrase: "dark gray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0556636:gray [Quantitative Concept]
   861   C1269776:Gray [Qualitative Concept]

Phrase: "(NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257739:NIH/3T3 [Cell]

Phrase: ")"

Phrase: "bars."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]
Processing 00000000.tx.226: The two vertical dashed lines indicate the percent exon 15inclusion in the wild type MG2 transcripts. 

Phrase: "The two vertical dashed lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "indicate"

Phrase: "the percent exon 15inclusion in the wild type MG2 transcripts."
Processing 00000000.tx.227: The p values of mutant constructs versus the parental minigene MG2 were determined by Student's t test; 

Phrase: "The p values of mutant constructs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1709380:P-Value [Quantitative Concept]
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "versus"

Phrase: "the parental minigene MG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1417500:MG2 [Gene or Genome]
   827   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "were"

Phrase: "determined by Student's t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.228: *, p<0.05; 

Phrase: "*,"

Phrase: "p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.229: **, p<0.01; 

Phrase: "*"

Phrase: "*,"

Phrase: "p<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.230: and ***, p<0.001.B, left panel, scheme of minigenes to study sequence-specific effects. 

Phrase: "and **"

Phrase: "*,"

Phrase: "p<0.001.B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C1539794:P-B [Gene or Genome]

Phrase: "left panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "scheme of minigenes to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519193:Scheme [Intellectual Product]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "sequence-specific effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.231: DCR contains a total deletion of nucleotides 21-158. 

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a total deletion of nucleotides 21-158."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1442161:Deletion [Cell or Molecular Dysfunction]
   748   C1511760:Deletion [Genetic Function]
   748   C1880274:Deletion [Activity]
Processing 00000000.tx.232: RCD carries an inverted copy of nucleotides 21-158 (black box with white arrow). 

Phrase: "RCD"

Phrase: "carries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:Carries [Finding]

Phrase: "an inverted copy of nucleotides 21-158"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1948062:Copy [Manufactured Object]

Phrase: "(black box with white arrow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0179400:Box [Manufactured Object]
   760   C1533124:Box [Medical Device]

Phrase: ")."
Processing 00000000.tx.233: Right panel, quantitative determination of percent exon 15inclusion in these minigene-derived transcripts. 

Phrase: "Right panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "quantitative determination of percent exon 15inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]

Phrase: "in these minigene-derived transcripts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.234: At least three independent experiments were performed in duplicate and analyzed by PhosphorImager. 

Phrase: "At least three independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed in duplicate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "analyzed by PhosphorImager."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.235: In the case of DCR all measured values (NIH3T3 n=13; P19 n=11) during this study were used in this diagram. 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "all measured values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "(NIH3T3 n=13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1257739:NIH/3T3 [Cell]

Phrase: "; P19 n=11"

Phrase: ")"

Phrase: "during this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "used in this diagram."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0681494:Diagram [Intellectual Product]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.236: The symbols in this diagram are the same as used in A.Below autoradiograms are depicted, showing the splicing pattern of the minigenes described above. 

Phrase: "The symbols in this diagram"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0679214:symbols [Idea or Concept]
   726 E C1698987:symbol [Intellectual Product]

Phrase: "are"

Phrase: "the same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "as"

Phrase: "used in A."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "Below autoradiograms"

Phrase: "are"

Phrase: "depicted"

Phrase: ","

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the splicing pattern of the minigenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.237: Both cis-Elements Act in a Distance-dependent Manner Regulating the Recognition of Exon 15-- From the deletion analysis of the intronic regions proximal to exon 15,we concluded that these sequences contain cis-acting elements (UCR and DCR, respectively), both having an inhibitory influence on the exon 15inclusion in non-neuronal cells. 

Phrase: "Both cis-Elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "Act in a Distance-dependent Manner"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0012751:Distance [Quantitative Concept]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "Regulating"

Phrase: "the Recognition of Exon 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0524637:Recognition [Mental Process]

Phrase: "-"

Phrase: "-"

Phrase: "From the deletion analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "of the intronic regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "proximal to exon 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205107:Proximal [Spatial Concept]

Phrase: "we"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "these sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "cis-acting elements"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   988   C0599780:cis acting element [Nucleotide Sequence]
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "(UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "DCR,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "both"

Phrase: "having"

Phrase: "an inhibitory influence on the exon 15inclusion"

Phrase: "in non-neuronal cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.238: To test the functional relationship between these cis-elements and exon 15,we increased the distance between exon 15and UCR from 68to 418nt and between exon 15and DCR from 20to 711nt (Fig. 6A, UCR1 and DCR1). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the functional relationship between these cis-elements"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C2700217:Functional Relationship [Conceptual Entity]
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "exon 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the distance between exon 15and UCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0012751:Distance [Quantitative Concept]

Phrase: "from 68to 418nt"

Phrase: "and between exon 15and DCR"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   774   C1883633:Downstream Region [Nucleotide Sequence]
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0522506:Downstream [Spatial Concept]
   748   C1515981:And [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "from 20to 711nt"

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "UCR1"

Phrase: "and"

Phrase: "DCR1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1333218:DCR1 [Gene or Genome]
  1000   C1420803:DCR1 [Gene or Genome]
  1000   C1720962:DcR1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C3539668:DCR1 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.239: In both cases an increase of the distance between exon 15and the corresponding cis-element resulted in an enhanced inclusion of exon 15in the minigene mRNA of NIH3T3 cells. 

Phrase: "In both cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "an increase of the distance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "between exon 15and"

Phrase: "the corresponding cis-element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C1705248:Element [Conceptual Entity]

Phrase: "resulted in an enhanced inclusion of exon 15in"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1512693:Inclusion [Qualitative Concept]
   744   C2349975:Enhanced [Activity]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "the minigene mRNA of NIH3T3 cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.240: The observed effect was associated by an increase of the relative MG-APPex15 amount up to 723(n=4,UCR1) and 822% (n=8,DCR1) in comparison to 525% of MG-APPex15 (n=26,MG2) in wild type-transfected control cells (Fig. 6, A and B, lanes 1and 3versus 6). 

Phrase: "The observed effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "associated by an increase of the relative MG-APPex15 amount"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C0332281:Associated [Qualitative Concept]
   739   C0439269:mg% [Quantitative Concept]
   739   C0442805:Increase [Functional Concept]
   739   C1265611:Amount [Quantitative Concept]
   739   C1547039:*Relative [Quantitative Concept]
   739   C1960952:mg % [Quantitative Concept]
   739   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1706221:Associate [Professional or Occupational Group]

Phrase: "up to 723"

Phrase: "(n=4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "UCR1"

Phrase: ")"

Phrase: "and"

Phrase: "822%"

Phrase: "(n=8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "DCR1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1333218:DCR1 [Gene or Genome]
  1000   C1420803:DCR1 [Gene or Genome]
  1000   C1720962:DcR1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C3539668:DCR1 [Gene or Genome]

Phrase: ")"

Phrase: "in comparison to 525%"

Phrase: "of MG-APPex15"

Phrase: "(n=26,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "MG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "in wild type-transfected control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   858   C0449475:type cell [Intellectual Product]
   804   C0007634:Cells [Cell]
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "lanes 1and 3versus 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.241: However, the spacing between UCR and exon 15did not affect the usage of the differential exon in P19 cells (Fig. 6B, lane 7). 

Phrase: "However,"

Phrase: "the spacing between UCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710137:Spacing [Quantitative Concept]

Phrase: "and"

Phrase: "exon 15did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the usage of the differential exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0457083:Usage [Functional Concept]

Phrase: "in P19 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6B,"

Phrase: "lane 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.242: Enlarging the distance between DCR and exon 15slightly improved the usage of exon 15in P19 cells (Fig. 6B, DCR1, lane 9) similar to that observed in cells expressing a DCR-deficient minigene (Fig. 5B, DCR, lane 5). 

Phrase: "Enlarging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442800:enlarging [Qualitative Concept]

Phrase: "the distance between DCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0012751:Distance [Quantitative Concept]

Phrase: "and"

Phrase: "exon 15slightly"

Phrase: "improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "the usage of exon 15in P19 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0457083:Usage [Functional Concept]

Phrase: "(Fig. 6B,"

Phrase: "DCR1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1333218:DCR1 [Gene or Genome]
  1000   C1420803:DCR1 [Gene or Genome]
  1000   C1720962:DcR1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C3539668:DCR1 [Gene or Genome]

Phrase: "lane 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1441672:Observed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "a DCR-deficient minigene"

Phrase: "(Fig. 5B,"

Phrase: "DCR,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.243: Thus, these results suggested that the proximity of both regulatory elements to exon 15is one of the essential parameters determining their inhibitory function. 

Phrase: "Thus,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the proximity of both regulatory elements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514583:Proximity [Spatial Concept]

Phrase: "to exon 15is"

Phrase: "one of the essential parameters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "determining"

Phrase: "their inhibitory function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.244: View larger version (41K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.245: 6.  

Phrase: "6."
Processing 00000000.tx.246: Properties of UCR and DCR. 

Phrase: "Properties of UCR"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "DCR."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.247: A, left panel, maps of constructs for analyzing distance, enhancing and cooperative effects of UCR and DCR. 

Phrase: "A,"

Phrase: "left panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "maps of constructs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0024779:Map [Manufactured Object]
   790   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1706473:Map [Conceptual Entity]
   756   C2827421:Construct [Classification]

Phrase: "for analyzing distance,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0012751:Distance [Quantitative Concept]
   789 E C0443203:Distant [Spatial Concept]

Phrase: "enhancing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "and"

Phrase: "cooperative effects of UCR"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "DCR."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.248: On top the genomic map of MG2 is shown. 

Phrase: "On top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "the genomic map of MG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0024779:Map [Manufactured Object]
   760   C1706473:Map [Conceptual Entity]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.249: Below the genomic PacI/AflII fragments of MG2 and the mutated minigenes are enlarged, indicating exon 15(gray box), introns (bold solid lines), cis-elements UCR, DCR (white boxes with cross-hatching), and deletions (open triangle). 

Phrase: "Below the genomic PacI/AflII"

Phrase: "fragments of MG2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332255:fragment [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   790   C1417500:MG2 [Gene or Genome]
   790   C1708096:Fragment [Qualitative Concept]
   790   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "the mutated minigenes"

Phrase: "are"

Phrase: "enlarged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442800:Enlarged [Qualitative Concept]
  1000   C1293134:Enlarged [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "indicating"

Phrase: "exon 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(gray box"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "introns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021920:Introns [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(bold solid lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "cis-elements UCR,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   853   C1883644:Upstream Region [Nucleotide Sequence]
   804   C0017446:Region [Geographic Area]
   804   C0205147:Region [Spatial Concept]
   733 E C0205276:Regional [Spatial Concept]
   733 E C1947913:Regional [Spatial Concept]

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "(white boxes with"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0179400:boxes [Manufactured Object]
   790   C1638312:Boxes [Quantitative Concept]
   756 E C1533124:Box [Medical Device]

Phrase: "cross-hatching"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0598016:hatching [Organism Function]
   861   C2828360:Cross [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880274:Deletions [Activity]
   966 E C1442161:Deletion [Cell or Molecular Dysfunction]
   966 E C1511760:Deletion [Genetic Function]

Phrase: "(open triangle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205119:Triangle [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.250: Size of sequence elements is marked by numbers but not drawn in scale. 

Phrase: "Size of sequence elements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456389:size [Spatial Concept]

Phrase: "is"

Phrase: "marked by numbers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]
   790   C0522501:Marked [Qualitative Concept]
   790   C1706089:Marked [Qualitative Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "drawn in scale."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0175659:Scale [Medical Device]
   790   C0349674:Scale [Intellectual Product]
   790   C1947916:Scale [Activity]
   790   C3536777:Scale [Manufactured Object]
   756   C0013113:Draw [Intellectual Product]
   718 E C1710017:Scalar [Qualitative Concept]
   706 E C0222045:Scales [Body Part, Organ, or Organ Component]
Processing 00000000.tx.251: Right panel, quantitative analysis of exon 15inclusion in the minigene-derived mRNA molecules from NIH3T3 and P19 cells. 

Phrase: "Right panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "quantitative analysis of exon 15inclusion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in the minigene-derived mRNA molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:molecules [Substance]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "from NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257739:NIH/3T3 [Cell]

Phrase: "and"

Phrase: "P19 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.252: At least two independent transfection experiments were performed in duplicate and analyzed by using a PhosphorImager. 

Phrase: "At least two independent transfection experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed in duplicate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "analyzed by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PhosphorImager."
Processing 00000000.tx.253: The mean of MG-APP for minigene MG2 was calculated by using all values that were determined together with the mutated minigenes (NIH3T3, n=26; P19, n=26). 

Phrase: "The mean of MG-APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0444504:Mean [Quantitative Concept]
   748   C2347634:Mean [Quantitative Concept]
   748   C2348143:Mean [Quantitative Concept]

Phrase: "for minigene MG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417500:MG2 [Gene or Genome]
   861   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "calculated by"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0444686:Calculated [Functional Concept]
   833   C1441506:Calculated [Activity]
   833   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "all values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "determined together with the mutated minigenes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C1705285:Mutated [Cell or Molecular Dysfunction]
   753   C1883357:Together [Qualitative Concept]
   719 E C1513776:Mutate [Genetic Function]

Phrase: "(NIH3T3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257739:NIH/3T3 [Cell]

Phrase: "n=26"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; P19,"

Phrase: "n=26"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.254: The bars symbolize the meanS.E. of percent exon 15inclusion (gray P19, dark gray NIH3T3). 

Phrase: "The bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "symbolize"

Phrase: "the meanS.E."

Phrase: "of percent exon 15inclusion"

Phrase: "(gray P19,"

Phrase: "dark gray NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1257739:NIH/3T3 [Cell]

Phrase: ")."
Processing 00000000.tx.255: The two vertical dashed lines indicate the percent of exon 15usage for MG2 in both cell lines. 

Phrase: "The two vertical dashed lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "indicate"

Phrase: "the percent of exon 15usage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439165:Percent [Quantitative Concept]

Phrase: "for MG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "in both cell lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.256: The p values of mutant constructs versus MG2 were determined by Student's t test; 

Phrase: "The p values of mutant constructs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1709380:P-Value [Quantitative Concept]
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "versus"

Phrase: "MG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "were"

Phrase: "determined by Student's t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.257: *, p<0.05; 

Phrase: "*,"

Phrase: "p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.258: **, p<0.01; 

Phrase: "*"

Phrase: "*,"

Phrase: "p<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.259: and ***, p<0.001.B, autoradiograms showing the splicing pattern of the minigenes described above. 

Phrase: "and **"

Phrase: "*,"

Phrase: "p<0.001.B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C1539794:P-B [Gene or Genome]

Phrase: "autoradiograms"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the splicing pattern of the minigenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.260: Many intronic cis-acting elements are characterized by their redundant architecture, which is reflected by the presence of multiple binding sites for certain trans-acting factors forming a regulatory protein complex (25-27). 

Phrase: "Many intronic cis-acting elements"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   912   C0599780:cis acting element [Nucleotide Sequence]
   812   C0013879:Elements [Element, Ion, or Isotope]
   779 E C1705248:Element [Conceptual Entity]

Phrase: "are"

Phrase: "characterized by their redundant architecture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0003737:Architecture [Occupation or Discipline]
   760   C0425087:Redundant [Finding]
   760   C1313915:Redundant [Functional Concept]
   760   C1880022:Characterized [Activity]

Phrase: "which"

Phrase: "is"

Phrase: "reflected by the presence of multiple binding sites"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0005456:Binding Sites [Receptor]
   750   C2945843:Site of [Qualitative Concept]
   744   C0205145:Sites [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0439064:Multiple [Quantitative Concept]
   744   C0558058:reflected [Mental Process]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   737 E C0682969:Binding Site [Amino Acid Sequence]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "for certain trans-acting factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0040627:Trans-Acting Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C2826298:TRANS [Idea or Concept]
   779   C0079613:ACT [Therapeutic or Preventive Procedure]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205431:Forming [Functional Concept]
  1000   C1522492:Forming [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]

Phrase: "a regulatory protein complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1523872:protein complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
   734   C0815047:Regulatory Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-27"

Phrase: ")."
Processing 00000000.tx.261: To examine this, the sequences of UCR and DCR were duplicated (Fig. 6A, dUCR and dDCR). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "this,"

Phrase: "the sequences of UCR"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0162326:Sequences [Nucleotide Sequence]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "were"

Phrase: "duplicated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332597:Duplicated [Functional Concept]
   966 E C0205173:Duplicate [Functional Concept]
   966 E C3539942:Duplicate [Intellectual Product]

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "dUCR"

Phrase: "and"

Phrase: "dDCR"

Phrase: ")."
Processing 00000000.tx.262: The duplication of UCR enhanced the blockage on exon 15recognition in NIH3T3 cells (Fig. 6B, lane 2), reflected by a decrease of the relative MG-APPex15 to 271% (Fig. 6A, n=6) compared with 535% MG-APPex15 (n=26) in control cells expressing wild type minigene MG2 (Fig. 6, A and B, lane 6). 

Phrase: "The duplication of UCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332597:Duplication [Functional Concept]
   753   C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the blockage on exon 15recognition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1706968:Blockage [Finding]
   760   C1879887:Blockage [Phenomenon or Process]

Phrase: "in NIH3T3 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6B,"

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "reflected by a decrease of the relative MG-APPex15"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C0392756:Decrease [Qualitative Concept]
   742   C0439269:mg% [Quantitative Concept]
   742   C0547047:Decrease [Quantitative Concept]
   742   C0558058:reflected [Mental Process]
   742   C1547039:*Relative [Quantitative Concept]
   742   C1960952:mg % [Quantitative Concept]
   742   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "to 271%"

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "compared with 535% MG-APPex15"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439269:mg% [Quantitative Concept]
   760   C1707455:Compared [Activity]
   760   C1960952:mg % [Quantitative Concept]
   760   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(n=26"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild type minigene MG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1417500:MG2 [Gene or Genome]
   812   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.263: Surprisingly, in P19 cells the dUCR construct slightly repressed the usage of exon 15too (Fig. 6B, lane 8), reducing the MG-APPex15 value to 847% (Fig. 6A, n=6). 

Phrase: "Surprisingly,"

Phrase: "in P19 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the dUCR"

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "repressed"

Phrase: "the usage of exon 15too"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0457083:Usage [Functional Concept]

Phrase: "(Fig. 6B,"

Phrase: "lane 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the MG-APPex15 value to 847%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522609:Value [Quantitative Concept]

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.264: In contrary, duplication of DCR did not measurably inhibit the usage of exon 15neither in NIH3T3 nor in P19 cells (Fig. 6, A and B, lanes 4and 10). 

Phrase: "In contrary,"

Phrase: "duplication of DCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332597:Duplication [Functional Concept]
   760   C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: "did"

Phrase: "not measurably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the usage of exon 15neither"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0457083:Usage [Functional Concept]

Phrase: "in NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257739:NIH/3T3 [Cell]

Phrase: "nor in P19 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0028423:NOR [Geographic Area]
   770   C0028609:NOR [Cell Component]
   770   C1513854:NOR [Mammal]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "lanes 4and 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.265: To address the question whether both cis-elements contained all sequence information to control the exon 15recognition in non-neuronal cells, minigene M2 carrying a deletion of UCR and DCR was analyzed in NIH3T3 and P19 cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "both cis-elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "all sequence information to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1533716:Information [Idea or Concept]
   755 E C3242430:informational [Idea or Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the exon 15recognition in non-neuronal cells,"

Phrase: "minigene M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457242:m2 [Quantitative Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "a deletion of UCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "was"

Phrase: "analyzed in NIH3T3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0936012:Analyzed [Research Activity]
   790   C1257739:NIH/3T3 [Cell]

Phrase: "and"

Phrase: "P19 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.266: In NIH3T3 cells exon 15of the M2 pre-mRNA molecules was almost constitutively included into the mRNA (Fig. 6B, lane 5), reflected by a strong increase of the relative MG-APPex15 portion to 913% (n=6) compared with 535% MG-APPex15 (n=26) in control cells transfected with an APP minigene containing both regulatory regions (Fig. 6, A and B, lane 6). 

Phrase: "In NIH3T3 cells exon 15of"

Phrase: "the M2 pre-mRNA molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:molecules [Substance]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "was"

Phrase: "almost constitutively"

Phrase: "included into the mRNA (Fig. 6B,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0332257:included [Functional Concept]
   753   C0349966:Fig [Food]
   753   C1337208:FIG [Food]
   753   C3538986:INCLUDED [Gene or Genome]
   719 E C1552866:include [Idea or Concept]
   719 E C2700399:Include [Activity]

Phrase: "lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "reflected by a strong increase of the relative MG-APPex15 portion"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   738   C0080103:Relative [Family Group]
   738   C0205345:Relative [Qualitative Concept]
   738   C0439269:mg% [Quantitative Concept]
   738   C0442805:Increase [Functional Concept]
   738   C0442821:Strong [Qualitative Concept]
   738   C0449719:Portion [Spatial Concept]
   738   C0558058:reflected [Mental Process]
   738   C1547039:*Relative [Quantitative Concept]
   738   C1960952:mg % [Quantitative Concept]
   738   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "to 913%"

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "compared with 535% MG-APPex15"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439269:mg% [Quantitative Concept]
   760   C1707455:Compared [Activity]
   760   C1960952:mg % [Quantitative Concept]
   760   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(n=26"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with an APP minigene"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "both regulatory regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0034987:Regulatory Regions [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.267: As expected, in P19 cells the removal of both cis-elements caused a slight activation of exon 15inclusion producing 981% MG-APPex15 (Fig. 6, A and B, lane 12), as it was observed by deleting DCR alone (Fig. 5B, DCR). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "in P19 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the removal of both cis-elements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015252:Removal [Therapeutic or Preventive Procedure]
   753   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a slight activation of exon 15inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "producing"

Phrase: "981% MG-APPex15"

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "lane 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "it"

Phrase: "was"

Phrase: "observed by deleting DCR alone"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   774   C1883633:Downstream Region [Nucleotide Sequence]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C0205171:Alone [Quantitative Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0439044:alone [Finding]
   748   C0522506:Downstream [Spatial Concept]
   748   C0679994:alone [Group Attribute]
   748   C1441672:Observed [Functional Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714   C1880274:Delete [Activity]

Phrase: "(Fig. 5B,"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.268: Shifting the splicing pattern toward the neuronal splice site recognition in non-neuronal cells by removing UCR and DCR suggested that both elements are key players mediating the blockage of exon 15usage in NIH3T3 cells. 

Phrase: "Shifting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0333051:shifting [Functional Concept]
   966 E C2347509:Shift [Phenomenon or Process]

Phrase: "the splicing pattern toward the neuronal splice site recognition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1518918:Pattern Recognition [Mental Process]
   742   C0449774:Pattern [Spatial Concept]

Phrase: "in non-neuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "by removing UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   875   C1883644:Upstream Region [Nucleotide Sequence]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013879:Elements [Element, Ion, or Isotope]
   966 E C1705248:Element [Conceptual Entity]

Phrase: "are"

Phrase: "key players"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "the blockage of exon 15usage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1706968:Blockage [Finding]
   760   C1879887:Blockage [Phenomenon or Process]

Phrase: "in NIH3T3 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.269: The Combination of Multiple Sequences Is Involved in the Inhibitory Function of UCR and DCR-- The inhibitory effect of UCR duplication on the recognition of exon 15described in the previous section implicated a redundant architecture of this sequence element. 

Phrase: "The Combination of Multiple Sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "Is"

Phrase: "Involved in the Inhibitory Function of UCR"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   762   C1883644:Upstream Region [Nucleotide Sequence]
   762   C2587213:Control function [Functional Concept]
           Control
   762   C3274768:Inhibitory Control [Cell Function]
   742   C0017446:Region [Geographic Area]
   742   C0031843:function [Physiologic Function]
   742   C0205147:Region [Spatial Concept]
   742   C0243148:control [Qualitative Concept]
   742   C0522505:Upstream [Spatial Concept]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1314939:Involved [Functional Concept]
   742   C1550141:Control [Substance]
   742   C1705273:Function [Intellectual Product]
   742   C1882979:Control [Conceptual Entity]
   742   C3274648:Control [Qualitative Concept]
   742   C3463820:Inhibitory [Activity]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The inhibitory effect of UCR duplication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on the recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524637:Recognition [Mental Process]

Phrase: "of exon 15described"

Phrase: "in the previous section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205155:Section [Spatial Concept]
   861   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   861   C1522472:Section [Substance]
   861   C1552923:Section [Quantitative Concept]
   861   C1705191:Section [Physical Object]

Phrase: "implicated"

Phrase: "a redundant architecture of this sequence element."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003737:Architecture [Occupation or Discipline]
Processing 00000000.tx.270: UCR from both the human and the mouse APP gene displays a high pyrimidine content of ~75% (Fig. 7A). 

Phrase: "UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "from both"

Phrase: "the human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "the mouse APP gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Gene [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a high pyrimidine content of ~75%"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0034284:Pyrimidine [Organic Chemical]
   804   C0034289:Pyrimidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205250:High [Qualitative Concept]
   804   C0423896:Content [Mental Process]
   804   C0456205:Content [Conceptual Entity]
   804   C1299351:High [Qualitative Concept]
   804   C2700149:HIGH [Intellectual Product]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.271: The majority of the pyrimidine residues are organized in three stretches, each consisting of between 8and 14successive pyrimidines. 

Phrase: "The majority of the pyrimidine residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "are"

Phrase: "organized in three stretches,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205449:Three [Quantitative Concept]
   770   C0270814:Stretches [Disease or Syndrome]
   770   C1300196:Organized [Functional Concept]
   737 E C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "each"

Phrase: "consisting of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0332529:CONSIST [Qualitative Concept]

Phrase: "between 8and 14successive pyrimidines."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0034289:Pyrimidines [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793 E C0034284:Pyrimidine [Organic Chemical]
Processing 00000000.tx.272: We therefore referred to these sequence elements as polypyrimidine-rich sequences PPSI, PPSII, and PPSIII (Fig. 7A). 

Phrase: "We therefore"

Phrase: "referred to these sequence elements"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C1555599:Referred to [Idea or Concept]
   806   C1691010:Referred to [Functional Concept]
           Referred
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0013879:Elements [Element, Ion, or Isotope]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0205543:referred [Functional Concept]
   760   C1519249:Sequence [Functional Concept]
   726 E C1705248:Element [Conceptual Entity]

Phrase: "as polypyrimidine-rich sequences PPSI,"

Phrase: "PPSII,"

Phrase: "and"

Phrase: "PPSIII"

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.273: Furthermore, PPSII and PPSIII are flanked at one or both ends, respectively, by a tetranucleotide motif UGCU. 

Phrase: "Furthermore,"

Phrase: "PPSII"

Phrase: "and"

Phrase: "PPSIII"

Phrase: "are"

Phrase: "flanked at one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205447:One [Quantitative Concept]
   756   C0230171:Flank [Body Location or Region]

Phrase: "or"

Phrase: "both ends,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0444930:ends [Spatial Concept]
   966 E C2746065:End [Temporal Concept]
   928 E C0205088:Terminal [Temporal Concept]
   928 E C1705314:Terminal [Manufactured Object]
   928 E C1705315:Terminal [Spatial Concept]

Phrase: "respectively,"

Phrase: "by a tetranucleotide motif UGCU."
Processing 00000000.tx.274: To examine the role of PPSI, PPSII, and PPSIII in the inhibition of exon 15inclusion in non-neuronal cells, point mutations were introduced into each element as depicted in Fig. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the role of PPSI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "PPSII,"

Phrase: "and"

Phrase: "PPSIII in the inhibition of exon 15inclusion"

Phrase: "in non-neuronal cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "introduced into each element"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0013879:Element [Element, Ion, or Isotope]
   770   C1705248:Element [Conceptual Entity]
   737   C1292748:introduce [Functional Concept]

Phrase: "as"

Phrase: "depicted in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.275: 7A, and the expression pattern of the corresponding constructs was examined in NIH3T3 and P19 cells. 

Phrase: "7A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the expression pattern of the corresponding constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "examined in NIH3T3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332128:Examined [Finding]
   790   C1257739:NIH/3T3 [Cell]

Phrase: "and"

Phrase: "P19 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.276: All point mutations in PPSI, PPSII, and PPSIII (Fig. 7A, PM25, PM26, and PM23, respectively) weakened the inhibitory function of UCR in non-neuronal cells that was reflected by an increase of the relative MG-APPex15 amount in NIH3T3 cells between 672and 744% in comparison to control cells expressing the parental APP construct MG2 (494%). 

Phrase: "All point mutations in PPSI,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   760   C0026882:Mutations [Genetic Function]
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "PPSII,"

Phrase: "and"

Phrase: "PPSIII"

Phrase: "(Fig. 7A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "PM25,"

Phrase: "PM26,"

Phrase: "and"

Phrase: "PM23,"

Phrase: "respectively"

Phrase: ")"

Phrase: "weakened"

Phrase: "the inhibitory function of UCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C2587213:Control function [Functional Concept]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "in non-neuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "was"

Phrase: "reflected by an increase of the relative MG-APPex15 amount"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C0439269:mg% [Quantitative Concept]
   739   C0442805:Increase [Functional Concept]
   739   C0558058:reflected [Mental Process]
   739   C1265611:Amount [Quantitative Concept]
   739   C1547039:*Relative [Quantitative Concept]
   739   C1960952:mg % [Quantitative Concept]
   739   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "in NIH3T3 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "between 672and 744%"

Phrase: "in comparison to control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the parental APP construct MG2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1417500:MG2 [Gene or Genome]
   799   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(494%"

Phrase: ")."
Processing 00000000.tx.277: In contrast, these mutations did not significantly affect the usage of exon 15in P19 cells (Fig. 7A). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "these mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the usage of exon 15in P19 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0457083:Usage [Functional Concept]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.278: The strength of this effect was in the range of that observed for the constructs UCR (793%) and RCU (803%), both completely destroying this regulatory element (Fig. 4B). 

Phrase: "The strength of this effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237897:Strength [Quantitative Concept]
   760   C0808080:Strength [Idea or Concept]
   760   C1705922:Strength [Qualitative Concept]

Phrase: "was in the range of that"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1421478:WAS [Gene or Genome]
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "observed for the constructs UCR"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   774   C1883644:Upstream Region [Nucleotide Sequence]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0522505:Upstream [Spatial Concept]
   748   C1441672:Observed [Functional Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714   C2827421:Construct [Classification]

Phrase: "(793%"

Phrase: ")"

Phrase: "and"

Phrase: "RCU (803%"

Phrase: ")"

Phrase: ","

Phrase: "both completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "destroying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Destroy [Idea or Concept]

Phrase: "this regulatory element"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   861   C1705248:Element [Conceptual Entity]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.279: This indicates that PPSI, PPSII, and PPSIII are involved in the repression of exon 15recognition in non-neuronal cells. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that PPSI,"

Phrase: "PPSII,"

Phrase: "and"

Phrase: "PPSIII"

Phrase: "are"

Phrase: "involved in the repression of exon 15recognition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0035143:Repression [Mental Process]
   748   C1314939:Involved [Functional Concept]

Phrase: "in non-neuronal cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.280: View larger version (25K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.281: 7.  

Phrase: "7."
Processing 00000000.tx.282: Point mutation analysis of UCR and DCR. 

Phrase: "Point mutation analysis of UCR"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   778   C0796357:mutation analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0026882:Mutation [Genetic Function]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1552961:Point [Quantitative Concept]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
   748   C2347617:point [Quantitative Concept]

Phrase: "and"

Phrase: "DCR."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.283: A, left panel, on top, an alignment between the mouse (positions 138 to 69) and human UCR RNA sequence is depicted, and identical nucleotides are marked by bold vertical lines. 

Phrase: "A,"

Phrase: "left panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "on top,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "an alignment between the mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706765:Alignment [Quantitative Concept]

Phrase: "(positions 138 to 69"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0450388:69 [Intellectual Product]
   770   C0733755:positions [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "human UCR RNA sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0162327:RNA Sequence [Nucleotide Sequence]
           Sequence
   799   C0004793:Sequence [Nucleotide Sequence]
   799   C0162326:Sequence [Nucleotide Sequence]
   799   C1519249:Sequence [Functional Concept]
   727 E C1548958:Sequential [Idea or Concept]
   727 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "depicted"

Phrase: ","

Phrase: "and"

Phrase: "identical nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "marked by bold vertical lines."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205128:Vertical [Spatial Concept]
   760   C0205132:lines [Spatial Concept]
   760   C0522501:Marked [Qualitative Concept]
   760   C1706089:Marked [Qualitative Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.284: Polypyrimidine-rich sequences (PPSI-III, typed in boldface nucleotides) are framed by black lines. 

Phrase: "Polypyrimidine-rich sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "(PPSI-III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "typed in boldface nucleotides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   737   C0332307:Type [Qualitative Concept]
   737   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "framed by black lines."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0005680:Black [Population Group]
   770   C0027567:Black [Population Group]
   770   C0085756:Black [Population Group]
   770   C0205132:lines [Spatial Concept]
   770   C0439541:Black [Qualitative Concept]
   737   C0080089:Frame [Nucleotide Sequence]
   737   C0180979:Frame [Medical Device]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]
   737   C1705858:Frame [Manufactured Object]
Processing 00000000.tx.285: Below the point mutations PM23, PM25, and PM26 are shown, indicating the mutated sequences. 

Phrase: "Below the point mutations PM23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0162735:Point Mutations [Cell or Molecular Dysfunction]

Phrase: "PM25,"

Phrase: "and"

Phrase: "PM26"

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "indicating"

Phrase: "the mutated sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.286: Right panel, the meanS.E. of percent exon 15inclusion measured in two independent experiments with double samples is shown. 

Phrase: "Right panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "the meanS.E."

Phrase: "of percent exon 15inclusion"

Phrase: "measured in two independent experiments"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0085862:Independent [Idea or Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1299583:Independent [Finding]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "with double samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.287: B, left panel, on top an alignment between the first 47nucleotides of the mouse and human DCR RNA sequence is shown, using the same symbols as in A. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "left panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "on top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "an alignment between the first 47nucleotides of the mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1706765:Alignment [Quantitative Concept]

Phrase: "and"

Phrase: "human DCR RNA sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0162327:RNA Sequence [Nucleotide Sequence]
           Sequence
   799   C0004793:Sequence [Nucleotide Sequence]
   799   C0162326:Sequence [Nucleotide Sequence]
   799   C1519249:Sequence [Functional Concept]
   727 E C1548958:Sequential [Idea or Concept]
   727 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "as in A."
Processing 00000000.tx.288: The conserved RNA motifs GCCUCU(C)(U) and GCUCUCU are typed in boldface letters and framed by black lines. 

Phrase: "The conserved RNA motifs GCCUCU"

Phrase: "(C)(U"

Phrase: ")"

Phrase: "and"

Phrase: "GCUCUCU"

Phrase: "are"

Phrase: "typed in boldface letters"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0282413:letters [Intellectual Product]
   737   C0332307:Type [Qualitative Concept]
   737 E C1096774:Letter [Intellectual Product]
   737   C1547052:*Type [Quantitative Concept]
   737 E C2360551:Letter [Clinical Attribute]

Phrase: "and"

Phrase: "framed by black lines."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0005680:Black [Population Group]
   770   C0027567:Black [Population Group]
   770   C0085756:Black [Population Group]
   770   C0205132:lines [Spatial Concept]
   770   C0439541:Black [Qualitative Concept]
   737   C0080089:Frame [Nucleotide Sequence]
   737   C0180979:Frame [Medical Device]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]
   737   C1705858:Frame [Manufactured Object]
Processing 00000000.tx.289: Right panel illustrates the meanS.E. of percent exon 15inclusion, determined in two independent experiments performed in duplicate. 

Phrase: "Right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "illustrates"

Phrase: "the meanS.E."

Phrase: "of percent exon 15inclusion,"

Phrase: "determined in two independent experiments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0085862:Independent [Idea or Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1299583:Independent [Finding]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "performed in duplicate."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.290: Similar analysis was performed for the other cis-regulatory region DCR (Fig. 7B). 

Phrase: "Similar analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed for the"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "other cis-regulatory region DCR"

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.291: In contrast to UCR, the pyrimidine content of human and mouse DCR is more balanced making up ~60% of all residues. 

Phrase: "In contrast to UCR,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "the pyrimidine content of human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "mouse DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   875   C1883633:Downstream Region [Nucleotide Sequence]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "balanced"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205415:Balanced [Functional Concept]
   966 E C0014653:Balance [Organism Function]
   966 E C0560184:Balance [Finding]

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "up ~60% of all residues."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0547043:Up [Spatial Concept]
   760   C1282911:Up [Spatial Concept]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.292: Approximately 50% of the pyrimidines are clustered in four (murine DCR) or five (human DCR) short stretches between 5and 16nt in length, located at both ends of the DCR. 

Phrase: "Approximately 50% of the pyrimidines"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0034289:Pyrimidines [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0332232:Approximately [Qualitative Concept]
   726 E C0034284:Pyrimidine [Organic Chemical]

Phrase: "are"

Phrase: "clustered in four"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205450:Four [Quantitative Concept]
   756   C1555715:Cluster [Idea or Concept]
   756   C1704332:Cluster [Quantitative Concept]

Phrase: "(murine DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   875   C1883633:Downstream Region [Nucleotide Sequence]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "five"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205451:Five [Quantitative Concept]

Phrase: "(human DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   875   C1883633:Downstream Region [Nucleotide Sequence]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: ")"

Phrase: "short stretches between 5and 16nt"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0270814:Stretches [Disease or Syndrome]
   726 E C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "in length,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]

Phrase: "located at both"

Phrase: "ends of the DCR."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C1883633:Downstream Region [Nucleotide Sequence]
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C0243148:control [Qualitative Concept]
   753   C0444930:End [Spatial Concept]
   753   C0522506:Downstream [Spatial Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C2746065:End [Temporal Concept]
   753   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.293: Two of these pyrimidine-rich sequences contain a short conserved repeat GCCUCU(C)(U) and a truncated version GCUCUC (Fig. 7B). 

Phrase: "Two of these pyrimidine-rich sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205448:Two [Quantitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a short conserved repeat GCCUCU"

Phrase: "(C)(U"

Phrase: ")"

Phrase: "and"

Phrase: "a truncated version GCUCUC"

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.294: The involvement of these elements in the inhibitory function of DCR was tested by mutating them to the complementary sequences shown in Fig. 

Phrase: "The involvement of these elements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in the inhibitory function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "of DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "was"

Phrase: "tested by mutating"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0392366:tested [Intellectual Product]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]
   756   C1513776:Mutate [Genetic Function]

Phrase: "them to the complementary sequences"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.295: 7B. 

Phrase: "7B."
Processing 00000000.tx.296: Point mutations present in the constructs PM13, PM14, and PM15 had no significant effect on exon 15usage neither in NIH3T3 nor in P19 cells (Fig. 7B). 

Phrase: "Point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "present in the constructs PM13,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   726   C2827421:Construct [Classification]

Phrase: "PM14,"

Phrase: "and"

Phrase: "PM15"

Phrase: "had"

Phrase: "no significant effect on exon 15usage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "neither in NIH3T3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1257739:NIH/3T3 [Cell]
   790   C3274651:Neither [Qualitative Concept]

Phrase: "nor in P19 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0028423:NOR [Geographic Area]
   770   C0028609:NOR [Cell Component]
   770   C1513854:NOR [Mammal]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.297: Since the function of an intronic cis-element is often mediated by a combination of different sequence motifs (27), in minigenes PM34.1 and PM35 parts of the mutated sequences in PM13 or PM15 were combined with the mutation of construct PM14, respectively (Fig. 7B). 

Phrase: "Since"

Phrase: "the function of an intronic cis-element"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "mediated by a combination of different sequence motifs"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0205195:Combination [Qualitative Concept]
   744   C1519249:Sequence [Functional Concept]
   744   C1705242:Different [Qualitative Concept]
   744   C1947911:Combination [Physical Object]
   711   C1514562:Motif [Amino Acid Sequence]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "in minigenes PM34.1"

Phrase: "and"

Phrase: "PM35 parts of the mutated sequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C1292711:Part of [Spatial Concept]
   753   C0449719:parts [Spatial Concept]
   753   C1709471:PARTS [Quantitative Concept]

Phrase: "in PM13"

Phrase: "or"

Phrase: "PM15"

Phrase: "were"

Phrase: "combined with the mutation of construct PM14,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0026882:Mutation [Genetic Function]
   748   C0205195:Combined [Qualitative Concept]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
   748   C2827421:Construct [Classification]
   714 E C0336789:Combine [Manufactured Object]

Phrase: "respectively"

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.298: These double mutations drastically impaired the inhibitory function of DCR in NIH3T3 cells increasing the relative amount of APPex15 to 784% (n=4) for PM34.1 and 741% (n=4) for PM35 compared with 5310% (n=12) for the MG2-transfected control cells. 

Phrase: "These double mutations drastically"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "the inhibitory function of DCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C2587213:Control function [Functional Concept]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "in NIH3T3 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the relative amount of APPex15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "to 784%"

Phrase: "(n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "for PM34.1"

Phrase: "and"

Phrase: "741%"

Phrase: "(n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "for PM35"

Phrase: "compared with 5310%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "(n=12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "for the MG2-transfected control cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0007634:Cells [Cell]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.299: In P19 cells, these mutations caused no significant alteration of the splicing pattern (Fig. 7B). 

Phrase: "In P19 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "these mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "no significant alteration of the splicing pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515926:Alteration [Idea or Concept]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.300: Therefore, we concluded that at least two of these RNA motifs in the DCR sequence are necessary to inhibit the usage of exon 15in NIH3T3 cells. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that at least two of these RNA motifs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C3178797:RNA Motifs [Nucleotide Sequence]
   744   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0205448:Two [Quantitative Concept]
   711   C1514562:Motif [Amino Acid Sequence]

Phrase: "in the DCR sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]
   708   C1883633:Downstream Region [Nucleotide Sequence]

Phrase: "are"

Phrase: "necessary to"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the usage of exon 15in NIH3T3 cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0457083:Usage [Functional Concept]
Processing 00000000.tx.301: UCR and DCR Regulate the Inclusion of a Hybrid Exon in a Constitutive Splicing Background-- The results reported in the preceding sections showed that the identified cis-elements block the recognition of exon 15in NIH3T3 cells. 

Phrase: "UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "Regulate"

Phrase: "the Inclusion of a Hybrid Exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1512693:Inclusion [Qualitative Concept]

Phrase: "in a Constitutive Splicing Background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706907:Background [Conceptual Entity]

Phrase: "-"

Phrase: "-"

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "reported in the preceding sections"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0332152:Preceding [Temporal Concept]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]
   726 E C3273238:Report [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the identified cis-elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the recognition of exon 15in NIH3T3 cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0678836:cell recognition [Cell Function]
   748   C0524637:Recognition [Mental Process]
Processing 00000000.tx.302: To examine the ability of UCR and DCR to regulate the cell type-specific inclusion of a chimeric exon, both elements were grafted into the constitutive splicing background of the human APLP1 gene, a member of the APP gene family (28-30). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the ability of UCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "DCR to"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   875   C1883633:Downstream Region [Nucleotide Sequence]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   812   C0243148:control [Qualitative Concept]
   812   C0522506:Downstream [Spatial Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "regulate"

Phrase: "the cell type-specific inclusion of a chimeric exon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0205708:cell inclusion [Cell Component]
   742   C1512693:Inclusion [Qualitative Concept]

Phrase: "both elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013879:Elements [Element, Ion, or Isotope]
   966 E C1705248:Element [Conceptual Entity]

Phrase: "were"

Phrase: "grafted into the constitutive splicing background of the human APLP1 gene,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   756   C1412466:APLP1 gene [Gene or Genome]
           APLP1
   754   C0017365:gene splicing [Gene or Genome]
   754   C0017387:Gene Splicing [Molecular Biology Research Technique]
   754   C0314604:Human gene [Gene or Genome]
   738   C0017337:Gene [Gene or Genome]
   738   C0035687:Splicing [Genetic Function]
   738   C0086418:Human [Human]
   738   C0700106:Grafted [Functional Concept]
   738   C1706907:Background [Conceptual Entity]
   738   C2610186:splicing [Genetic Function]
   704 E C0181074:{Graft} [Biomedical or Dental Material]
   704 E C0332835:Graft [Tissue]
   704 E C1961139:Graft, NOS [Therapeutic or Preventive Procedure]

Phrase: "a member of the APP gene family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0086282:Family member [Family Group]
   762   C1611821:Family Member [Intellectual Product]
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "(28-30"

Phrase: ")."
Processing 00000000.tx.303: For this purpose, a 553-bp genomic segment of the APLP1 gene, encompassing the constitutively spliced exons 15-17, was amplified by PCR from genomic DNA and subcloned into the pZeoSV vector, generating APLP1 minigene MG4. 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "a 553-bp genomic segment of the APLP1 gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1517520:Genomic Segment [Conceptual Entity]
   742   C0441635:Segment [Spatial Concept]

Phrase: "encompassing"

Phrase: "the constitutively spliced exons 15-17,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "from genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "subcloned into the pZeoSV vector,"

Phrase: "generating"

Phrase: "APLP1 minigene MG4."
Processing 00000000.tx.304: To minimize possible effects of potential cis-acting elements in exon 16(144bp length) of APLP1 and to reduce the size of the exon to that of the APP exon 15(54bp), the minigene construct E1690 was created by deleting 90bp of the central part of APLP1 exon 16(Fig. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "possible effects of potential cis-acting elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "in exon 16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(144bp length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: ")"

Phrase: "of APLP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412466:APLP1 [Gene or Genome]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "the size of the exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0456389:size [Spatial Concept]

Phrase: "to that"

Phrase: "of the APP exon 15"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "(54bp"

Phrase: ")"

Phrase: ","

Phrase: "the minigene construct E1690"

Phrase: "was"

Phrase: "created by deleting 90bp of the central part of APLP1 exon 16"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   753   C1707531:Created By [Qualitative Concept]
   751   C1292711:Part of [Spatial Concept]
   736   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0205099:Central [Spatial Concept]
   736   C0449719:Part [Spatial Concept]
   736   C1412466:APLP1 [Gene or Genome]
   736   C1706214:Created [Activity]
   736   C1709471:Part [Quantitative Concept]
   736   C1879652:Central - [Laboratory Procedure]
   703   C1880274:Delete [Activity]
   703 E C3244320:create [Functional Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.305: 8A). 

Phrase: "8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.306: Since P19 cells did not accept the minigene-derived pre-mRNA molecules as splicing substrates (data not shown), for this particular study the neuroblastoma cell line N2a was used as a neuronal splicing system. 

Phrase: "Since"

Phrase: "P19 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accept"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272684:accept [Qualitative Concept]
  1000   C1548601:Accept [Idea or Concept]

Phrase: "the minigene-derived pre-mRNA molecules as splicing substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0567416:molecules [Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "for this particular"

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the neuroblastoma cell line N2a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0445079:N2a [Finding]

Phrase: "was"

Phrase: "used as a neuronal splicing system."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0035687:Splicing [Genetic Function]
   753   C0449913:System [Functional Concept]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C1273517:used [Finding]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C2610186:splicing [Genetic Function]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.307: After transient transfection of MG4 and E1690 into NIH3T3 and N2a cells, the splicing pattern of the minigene-derived mRNA molecules was monitored by qualitative RT-PCR using minigene-specific primers spZEO1 and apZEO2 (Fig. 2A). 

Phrase: "After transient transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of MG4"

Phrase: "and"

Phrase: "E1690 into NIH3T3"

Phrase: "and"

Phrase: "N2a cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the splicing pattern of the minigene-derived mRNA molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "monitored by qualitative RT-PCR"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0599161:RT-PCR [Molecular Biology Research Technique]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0205556:Qualitative [Qualitative Concept]
   760   C0677874:pCR [Finding]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726   C1521743:Monitor [Professional or Occupational Group]
   726   C1704646:Monitor [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "minigene-specific primers spZEO1"

Phrase: "and"

Phrase: "apZEO2"

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.308: The identity of each PCR product was confirmed by sequencing (data not shown). 

Phrase: "The identity of each PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0424215:Identity [Mental Process]
   753   C2003939:Identity [Finding]

Phrase: "was"

Phrase: "confirmed by sequencing"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.309: As expected, APLP1 exon 16was constitutively included in chimeric mRNA molecules from both cell lines (Fig. 8B, lanes 1and 2). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "APLP1 exon 16was constitutively"

Phrase: "included in chimeric mRNA molecules"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0008109:chimeric [Organism]
   760   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0332257:included [Functional Concept]
   760   C0567416:molecules [Substance]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]

Phrase: "from both cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig. 8B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: "lanes 1and 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.310: However, removing 90bp of the internal sequence in exon 16(exon 90) yielded a very different result, reflected by the generation of two splice products of 341-and 287-bp length in both cell lines (Fig. 8B, lanes 3and 4). 

Phrase: "However,"

Phrase: "removing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0849355:remove [Qualitative Concept]
   966   C1883720:Remove [Activity]
   966   C3244314:remove [Functional Concept]

Phrase: "90bp of the internal sequence"

Phrase: "in exon 16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(exon 90"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: "yielded"

Phrase: "a very different result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "reflected by the generation of two splice products of 341-"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   739   C0079411:Generation [Temporal Concept]
   739   C0205448:Two [Quantitative Concept]
   739   C0558058:reflected [Mental Process]
   739   C1514468:Products [Entity]
   739   C3146294:Generation [Activity]
   706 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "287-bp length in both cell lines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
   721   C0179740:Long line [Medical Device]

Phrase: "(Fig. 8B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: "lanes 3and 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.311: The faster migrating band corresponds to mRNA species lacking the exon 90. 

Phrase: "The faster migrating band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "corresponds to mRNA species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1705920:Species [Conceptual Entity]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the exon 90."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]
Processing 00000000.tx.312: To test whether UCR and DCR could block the inclusion of exon 90 in NIH3T3 cells, the first 10nt of exon 90 with the flanking intronic sequences were exchanged against the corresponding regions of exon 15with UCR and DCR (Fig. 8A, C1). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "could"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the inclusion of exon 90"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1512693:Inclusion [Qualitative Concept]

Phrase: "in NIH3T3 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the first 10nt of exon 90"

Phrase: "with the flanking intronic sequences"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   827   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequences [Nucleotide Sequence]
   827   C0230171:flanking [Body Location or Region]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "exchanged against the corresponding regions of exon 15with UCR"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   738   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0243148:control [Qualitative Concept]
   738   C0522505:Upstream [Spatial Concept]
   738   C1550141:Control [Substance]
   738   C1882979:Control [Conceptual Entity]
   738   C2587213:Control [Functional Concept]
   738   C3274648:Control [Qualitative Concept]
   737   C1883644:Upstream Region [Nucleotide Sequence]
   704   C0017446:Region [Geographic Area]
   704   C0205147:Region [Spatial Concept]
   704   C0678640:exchange [Social Behavior]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "(Fig. 8A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: "C1"

Phrase: ")."
Processing 00000000.tx.313: Expression of this chimeric construct in NIH3T3 showed that the recognition of the chimeric exon was impaired, producing mainly splicing variants without this exon (Fig. 8B, lane 5). 

Phrase: "Expression of this chimeric construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257739:NIH/3T3 [Cell]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the recognition of the chimeric exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0524637:Recognition [Mental Process]

Phrase: "was"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: ","

Phrase: "producing"

Phrase: "mainly splicing variants without this exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:variants [Qualitative Concept]

Phrase: "(Fig. 8B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: "lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.314: In contrast, the genomic APP portions of minigene C1 did not block the usage of this exon in N2a cells (Fig. 8B, lane 6). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the genomic APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "portions of minigene C1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449719:Portion [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the usage of this exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0457083:Usage [Functional Concept]

Phrase: "in N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 8B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.315: To confirm whether UCR and DCR were responsible for blockage of the chimeric exon in NIH3T3 cells, both cis-elements were deleted (Fig. 8A, minigene C2). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "whether"

Phrase: "UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "were"

Phrase: "responsible for blockage of the chimeric exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "in NIH3T3 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "both cis-elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "were"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "(Fig. 8A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: "minigene C2"

Phrase: ")."
Processing 00000000.tx.316: The removal of both regulatory regions neutralized the observed blockage of chimeric exon in NIH3T3 cells (Fig. 8B, lane 7). 

Phrase: "The removal of both regulatory regions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015252:Removal [Therapeutic or Preventive Procedure]
   753   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "neutralized"

Phrase: "the observed blockage of chimeric exon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1706968:Blockage [Finding]
   753   C1879887:Blockage [Phenomenon or Process]

Phrase: "in NIH3T3 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 8B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: "lane 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.317: Furthermore, this deletion led to a strong activation of the chimeric exon in NIH3T3 cells, resulting in its constitutive usage (Fig. 8B, lanes 7and 8). 

Phrase: "Furthermore,"

Phrase: "this deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "led to a strong activation of the chimeric exon"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   742   C0008109:chimeric [Organism]
   742   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0442821:Strong [Qualitative Concept]
   742   C1708698:LED [Manufactured Object]
   742   C1879547:Activation [Activity]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C1522538:Lead [Functional Concept]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in NIH3T3 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "resulting in its constitutive usage"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0332294:Resulting in [Functional Concept]
   760   C0457083:Usage [Functional Concept]
   760   C0678226:resulting [Functional Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "(Fig. 8B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: "lanes 7and 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.318: These results demonstrated first that UCR and DCR regulated the recognition of the chimeric exon in a cell type-specific manner, indicated by its inhibition in NIH3T3 cells, whereas in N2a cells the repression of the chimeric exon was not enhanced; 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrated"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "that UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "the recognition of the chimeric exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0524637:Recognition [Mental Process]

Phrase: "in a cell type-specific manner,"

Phrase: "indicated by its inhibition"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1444656:Indicated [Finding]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "in NIH3T3 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "whereas in N2a cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0445079:N2a [Finding]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "the repression of the chimeric exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035143:Repression [Mental Process]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: ";"
Processing 00000000.tx.319: and second that these effects could be reversed in NIH3T3 cells by deleting UCR and DCR. 

Phrase: "and"

Phrase: "second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "that"

Phrase: "these effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "reversed in NIH3T3 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1555029:Reverse [Idea or Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "by deleting UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   875   C1883644:Upstream Region [Nucleotide Sequence]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "DCR."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.320: View larger version (45K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(45K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.321: 8.  

Phrase: "8."
Processing 00000000.tx.322: Cell-specific regulation of a chimeric exon by UCR and DCR. 

Phrase: "Cell-specific regulation of a chimeric exon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "by UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "DCR."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.323: A, left panel, maps of APLP1 and chimeric APLP1/APP minigenes. 

Phrase: "A,"

Phrase: "left panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "maps of APLP1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0024779:Map [Manufactured Object]
   790   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1412466:APLP1 [Gene or Genome]
   790   C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "chimeric APLP1/APP minigenes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   709   C0162768:Chimeric Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.324: Exons and introns are marked by boxes and bold solid lines. 

Phrase: "Exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "introns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021920:Introns [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "marked by boxes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0179400:boxes [Manufactured Object]
   790   C0522501:Marked [Qualitative Concept]
   790   C1638312:Boxes [Quantitative Concept]
   790   C1706089:Marked [Qualitative Concept]
   756 E C1533124:Box [Medical Device]

Phrase: "and"

Phrase: "bold solid lines."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.325: Genomic portions of human APLP1 and mouse APP are drawn in gray and black, and small numbers indicate the size of the genomic fragments (numbering of the APLP1 exons corresponding to Ref. 50). 

Phrase: "Genomic portions of human APLP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0449719:Portion [Spatial Concept]

Phrase: "and"

Phrase: "mouse APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "are"

Phrase: "drawn in gray"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0556636:gray [Quantitative Concept]
   790   C1269776:Gray [Qualitative Concept]
   756   C0013113:Draw [Intellectual Product]

Phrase: "and"

Phrase: "black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "and"

Phrase: "small numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "indicate"

Phrase: "the size of the genomic fragments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0456389:size [Spatial Concept]

Phrase: "(numbering of the APLP1 exons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449788:numbering [Quantitative Concept]
   726 E C0237753:*Number [Quantitative Concept]

Phrase: "corresponding to Ref. 50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.326: On top parental APLP1 minigene MG4 containing a full-length exon 16(144nt). 

Phrase: "On top parental APLP1 minigene MG4"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a full-length exon 16"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   812   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0443225:Full [Qualitative Concept]
   812   C1444754:Length [Quantitative Concept]
   812   C1706316:LENGTH [Research Activity]
   741 E C0205166:Long [Qualitative Concept]
   741 E C1522425:Longest [Qualitative Concept]
   741 E C1706317:Long [Qualitative Concept]

Phrase: "(144nt"

Phrase: ")."
Processing 00000000.tx.327: Below E1690 derived from MG4 by a 90-bp deletion of the central part in exon 16,marked by an open triangle. 

Phrase: "Below E1690"

Phrase: "derived from MG4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "by a 90-bp deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1880274:Deletion [Activity]

Phrase: "of the central part"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205099:Central [Spatial Concept]
   861   C0449719:Part [Spatial Concept]
   861   C1709471:Part [Quantitative Concept]
   861   C1879652:Central - [Laboratory Procedure]

Phrase: "in exon 16,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "marked by an open triangle."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0175566:Open [Spatial Concept]
   760   C0205119:Triangle [Conceptual Entity]
   760   C0522501:Marked [Qualitative Concept]
   760   C1706089:Marked [Qualitative Concept]
Processing 00000000.tx.328: C1, 10nt of exon 90+59nt of the upstream intron and 10nt of exon 90+63nt of the intronic downstream region were exchanged by the corresponding one of APP exon 15with UCR and DCR. 

Phrase: "C1,"

Phrase: "10nt of exon 90+59nt of the upstream intron"

Phrase: "and"

Phrase: "10nt of exon 90+63nt of the intronic downstream region"

Phrase: "were"

Phrase: "exchanged by the corresponding one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205447:One [Quantitative Concept]
   726   C0678640:exchange [Social Behavior]

Phrase: "of APP exon 15with UCR"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   864   C1514562:Protein Region [Amino Acid Sequence]
   822   C1883644:Upstream Region [Nucleotide Sequence]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   721 E C0205276:Regional [Spatial Concept]
   721 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "DCR."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.329: C2, both cis-elements were deleted, symbolized by open triangles. 

Phrase: "C2,"

Phrase: "both cis-elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "were"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: ","

Phrase: "symbolized by open triangles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0175566:Open [Spatial Concept]
   770   C0205119:triangles [Conceptual Entity]
Processing 00000000.tx.330: B, qualitative analysis of the minigene splicing pattern in NIH3T3 and N2a cells by performing an RT-PCR with 30cycles using 1/20 of a cDNA preparation and the primer pair spZEO1/apZEO2. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "qualitative analysis of the minigene splicing pattern"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0205556:Qualitative [Qualitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "in NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257739:NIH/3T3 [Cell]

Phrase: "and"

Phrase: "N2a cells by performing"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "an RT-PCR with 30cycles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0599161:RT-PCR [Molecular Biology Research Technique]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1/20 of a cDNA preparation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0455052:Preparation [Health Care Activity]
   753   C1521827:Preparation [Functional Concept]
   753   C2827734:1+ [Quantitative Concept]
   753   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "the primer pair spZEO1/apZEO2."
Processing 00000000.tx.331: Ethidium bromide staining of two 1.5% agarose gels is shown. 

Phrase: "Ethidium bromide staining of two 1.5% agarose gels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0487602:Staining [Laboratory Procedure]
   742   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.332: The minigene-derived splicing products are marked by their exon structures symbolized by gray boxes. 

Phrase: "The minigene-derived splicing products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "are"

Phrase: "marked by their exon structures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0522501:Marked [Qualitative Concept]
   760   C0678594:structures [Spatial Concept]
   760   C1706089:Marked [Qualitative Concept]

Phrase: "symbolized by gray boxes."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0179400:boxes [Manufactured Object]
   770   C0556636:gray [Quantitative Concept]
   770   C1269776:Gray [Qualitative Concept]
   770   C1638312:Boxes [Quantitative Concept]
   737 E C1533124:Box [Medical Device]
Processing 00000000.tx.333: CE, chimeric exon; 

Phrase: "CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827664:CE [Idea or Concept]

Phrase: "chimeric exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.334: T, NIH3T3; 

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257739:NIH/3T3 [Cell]

Phrase: ";"
Processing 00000000.tx.335: N, N2a.  

Phrase: "N,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "N2a."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445079:N2a [Finding]
Processing 00000000.tx.336: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Alternative splicing plays a fundamental role in the regulation of eukaryotic gene expression, generating different mRNA isoforms from a single pre-mRNA precursor. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alternative splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002345:Alternative Splicing [Genetic Function]
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a fundamental role in the regulation of eukaryotic gene expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "generating"

Phrase: "different mRNA isoforms from a single pre-mRNA precursor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C3178793:mRNA Isoforms [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.337: In most cases, the usage of an alternatively spliced exon is controlled in a tissue-, developmental stage-, or sex-specific manner (reviewed in Refs. 31 and 32). 

Phrase: "In most cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the usage of an alternatively spliced exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0457083:Usage [Functional Concept]

Phrase: "is"

Phrase: "controlled in a tissue-,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0040300:Tissue [Tissue]
   770   C1547928:Tissue [Intellectual Product]
   770   C2587213:Controlled [Functional Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C1550141:Control [Substance]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]

Phrase: "developmental stage-,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0870411:Developmental Stage [Temporal Concept]
   861   C0205390:Stage [Temporal Concept]
   861   C0458003:Developmental [Qualitative Concept]
   861   C0678723:Developmental [Organism Function]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]
   789 E C0243107:development [Physiologic Function]
   789 E C1527148:Development [Functional Concept]

Phrase: "or"

Phrase: "sex-specific manner"

Phrase: "("

Phrase: "reviewed in Refs. 31"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0282443:reviewed [Intellectual Product]
   770   C0450355:31 [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.338: Cell Type-specific Recognition of Exon 15Is Conserved between Mouse and Rat-- Consistent with previously published data on the distribution of L-APP transcripts in rat (11), our expression analysis revealed the ubiquitous occurrence of L-APP in mouse tissues. 

Phrase: "Cell Type-specific Recognition of Exon 15Is"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0678836:cell recognition [Cell Function]
   748   C0524637:Recognition [Mental Process]

Phrase: "Conserved between Mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "Rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "--"

Phrase: "Consistent with previously published data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "on the distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "of L-APP transcripts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "in rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "our expression analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the ubiquitous occurrence of L-APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0243132:occurrence [Functional Concept]
   744   C1554210:occurrence [Idea or Concept]
   744   C2745955:Occurrence [Temporal Concept]

Phrase: "in mouse tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.339: On average, L-APP constituted ~55% of the total APP message in non-neuronal organs of mouse, and the measured relative L-APP levels were between 2and 20% higher than those determined in rat. 

Phrase: "On average,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "constituted"

Phrase: "~55% of the total APP message"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0007507:Protein 55 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   767   C0439177:Protein.total [Quantitative Concept]
   767   C0555903:Total protein [Laboratory Procedure]
   767   C1261360:total protein [Laboratory or Test Result]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0450382:55 [Intellectual Product]
   744   C0470166:Message [Intellectual Product]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "in non-neuronal organs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0178784:organs [Body Part, Organ, or Organ Component]

Phrase: "of mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "the measured relative L-APP levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   795   C0441889:Levels [Qualitative Concept]
   785   C0428479:Protein level [Laboratory or Test Result]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]

Phrase: "were between 2and 20% higher"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "than those"

Phrase: "determined in rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034693:Rat, NOS [Mammal]
   790   C0034721:Rat [Mammal]
Processing 00000000.tx.340: In both rodent species only low levels of L-APP were detected in brain (5-6%). 

Phrase: "In both rodent species only low levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "of L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "were"

Phrase: "detected in brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C0442726:Detected [Finding]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(5-6%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0442749:5 6 [Finding]
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.341: The major source of brain L-APP appear to be cells of non-neuronal origin, since L-APP was undetectable by our sensitive RT-PCR assay in RNA preparations from primary cultured mouse neurons (Fig. 1C). 

Phrase: "The major source of brain L-APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449416:Source [Finding]
   742   C1705919:Source [Idea or Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "cells of non-neuronal origin,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0027836:Non-neuronal cell [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "since"

Phrase: "L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "undetectable by our sensitive RT-PCR assay"

Phrase: "in RNA preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "from primary cultured mouse neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.342: In contrast, L-APP consisted of ~60% total APP transcripts in primary cultured microglial cells, in agreement with the previously reported relative abundance of L-APP in cultures of rat microglia and astrocytes (11). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "consisted"

Phrase: "of ~60% total APP transcripts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   713   C0439177:% of total protein [Quantitative Concept]

Phrase: "in primary cultured microglial cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   875   C0007600:cultured cells [Cell]
   875   C0007635:Cultured Cells [Cell]
   875   C3282338:Cells, Cultured [Cell]
   844   C0206116:Microglial cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with the previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "relative abundance of L-APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2346714:Abundance [Qualitative Concept]

Phrase: "in cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "of rat microglia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0206116:Microglia [Cell]
   789 E C0521398:Microglial [Body Location or Region]

Phrase: "and"

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.343: Taken together these data strongly indicate that the cell type-specific recognition of APP exon 15is conserved between both rodent species. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data strongly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the cell type-specific recognition of APP exon 15is"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0678836:cell recognition [Cell Function]
   738   C0524637:Recognition [Mental Process]

Phrase: "conserved between both rodent species."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035804:Rodent [Mammal]
   760   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.344: Therefore, the mouse model is a suitable system to analyze the molecular mechanism controlling the cell type-specific usage of APP exon 15in non-neuronal cells and neurons. 

Phrase: "Therefore,"

Phrase: "the mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "is"

Phrase: "a suitable system to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "analyze"

Phrase: "the molecular mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "the cell type-specific usage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0457083:Usage [Functional Concept]

Phrase: "of APP exon 15in non-neuronal cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0018956:precursor cell [Cell]
   823   C0027836:Non-neuronal cell [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.345: Two Intronic Regions Flanking Exon 15Repress Its Recognition in Non-neuronal Cells-- The principal aim of the present study was to identify cis-acting elements in the APP gene involved in alternative splicing regulation of exon 15.

Phrase: "Two Intronic Regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "Flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "Exon 15Repress"

Phrase: "Its Recognition in Non-neuronal Cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   809   C1154409:neuronal cell recognition [Cell Function]
           neuron recognition
   767   C0678836:cell recognition [Cell Function]
   753   C0524637:Recognition [Mental Process]

Phrase: "-"

Phrase: "-"

Phrase: "The principal aim of the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1947946:Aim [Idea or Concept]
   748   C2948600:Aim [Pharmacologic Substance]
   748   C3540471:AIM [Gene or Genome]
   748   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "cis-acting elements in the APP gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C0599780:cis acting element [Nucleotide Sequence]
   742   C0013879:Elements [Element, Ion, or Isotope]
   708 E C1705248:Element [Conceptual Entity]

Phrase: "involved in alternative splicing regulation of exon 15."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0002345:Alternative Splicing [Genetic Function]
   744   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0035687:Splicing [Genetic Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1314939:Involved [Functional Concept]
   744   C1327622:Regulation [Biologic Function]
   744   C1523987:Alternative [Conceptual Entity]
   744   C2610186:splicing [Genetic Function]
Processing 00000000.tx.346: Therefore, we established an APP minigene expression system, since this approach was very useful in the study of several alternatively spliced genes (33-36). 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "an APP minigene expression system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "since"

Phrase: "this approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "was"

Phrase: "very useful in the study of several alternatively spliced genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   722   C0869040:study use [Research Activity]
   722   C1524063:Use of [Functional Concept]

Phrase: "(33-36"

Phrase: ")."
Processing 00000000.tx.347: For this, the endogenous APPex15/L-APP splicing pattern of different murine cell lines was analyzed by quantitative RT-PCR. 

Phrase: "For this,"

Phrase: "the endogenous APPex15/L-APP splicing pattern"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   822   C1317658:Protein pattern [Clinical Attribute]
   793   C0449774:Pattern [Spatial Concept]

Phrase: "of different murine cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "was"

Phrase: "analyzed by quantitative RT-PCR."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   806   C0599161:RT-PCR [Molecular Biology Research Technique]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0677874:pCR [Finding]
   760   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.348: Determination of endogenous APPex15/L-APP mRNA levels revealed that P19 and N2a cells almost exclusively express APPex15 isoforms, an APP splicing pattern also observed in neurons (Fig. 1, C and D). 

Phrase: "Determination of endogenous APPex15/L-APP mRNA levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1148554:determination [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that P19"

Phrase: "and"

Phrase: "N2a cells almost exclusively"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0007634:Cells [Cell]
   812   C0445079:N2a [Finding]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "APPex15 isoforms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "an APP splicing pattern also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C1317658:Protein pattern [Clinical Attribute]
   799   C0449774:Pattern [Spatial Concept]

Phrase: "observed in neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C1441672:Observed [Functional Concept]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.349: In contrast, L-APP accounted for 12or 57% of the total APP message in AtT20 and NIH3T3 cells, respectively, representing the non-neuronal splicing type (Fig. 1, C and D). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "accounted for 12or 57% of the total APP message"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0439177:Protein.total [Quantitative Concept]
   754   C0555903:Total protein [Laboratory Procedure]
   754   C1261360:total protein [Laboratory or Test Result]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0439175:% total [Quantitative Concept]
   738   C0439810:Total [Qualitative Concept]
   738   C0470166:Message [Intellectual Product]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1709634:Precursor [Idea or Concept]
   704   C1551359:account [Idea or Concept]
   704   C2741673:Account # [Clinical Attribute]
   704   C2981730:Account [Classification]

Phrase: "in AtT20"

Phrase: "and"

Phrase: "NIH3T3 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "respectively,"

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "the non-neuronal splicing type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0682689:neuron type [Cell]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.350: To study the APP exon 15splicing regulation, we therefore chose P19 cells as neuronal splicing system and the NIH3T3 cells as representative for splicing pattern found in most non-neuronal cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the APP exon 15splicing regulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0851285:Regulation [Governmental or Regulatory Activity]
   799   C1327622:Regulation [Biologic Function]

Phrase: "we therefore"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "P19 cells as neuronal splicing system"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the NIH3T3 cells as representative"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   781   C0007634:THE CELL [Cell]
           Cells
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "for splicing pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "found in most non-neuronal cells."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   822   C0027836:Non-neuronal cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0150312:Found [Quantitative Concept]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C1518422:Non [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C0243095:Find [Finding]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.351: Transient expression of a 12.5-kb genomic APP fragment spanning exons 14-16 in this cell culture system showed that it contained all cis-acting elements required to regulate the usage of exon 15,since the minigene-derived mRNA molecules displayed a splicing pattern nearly indistinguishable from that of the endogenous APP gene (Fig. 3, A and B). 

Phrase: "Transient expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of a 12.5-kb genomic APP fragment spanning exons 14-16"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   812   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   812   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   807   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   787   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0011560:Amyloid [Pathologic Function]
   787   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   787   C0017428:Genomic [Gene or Genome]
   787   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0332255:fragment [Functional Concept]
   787   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0887950:genomic [Biomedical Occupation or Discipline]
   787   C1708096:Fragment [Qualitative Concept]
   787   C1709634:Precursor [Idea or Concept]
   754   C1711300:Span [Conceptual Entity]
   754   C2700613:Span [Quantitative Concept]

Phrase: "in this cell culture system"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C1516329:Cell Culture System [Molecular Biology Research Technique]
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C0449913:System [Functional Concept]
   827   C1269647:Cell [Cell]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "it"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "all cis-acting elements"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   988   C0599780:cis acting element [Nucleotide Sequence]
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "the usage of exon 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0457083:Usage [Functional Concept]

Phrase: "since"

Phrase: "the minigene-derived mRNA molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:molecules [Substance]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a splicing pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "nearly indistinguishable from that of the endogenous APP gene"

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.352: Sequence conservation within intronic regions proximal to exon 15of the human and mouse APP gene suggested the presence of cis-acting elements that might be involved in splicing regulation (Fig. 2B). 

Phrase: "Sequence conservation within intronic regions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
   760   C2347858:Conservation [Qualitative Concept]

Phrase: "proximal to exon 15of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205107:Proximal [Spatial Concept]

Phrase: "the human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "mouse APP gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Gene [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of cis-acting elements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "might"

Phrase: "be"

Phrase: "involved in splicing regulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0035687:Splicing [Genetic Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1314939:Involved [Functional Concept]
   770   C1327622:Regulation [Biologic Function]
   770   C2610186:splicing [Genetic Function]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.353: Deletion scan analysis of the intronic region upstream and downstream of exon 15,using our APP expression system, led to the identification of two regulatory elements (Figs. 4 and 5) as follows. 

Phrase: "Deletion scan analysis of the intronic region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "upstream"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522505:Upstream [Spatial Concept]

Phrase: "and downstream of exon 15,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0522506:Downstream [Spatial Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "our APP expression system,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "led to the identification of two regulatory elements"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   744   C0013879:Elements [Element, Ion, or Isotope]
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]
   744   C0205448:Two [Quantitative Concept]
   744   C0220905:regulatory [Regulation or Law]
   744   C1704735:Regulatory [Conceptual Entity]
   744   C1708698:LED [Manufactured Object]
   737   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1522538:Lead [Functional Concept]
   711 E C1705248:Element [Conceptual Entity]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(Figs. 4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.354: (i) The UCR is located 69nt upstream of the intron 14/exon 15border and spans at least 67nt. 

Phrase: "(i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "The UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "located"

Phrase: "69nt upstream of the intron 14/exon 15border"

Phrase: "and"

Phrase: "spans at least 67nt."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1711300:Span [Conceptual Entity]
   737   C2700613:Span [Quantitative Concept]
Processing 00000000.tx.355: (ii) the DCR starts 21nt downstream of exon 15/intron 15region and encompasses at least 138nt. 

Phrase: "(ii"

Phrase: ")"

Phrase: "the DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "starts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Start [Temporal Concept]

Phrase: "21nt downstream of exon 15/intron 15region"

Phrase: "and"

Phrase: "encompasses at least 138nt."
Processing 00000000.tx.356: Both cis-elements mediated a splice repressor function, blocking the recognition of exon 15in non-neuronal cells by acting in a sequence- and distance-dependent manner (Figs. 4B, 5B, and 6). 

Phrase: "Both cis-elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "a splice repressor function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the recognition of exon 15in non-neuronal cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   782   C1154409:neuronal cell recognition [Cell Function]
           neuron recognition
   750   C0678836:cell recognition [Cell Function]
   744   C0524637:Recognition [Mental Process]

Phrase: "by"

Phrase: "acting in a sequence-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]
   737   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "distance-dependent manner"

Phrase: "(Figs. 4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "5B,"

Phrase: "and"

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.357: Furthermore, UCR and DCR are the key players for regulating the exclusion of exon 15in the non-neuronal splicing system, since their complete removal impaired the cell-specific recognition of exon 15in non-neuronal cells (Fig. 6, M2). 

Phrase: "Furthermore,"

Phrase: "UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "the key players for"

Phrase: "regulating"

Phrase: "the exclusion of exon 15in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0680251:EXCLUSION [Functional Concept]
   760   C2828389:Exclusion [Activity]

Phrase: "the non-neuronal splicing system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "since"

Phrase: "their complete removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015252:Removal [Therapeutic or Preventive Procedure]
   861   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "the cell-specific recognition of exon 15in non-neuronal cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   775   C1154409:neuronal cell recognition [Cell Function]
           neuron recognition
   764   C1325882:cell-cell recognition [Cell Function]
   757   C0678836:cell recognition [Cell Function]
   739   C0524637:Recognition [Mental Process]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.358: The cell type-specific splice repressor function of UCR and DCR is underlined by the fact that the recognition of a chimeric exon in a constitutive splicing background is cell-specifically blocked in non-neuronal cells by the presence of both cis-elements, whereas in the neuronal splicing system these regulatory elements do not negatively influence the usage of this exon (Fig. 8, C1 and C2). 

Phrase: "The cell type-specific splice repressor function of UCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   754   C0007613:Cell Function [Cell Function]
   754   C2587213:Control function [Functional Concept]
   738   C0031843:function [Physiologic Function]
   738   C0542341:Function [Functional Concept]
   738   C0700205:FUNCTION [Classification]
   738   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "underlined by the fact"

Phrase: "that"

Phrase: "the recognition of a chimeric exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0524637:Recognition [Mental Process]

Phrase: "in a constitutive splicing background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706907:Background [Conceptual Entity]

Phrase: "is"

Phrase: "cell-specifically"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "blocked in non-neuronal cells"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   851   C0027836:Non-neuronal cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1518422:Non [Functional Concept]
   760   C2983591:BLOCKED [Research Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1533157:Block [Substance]
   726 E C1704653:Cell [Medical Device]
   726 E C1706084:Block [Geographic Area]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "by the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of both cis-elements,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "whereas in the neuronal splicing system"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0035687:Splicing [Genetic Function]
   753   C0449913:System [Functional Concept]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C2610186:splicing [Genetic Function]

Phrase: "these regulatory elements"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0013879:Elements [Element, Ion, or Isotope]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "do"

Phrase: "not negatively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "the usage of this exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0457083:Usage [Functional Concept]

Phrase: "(Fig. 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C1"

Phrase: "and"

Phrase: "C2"

Phrase: ")."
Processing 00000000.tx.359: In summary these experimental data clearly showed that these regulatory elements represent cell type-specific acting sequences controlling exon 15exclusion in the non-neuronal splicing system we used. 

Phrase: "In summary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "these experimental data clearly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "these regulatory elements"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0013879:Elements [Element, Ion, or Isotope]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "cell type-specific acting sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "exon 15exclusion in the non-neuronal splicing system"

Phrase: "we"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.360: One common feature of many intronic regulatory sequences, e.g. the neuron-specific N1 enhancer of c-src gene (25, 27), is their redundant and complex architecture. 

Phrase: "One common feature of many intronic regulatory sequences,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   750   C1517495:Sequence Feature [Gene or Genome]
   750   C1704991:Sequence Feature [Qualitative Concept]
   744   C1521970:Feature [Qualitative Concept]
   744   C1706388:Feature [Conceptual Entity]
   744   C2346469:Feature [Qualitative Concept]
   744   C2348519:Feature [Qualitative Concept]

Phrase: "e.g."

Phrase: "the neuron-specific N1 enhancer of c-src gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(25,"

Phrase: "27"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "their redundant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0425087:Redundant [Finding]
  1000   C1313915:Redundant [Functional Concept]

Phrase: "and"

Phrase: "complex architecture."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003737:Architecture [Occupation or Discipline]
Processing 00000000.tx.361: This is reflected by the presence of multiple binding sites for certain factors, the latter being part of a protein complex that regulates splice site selection (26, 37). 

Phrase: "This"

Phrase: "is"

Phrase: "reflected by the presence of multiple binding sites"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0005456:Binding Sites [Receptor]
   750   C2945843:Site of [Qualitative Concept]
   744   C0205145:Sites [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0439064:Multiple [Quantitative Concept]
   744   C0558058:reflected [Mental Process]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   737 E C0682969:Binding Site [Amino Acid Sequence]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "for certain factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "the latter"

Phrase: "being"

Phrase: "part of a protein complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "that"

Phrase: "regulates"

Phrase: "splice site selection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1327242:splice site selection [Genetic Function]
  1000   C1327244:splice site selection [Genetic Function]
   827   C0036576:selection [Genetic Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "(26,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.362: Hence, the enhanced repression of exon 15observed in non-neuronal cells after duplicating UCR can be interpreted as a reflection to its redundant architecture. 

Phrase: "Hence,"

Phrase: "the enhanced repression of exon 15observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035143:Repression [Mental Process]

Phrase: "in non-neuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "after duplicating UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   875   C1883644:Upstream Region [Nucleotide Sequence]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "interpreted as a reflection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1285553:interpreted [Functional Concept]

Phrase: "to its redundant architecture."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003737:Architecture [Occupation or Discipline]
Processing 00000000.tx.363: Moreover, duplication of UCR interferes with its cell type-specific function, since the recognition of exon 15was slightly impaired in neuronal cells, too (Fig. 6, dUCR). 

Phrase: "Moreover,"

Phrase: "duplication of UCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332597:Duplication [Functional Concept]
   760   C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: "interferes with its cell type-specific function,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   778   C0007634:Cell Type [Cell]
           Cell
   778   C0449475:cell type [Intellectual Product]
   778   C0521102:Interferes with [Qualitative Concept]
           Interfere
   774   C0007613:Cell Function [Cell Function]
   748   C0031843:function [Physiologic Function]
   748   C0205369:Specific [Qualitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1269647:Cell [Cell]
   748   C1547052:*Type [Quantitative Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1704653:Cell [Medical Device]
   748   C1705273:Function [Intellectual Product]
   748   C1948049:Cell [Spatial Concept]

Phrase: "since"

Phrase: "the recognition of exon 15was slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0524637:Recognition [Mental Process]

Phrase: "impaired in neuronal cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0221099:Impaired [Functional Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C0684336:Impaired [Pathologic Function]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "too"

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "dUCR"

Phrase: ")."
Processing 00000000.tx.364: This could be caused by cooperative interactions between different binding sites of the two duplicated cis-elements in neuronal cells causing a basal level of inhibition, similar to the activation of a heterologous exon by the duplicated neuron-specific N1 enhancer in non-neuronal cells (27). 

Phrase: "This"

Phrase: "could"

Phrase: "be"

Phrase: "caused by cooperative interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0679729:cooperative [Organization]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
   737   C1704675:Interaction [Functional Concept]

Phrase: "between different binding sites"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0005456:Binding Sites [Receptor]
   867 E C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Sites [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "of the two duplicated cis-elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0013879:Elements [Element, Ion, or Isotope]
   779 E C1705248:Element [Conceptual Entity]

Phrase: "in neuronal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "a basal level of inhibition,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "similar to the activation of a heterologous exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "by the duplicated neuron-specific N1 enhancer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in non-neuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.365: Alternatively, the increased number of potential binding sites could titrate for limited trans-acting factor(s) that neutralize(s) the negative function of UCR in neuronal cells. 

Phrase: "Alternatively,"

Phrase: "the increased number of potential binding sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0445108:Number of sites [Quantitative Concept]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "could"

Phrase: "titrate for limited trans-acting factor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0040627:Trans-Acting Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439801:Limited [Functional Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1883350:Titrate [Health Care Activity]
   753   C2826298:TRANS [Idea or Concept]
   753   C2827422:Factor [Conceptual Entity]
   753   C3542948:Limited [Intellectual Product]
   719   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "s)"

Phrase: "that"

Phrase: "neutralize"

Phrase: "("

Phrase: "s)"

Phrase: "the negative function of UCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C2587213:Control function [Functional Concept]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "in neuronal cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.366: The latter case is very unlikely, since a titration experiment with different dUCR plasmid DNA amounts (transfection of 50ng to 5g by liposome-mediated transfection) showed no enhanced function of UCR in P19 cells.2 In contrast, duplication of DCR did not strengthen its negative effect neither in P19 nor in NIH3T3 cells (Fig. 6, dDCR). 

Phrase: "The latter case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "is"

Phrase: "very unlikely,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "since"

Phrase: "a titration experiment with different dUCR plasmid DNA amounts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0681814:Experiment [Research Activity]
   742   C1706386:Experiment [Conceptual Entity]

Phrase: "(transfection of 50ng"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "to 5g"

Phrase: "by liposome-mediated transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no enhanced function of UCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C2587213:Control function [Functional Concept]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "in P19 cells.2"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "duplication of DCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332597:Duplication [Functional Concept]
   760   C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "strengthen"

Phrase: "its negative effect"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205160:Negative [Qualitative Concept]
   861   C1280500:Effect [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2348382:Effect [Qualitative Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]

Phrase: "neither in P19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3274651:Neither [Qualitative Concept]

Phrase: "nor in NIH3T3 cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   770   C0007634:Cells [Cell]
   770   C0028423:NOR [Geographic Area]
   770   C0028609:NOR [Cell Component]
   770   C1513854:NOR [Mammal]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "dDCR"

Phrase: ")."
Processing 00000000.tx.367: This result appears surprising, but in the context of the complex architecture of splicing regulatory sequences it is possible that DCR, spanning position +21 to +158, contains only a part of the target sequences for mediating its repressor function. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "surprising,"

Phrase: "but in the context of the complex architecture of splicing regulatory sequences"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   736   C0003737:Architecture [Occupation or Discipline]
   736   C0035687:Splicing [Genetic Function]
   736   C0162326:Sequences [Nucleotide Sequence]
   736   C0220905:regulatory [Regulation or Law]
   736   C0233535:but [Mental or Behavioral Dysfunction]
   736   C0439855:Complex [Qualitative Concept]
   736   C0449255:Context [Finding]
   736   C0542559:Context [Functional Concept]
   736   C1704241:Complex [Chemical Viewed Structurally]
   736   C1704735:Regulatory [Conceptual Entity]
   736   C2610186:splicing [Genetic Function]
   719   C0314642:Regulatory sequence [Nucleotide Sequence]
   703 E C0004793:Sequence [Nucleotide Sequence]
   703 E C0162327:Sequence [Nucleotide Sequence]
   703 E C1519249:Sequence [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that DCR,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "position +21 to +158,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0733755:Position [Spatial Concept]
   741 E C0240795:POSITIONAL [Finding]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a part of the target sequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "for"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "its repressor function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.368: Thus, a duplicated DCR did not amplify its inhibitory influence on exon 15recognition, since cooperative interactions between certain components were still lacking. 

Phrase: "Thus,"

Phrase: "a duplicated DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   875   C1883633:Downstream Region [Nucleotide Sequence]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "amplify"

Phrase: "its inhibitory influence on exon 15recognition,"

Phrase: "since"

Phrase: "cooperative interactions between certain components"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "still lacking."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332268:Lacking [Qualitative Concept]
Processing 00000000.tx.369: A similar effect has been reported for the neuron-specific intronic enhancer of the N1 exon; 

Phrase: "A similar effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported for the neuron-specific intronic enhancer of the N1 exon"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   738   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0027882:Neuron [Cell]
   738   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0205369:Specific [Qualitative Concept]
   738   C0441962:N1 [Finding]
   738   C0684224:Reported [Intellectual Product]
   738   C0700287:Reported [Health Care Activity]
   738   C1552740:specific [Intellectual Product]
   738   C3496591:Reported [Clinical Attribute]
   704 E C3273238:Report [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.370: duplication of the enhancer core sequence (position +38 to +70) moderately activated the differential exon in neuronal cells, whereas a multimerization of a larger area (position +38 to +142) strongly increased the amount of mRNA transcripts including N1 exon (25, 27). 

Phrase: "duplication of the enhancer core sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332597:Duplication [Functional Concept]
   753   C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: "(position +38 to +70"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0733755:Position [Spatial Concept]
   741 E C0240795:POSITIONAL [Finding]

Phrase: ")"

Phrase: "moderately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881878:Moderately [Qualitative Concept]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "the differential exon in neuronal cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "whereas"

Phrase: "a multimerization of a larger area"

Phrase: "(position +38 to +142"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0733755:Position [Spatial Concept]
   741 E C0240795:POSITIONAL [Finding]

Phrase: ")"

Phrase: "strongly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of mRNA transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "N1 exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(25,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.371: Models for the Regulation of the Alternatively Spliced Exon 15-- The recognition of an alternatively spliced exon in a three-exon system, like the APP minigene, is determined by the balance of splice site strength between the flanking exons and the internal exon, leading to the inclusion and/or exclusion of the internal exon. 

Phrase: "Models for the Regulation of the Alternatively Spliced Exon 15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C0814675:model regulation [Regulation or Law]
   739   C3161035:Models [Intellectual Product]

Phrase: "-"

Phrase: "-"

Phrase: "The recognition of an alternatively spliced exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0524637:Recognition [Mental Process]

Phrase: "in a three-exon system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "like the APP minigene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "determined by the balance of splice site strength"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C2945843:Site of [Qualitative Concept]
   744   C0014653:Balance [Organism Function]
   744   C0205145:Site [Spatial Concept]
   744   C0205415:Balance [Functional Concept]
   744   C0237897:Strength [Quantitative Concept]
   744   C0560184:Balance [Finding]
   744   C0808080:Strength [Idea or Concept]
   744   C1515974:Site [Body Location or Region]
   744   C1705922:Strength [Qualitative Concept]
   744   C2825164:Site [Spatial Concept]

Phrase: "between the flanking exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the internal exon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "leading to the inclusion"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0332152:Leading [Temporal Concept]
   770   C1512693:Inclusion [Qualitative Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and/or"

Phrase: "exclusion of the internal exon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0680251:EXCLUSION [Functional Concept]
   760   C2828389:Exclusion [Activity]
Processing 00000000.tx.372: Common features of the pre-mRNA molecule like exon length (34, 38), intron size (39), identity with splice site consensus (40, 41), and RNA secondary structures (42, 43) influence the splice site strength. 

Phrase: "Common features of the pre-mRNA molecule"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C1521970:Feature [Qualitative Concept]
   714   C1706388:Feature [Conceptual Entity]
   714   C2346469:Feature [Qualitative Concept]
   714   C2348519:Feature [Qualitative Concept]

Phrase: "like exon length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "(34,"

Phrase: "38"

Phrase: ")"

Phrase: ","

Phrase: "intron size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "(39"

Phrase: ")"

Phrase: ","

Phrase: "identity with splice site consensus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0424215:Identity [Mental Process]
   760   C2003939:Identity [Finding]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "RNA secondary structures"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C0162807:Secondary Structure [Spatial Concept]
   827   C0027627:secondary [Neoplastic Process]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0175668:Secondary [Temporal Concept]
   827   C0205436:Secondary [Quantitative Concept]
   827   C0678594:structures [Spatial Concept]

Phrase: "(42,"

Phrase: "43"

Phrase: ")"

Phrase: "influence"

Phrase: "the splice site strength."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   755 E C0442821:Strong [Qualitative Concept]
Processing 00000000.tx.373: A shift between both splicing pathways can be mediated by changing the strength of involved splice sites, mainly that of the alternatively spliced exon. 

Phrase: "A shift between both splicing pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333051:Shift [Functional Concept]
   753   C2347509:Shift [Phenomenon or Process]

Phrase: "can"

Phrase: "be"

Phrase: "mediated by changing"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C0392747:Changing [Functional Concept]
   790   C0443172:changing [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "the strength of involved splice sites,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0237897:Strength [Quantitative Concept]
   753   C0808080:Strength [Idea or Concept]
   753   C1705922:Strength [Qualitative Concept]

Phrase: "mainly"

Phrase: "that of the alternatively spliced exon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.374: In this context splicing enhancer and repressor elements located in intronic and exonic sequences play an important role in modulating the splice site strength of an alternatively spliced exon in a tissue-, sex-, or development-specific manner. 

Phrase: "In this context splicing enhancer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "repressor elements"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013879:Elements [Element, Ion, or Isotope]
   861   C1336789:Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "located in intronic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "exonic sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in modulating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "the splice site strength of an alternatively spliced exon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0237897:Strength [Quantitative Concept]
   742   C0808080:Strength [Idea or Concept]
   742   C1705922:Strength [Qualitative Concept]

Phrase: "in a tissue-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "sex-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "or"

Phrase: "development-specific manner."
Processing 00000000.tx.375: In the case of the APP minigene our presented data suggest that UCR and DCR are key players controlling the cell-specific recognition of exon 15in the non-neuronal splicing system. 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of the APP minigene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "our presented data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "key players"

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "the cell-specific recognition of exon 15in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0678836:cell recognition [Cell Function]
   748   C0524637:Recognition [Mental Process]

Phrase: "the non-neuronal splicing system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.376: In principal, the inhibitory function of both cis-elements can be mediated by two different mechanisms as follows. 

Phrase: "In principal,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205225:Principal [Qualitative Concept]
  1000   C0401925:Principal [Professional or Occupational Group]

Phrase: "the inhibitory function of both cis-elements"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "mediated by two different mechanisms"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0205448:Two [Quantitative Concept]
   760   C0441712:Mechanisms [Functional Concept]
   760   C1705242:Different [Qualitative Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.377: (i) UCR and DCR are involved in the formation of an RNA secondary structure, masking the splice sites of exon 15for its recognition by the spliceosomal components, as it was observed for exon 6B of the chicken -tropomyosin pre-mRNA (42). 

Phrase: "(i) UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   875   C1883644:Upstream Region [Nucleotide Sequence]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "involved in the formation of an RNA secondary structure,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0162807:Secondary Structure [Spatial Concept]
   762   C1623415:RNA formation [Genetic Function]
   742   C0027627:secondary [Neoplastic Process]
   742   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0175668:Secondary [Temporal Concept]
   742   C0205436:Secondary [Quantitative Concept]
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C0678594:Structure [Spatial Concept]
   742   C1314939:Involved [Functional Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "masking"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0150112:masking [Functional Concept]
   966 E C0024861:Mask [Medical Device]
   966 E C1538279:MASK [Gene or Genome]
   966 E C1845191:MASK [Gene or Genome]

Phrase: "the splice sites of exon 15for"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   773   C2945843:Site of [Qualitative Concept]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "its recognition by the spliceosomal components,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0524637:Recognition [Mental Process]

Phrase: "as"

Phrase: "it"

Phrase: "was"

Phrase: "observed for exon 6B of the chicken -tropomyosin pre-mRNA (42"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   756   C0026661:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0035695:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0008051:Chicken [Bird]
   738   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0041197:Tropomyosin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0332152:Pre [Temporal Concept]
   738   C0677521:Chicken [Food]
   738   C0740175:Pre [Qualitative Concept]
   738   C1365945:CHICKEN [Food]
   738   C1441672:Observed [Functional Concept]
   738   C2257086:PRE [Genetic Function]

Phrase: ")."
Processing 00000000.tx.378: (ii) UCR and DCR contain multiple binding sequences for assembling a proteinaceous repressor complex in non-neuronal cells. 

Phrase: "(ii"

Phrase: ")"

Phrase: "UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "multiple binding sequences for assembling"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "a proteinaceous repressor complex in non-neuronal cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439855:Complex [Qualitative Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.379: We propose that both regulatory regions serve as target sequences for the formation of a protein repressor complex, since RNA secondary structure predictions identified no potential stem loop structures that can be involved in splice site selection. 

Phrase: "We"

Phrase: "propose"

Phrase: "that"

Phrase: "both regulatory regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0034987:Regulatory Regions [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "serve as target sequences"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0162326:Sequences [Nucleotide Sequence]
   770   C1521840:Target [Functional Concept]
   770   C2986546:TARGET [Diagnostic Procedure]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "for the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of a protein repressor complex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1523872:protein complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "since"

Phrase: "RNA secondary structure predictions"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0162807:Secondary Structure [Spatial Concept]
   812   C0027627:secondary [Neoplastic Process]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0175668:Secondary [Temporal Concept]
   812   C0205436:Secondary [Quantitative Concept]
   812   C0678594:Structure [Spatial Concept]
   812   C0681842:predictions [Idea or Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "no potential stem loop structures"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0242767:Stem [Plant]
   812   C0419518:Loop [Medical Device]
   812   C0445022:Loop [Spatial Concept]
   812   C0678594:structures [Spatial Concept]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "involved in splice site selection."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1327242:splice site selection [Genetic Function]
   862   C1327244:splice site selection [Genetic Function]
   760   C0036576:selection [Genetic Function]
   760   C0205145:Site [Spatial Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
Processing 00000000.tx.380: The genomic localization, presence of pyrimidine-rich sequence elements, and inhibitory function of UCR and DCR resembled the situation of the intronic elements URE and DRE flanking exon 3of -tropomyosin. 

Phrase: "The genomic localization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "presence of pyrimidine-rich sequence elements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "inhibitory function of UCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C2587213:Control function [Functional Concept]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "resembled"

Phrase: "the situation of the intronic elements URE"

Phrase: "and"

Phrase: "DRE flanking exon 3of -tropomyosin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0041197:Tropomyosin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.381: These regulatory elements repress the recognition of -tropomyosin exon 3in smooth muscle cells (44). 

Phrase: "These regulatory elements"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0013879:Elements [Element, Ion, or Isotope]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "repress"

Phrase: "the recognition of -tropomyosin exon 3in smooth muscle cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   835   C1135918:Smooth Muscle Cells [Cell]
   812   C0596981:Muscle Cells [Cell]
   812   C1267092:Muscle, Smooth [Tissue]
   793   C0007634:Cells [Cell]
   793   C0026845:Muscle [Tissue]
   793   C0205357:Smooth [Qualitative Concept]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]
   721 E C0442025:Muscular [Spatial Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.382: Key mediator for the inhibition of exon 3in smooth muscle cells is the "polypyrimidine tract binding protein" (PTB) that binds to pyrimidine-rich elements within DRE (45-47). 

Phrase: "Key mediator for the inhibition of exon 3in smooth muscle cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "the ""polypyrimidine tract binding protein"""
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0137872:Polypyrimidine Tract-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1148864:poly-pyrimidine tract binding [Genetic Function]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1185740:Tract [Body Part, Organ, or Organ Component]

Phrase: "(PTB)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419054:PTB [Gene or Genome]
  1000   C1425029:PTB [Gene or Genome]
  1000   C1518827:PTB [Amino Acid Sequence]

Phrase: "that"

Phrase: "binds to pyrimidine-rich elements"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0013879:Elements [Element, Ion, or Isotope]
   760   C0034284:Pyrimidine [Organic Chemical]
   760   C0034289:Pyrimidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0699759:Rich [Qualitative Concept]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   726 E C1705248:Element [Conceptual Entity]

Phrase: "within DRE (45-47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1384593:DRE [Diagnostic Procedure]

Phrase: ")."
Processing 00000000.tx.383: Regarding its high pyrimidine content of almost 80%, the UCR sequence could serve as a PTB-binding target, too. 

Phrase: "Regarding"

Phrase: "its high pyrimidine content of almost 80%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "the UCR sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]
   708   C1883644:Upstream Region [Nucleotide Sequence]

Phrase: "could"

Phrase: "serve as a PTB-binding target,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1419054:PTB [Gene or Genome]
   753   C1425029:PTB [Gene or Genome]
   753   C1518827:PTB [Amino Acid Sequence]
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "too."
Processing 00000000.tx.384: Comparison of the UCR sequence with the PTB binding consensus ((U/G)C(A/Y)GCCUG(Y/G)UGCYYYYCYYYYG(Y/G)CCC) (46) identified three potential PTB-binding sites sharing 17-18 nucleotides with the PTB consensus, whereas the pyrimidine-rich sequences (PPSI to III) of UCR form the internal pyrimidine core of the potential PTB-binding sites: PPSI (UCACAAAGGUUCUUUUUUUUCCCAGC), PPSII (CCAG-CUGCU-CCUUUUUCAUGACUU), and PPSIII (UAUUGCAAAUGCU-UUCCCUUGCUCU) (where Y is pyrimidine; identical nucleotides with PTB consensus are in boldface letters; pyrimidine core is underlined; dash indicates missing nucleotide). 

Phrase: "Comparison of the UCR sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707455:Comparison [Activity]

Phrase: "with the PTB binding consensus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0376298:Consensus [Social Behavior]

Phrase: "("

Phrase: "(U/G)C(A/Y)GCCUG"

Phrase: "(Y/G)UGCYYYYCYYYYG"

Phrase: "(Y/G)CCC) (46"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "three potential PTB-binding sites"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   840   C0005456:Binding Sites [Receptor]
   806 E C0682969:Binding Site [Amino Acid Sequence]
   804   C0205145:Sites [Spatial Concept]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   771 E C1515974:Site [Body Location or Region]
   771 E C2825164:Site [Spatial Concept]

Phrase: "sharing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Sharing [Social Behavior]

Phrase: "17-18 nucleotides with the PTB consensus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "whereas"

Phrase: "the pyrimidine-rich sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "(PPSI to III"

Phrase: ")"

Phrase: "of UCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the internal pyrimidine core of the potential PTB-binding sites"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0444669:Core [Spatial Concept]
   739   C1167518:core [Cell Component]
   739   C1706352:Core [Medical Device]
   739   C1882467:Core [Manufactured Object]
   739   C3274653:Core [Body Substance]

Phrase: ":"

Phrase: "PPSI"

Phrase: "(UCACAAAGGUUCUUUUUUUUCCCAGC"

Phrase: ")"

Phrase: ","

Phrase: "PPSII"

Phrase: "(CCAG-CUGCU-CCUUUUUCAUGACUU"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "PPSIII"

Phrase: "(UAUUGCAAAUGCU-UUCCCUUGCUCU"

Phrase: ")"

Phrase: "(where Y"

Phrase: "is"

Phrase: "pyrimidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034284:Pyrimidine [Organic Chemical]
  1000   C0034289:Pyrimidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "; identical nucleotides with PTB consensus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are in boldface letters"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0282413:letters [Intellectual Product]
   770   C1551058:Are [Quantitative Concept]
   737 E C1096774:Letter [Intellectual Product]
   737 E C2360551:Letter [Clinical Attribute]

Phrase: "; pyrimidine core"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0444669:Core [Spatial Concept]
   861   C1167518:core [Cell Component]
   861   C1706352:Core [Medical Device]
   861   C1882467:Core [Manufactured Object]
   861   C3274653:Core [Body Substance]

Phrase: "is"

Phrase: "underlined"

Phrase: "; dash"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827624:DASH [Intellectual Product]

Phrase: "indicates"

Phrase: "missing nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.385: A possible involvement of PTB in the regulation of APP exon 15splicing is strengthened by the fact that the destruction of PPSI, -II, or -III weakened the inhibitory function of UCR (Fig. 7A). 

Phrase: "A possible involvement of PTB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of APP exon 15splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "is"

Phrase: "strengthened by the fact"

Phrase: "that"

Phrase: "the destruction of PPSI, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1261381:Destruction [Therapeutic or Preventive Procedure]
   770   C1948029:Destruction [Activity]

Phrase: "II,"

Phrase: "or -III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "weakened"

Phrase: "the inhibitory function of UCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C2587213:Control function [Functional Concept]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.386: The second regulatory region, DCR, contained the conserved RNA motifs GCCUCU(C)(U) two times and a truncated version GCUCUCU which shows sequence homology to the intronic CUCUCU element located upstream of c-src gene N1 exon. 

Phrase: "The second regulatory region,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "DCR,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the conserved RNA motifs GCCUCU"

Phrase: "(C)(U"

Phrase: ")"

Phrase: "two times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1948050:Two Times [Quantitative Concept]
   861   C0040223:times [Temporal Concept]
   861   C0205448:Two [Quantitative Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "a truncated version GCUCUCU"

Phrase: "which"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "sequence homology to the intronic CUCUCU element"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0162775:Sequence Homology [Quantitative Concept]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1334043:Homology [Gene or Genome]
   748   C1519249:Sequence [Functional Concept]
   748   C2697616:Homology [Qualitative Concept]
   728 E C0162774:Sequence Homolog [Molecular Sequence]

Phrase: "located upstream of c-src gene N1 exon."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0038085:src Gene [Gene or Genome]
   770   C0079073:SRC Gene [Gene or Genome]
   770   C0080298:SRC gene [Gene or Genome]
   744   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0017337:Gene [Gene or Genome]
   744   C0441962:N1 [Finding]
   744   C0522505:Upstream [Spatial Concept]
Processing 00000000.tx.387: This short element blocks the inclusion of the neuron-specific N1 exon in non-neuronal cells (48) by binding PTB (49). 

Phrase: "This short element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the inclusion of the neuron-specific N1 exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1512693:Inclusion [Qualitative Concept]

Phrase: "in non-neuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(48"

Phrase: ")"

Phrase: "by binding PTB (49"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1419054:PTB [Gene or Genome]
   827   C1425029:PTB [Gene or Genome]
   827   C1518827:PTB [Amino Acid Sequence]

Phrase: ")."
Processing 00000000.tx.388: The mutation analysis of these elements in DCR indicated that this could also be the case in exon 15splicing, since the destruction of two of these RNA motifs impaired the cell-specific exclusion of exon 15in non-neuronal cells (Fig. 7B). 

Phrase: "The mutation analysis of these elements"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0796357:mutation analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "this"

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "the case in exon 15splicing,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: "since"

Phrase: "the destruction of two of these RNA motifs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1261381:Destruction [Therapeutic or Preventive Procedure]
   744   C1948029:Destruction [Activity]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "the cell-specific exclusion of exon 15in non-neuronal cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0680251:EXCLUSION [Functional Concept]
   739   C2828389:Exclusion [Activity]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.389: Therefore, PTB is an attractive candidate that mediates the repressor function of UCR and DCR in the APP exon 15splicing system. 

Phrase: "Therefore,"

Phrase: "PTB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419054:PTB [Gene or Genome]
  1000   C1425029:PTB [Gene or Genome]
  1000   C1518827:PTB [Amino Acid Sequence]

Phrase: "is"

Phrase: "an attractive candidate"

Phrase: "that"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the repressor function of UCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C2587213:Control function [Functional Concept]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "DCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "in the APP exon 15splicing system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.390: Since the presence or absence of the region encoded by exon 15influences the proteolytic processing of APP to A peptide (18) and neurons do not produce L-APP, one could speculate that APPex15 and L-APP might play a different role in the progression of Alzheimer's disease. 

Phrase: "Since"

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of the region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "encoded by exon 15influences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0679058:encoded [Mental Process]
   770   C2700640:Encoded [Activity]

Phrase: "the proteolytic processing of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1514570:Proteolytic Processing [Molecular Function]
   774   C0033666:protein processing [Molecular Function]
   748   C1709694:Processing [Activity]

Phrase: "to A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(18"

Phrase: ")"

Phrase: "and"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "produce"

Phrase: "L-APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "could"

Phrase: "speculate"

Phrase: "that APPex15"

Phrase: "and"

Phrase: "L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a different role in the progression of Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.391: If this is the case the identified regulatory sequences could serve as a target to modulate neuronal APP splicing and may be beneficial in preventing or treating Alzheimer's disease.  

Phrase: "If"

Phrase: "this"

Phrase: "is"

Phrase: "the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the identified regulatory sequences"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   867   C0314642:Regulatory sequence [Nucleotide Sequence]
   827   C0162326:Sequences [Nucleotide Sequence]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "could"

Phrase: "serve as a target to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "neuronal APP splicing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0376437:Protein Splicing [Genetic Function]
   804   C0035687:Splicing [Genetic Function]
   804   C2610186:splicing [Genetic Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "beneficial in preventing"

Phrase: "or"

Phrase: "treating Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.392: ACKNOWLEDGEMENTS We are grateful to Dr. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Dr."
Processing 00000000.tx.393: Yoshiyuki Sakaki, Tokyo, Japan, for making available genomic human APP sequences prior to publication and Dr. 

Phrase: "Yoshiyuki Sakaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1207167:sakaki [Plant]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "for making available genomic human APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   845   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   845   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   829   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0011560:Amyloid [Pathologic Function]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1709634:Precursor [Idea or Concept]

Phrase: "sequences prior to publication"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0332152:Prior to [Temporal Concept]
           Prior
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0034036:Publication [Intellectual Product,Manufactured Object]
   770   C0034037:Publication [Occupational Activity]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]
   770   C1704324:Publication [Intellectual Product]
   770   C2826257:PRIOR [Event]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.394: Christine Bergmann and Dr. 

Phrase: "Christine Bergmann"

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.395: Martin Picard, ZMBH Heidelberg, Germany, for primary neuronal and glial tissue culture samples. 

Phrase: "Martin Picard,"

Phrase: "ZMBH Heidelberg,"

Phrase: "Germany,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "for primary neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521390:Neuronal [Immunologic Factor]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "glial tissue culture samples."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1292533:Tissue Sample [Tissue]
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.396: We thank Christine Elle, Heike Grimm, and Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Christine Elle,"

Phrase: "Heike Grimm,"

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.397: Gerd Multhaup for critically reading the manuscript.  

Phrase: "Gerd Multhaup for critically"

Phrase: "reading"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Reading [Daily or Recreational Activity]
  1000   C1705179:Reading [Finding]

Phrase: "the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.398: FOOTNOTES * This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 317and the Bundesministerium fr Bildung, Wissenschaft, forschung und Technologie.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Deutsche Forschungsgemeinschaft Grant SFB 317and"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0018173:Grant [Quantitative Concept]
   748   C1521721:Supported [Conceptual Entity]
   748   C1548284:Grant [Idea or Concept]
   714 E C0183683:Support [Medical Device]

Phrase: "the Bundesministerium fr Bildung,"

Phrase: "Wissenschaft,"

Phrase: "forschung und Technologie."
Processing 00000000.tx.399: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.400: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.401: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.402: The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF199003, AF199004, and AF199005.  

Phrase: "The nucleotide sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: "reported in this paper"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0030351:Paper [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1547566:Paper [Idea or Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "submitted to the GenBankTM/EMBL Data Bank"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0242356:Data Bank [Intellectual Product]
   748   C0442598:Bank [Manufactured Object]
   748   C0872261:Bank [Manufactured Object]
   748   C1511726:Data [Idea or Concept]
   748   C1515023:Submitted [Functional Concept]
   748   C3245479:data [Medical Device]

Phrase: "with accession number"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1510755:Accession Number [Intellectual Product]
           Accession
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]
   861   C1706078:Accession [Activity]

Phrase: "("

Phrase: "s)"

Phrase: "AF199003,"

Phrase: "AF199004,"

Phrase: "and"

Phrase: "AF199005."
Processing 00000000.tx.403: To whom correspondence should be addressed: Lehrstuhl fr Biochemie I, University of Regensburg, Universittsstrasse 31,D-93040 Regensburg, Germany; 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Lehrstuhl fr Biochemie I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "University of Regensburg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Universittsstrasse 31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "D-"

Phrase: "93040 Regensburg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ";"
Processing 00000000.tx.404: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.405: 49-941-9434914; 

Phrase: "49-941-9434914"

Phrase: ";"
Processing 00000000.tx.406: Fax: 49-941-9432936; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "49-941-9432936"

Phrase: ";"
Processing 00000000.tx.407: E-mail: christian.bergsdorf@vkl.uni-regensburg.de. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "christian.bergsdorf@vkl.uni-regensburg.de."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0011198:DE [Geographic Area]
   799   C0017480:DE [Geographic Area]
   799   C3541240:DE [Idea or Concept]
Processing 00000000.tx.408: 2 C. 

Phrase: "2 C."
Processing 00000000.tx.409: Bergsdorf and K.

Phrase: "Bergsdorf"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.410: Beyreuther, unpublished data.  

Phrase: "Beyreuther,"

Phrase: "unpublished data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.411: ABBREVIATIONS The abbreviations used are: APP, amyloid precursor protein; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.412: APLP1, amyloid precursor-like protein 1; 

Phrase: "APLP1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412466:APLP1 [Gene or Genome]

Phrase: "amyloid precursor-like protein 1"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
  1000   C1412466:AMYLOID PRECURSOR-LIKE PROTEIN 1 [Gene or Genome]
           AMYLOID PRECURSOR-LIKE PROTEIN
           amyloid-like protein 1
   888   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   888   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   853   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.413: L-APP, leukocyte-derived APP; 

Phrase: "L-APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "leukocyte-derived APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C0682634:Leukocyte precursor [Cell]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.414: bp, base pair(s); 

Phrase: "bp,"

Phrase: "base pair"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0600436:Base Pair [Molecular Function]
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C1709450:Pair [Qualitative Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: ";"
Processing 00000000.tx.415: MG-APPex15, minigene-derived APPex15; 

Phrase: "MG-APPex15,"

Phrase: "minigene-derived APPex15"

Phrase: ";"
Processing 00000000.tx.416: MG-L-APP, minigene-derived L-APP; 

Phrase: "MG-L-APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "minigene-derived L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.417: nt, nucleotides; 

Phrase: "nt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332126:NT [Qualitative Concept]
  1000   C1449832:NT [Diagnostic Procedure]

Phrase: "nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.418: PCR, polymerase chain reaction; 

Phrase: "PCR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "polymerase chain reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.419: PTB, polypyrimidine tract-binding protein; 

Phrase: "PTB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419054:PTB [Gene or Genome]
  1000   C1425029:PTB [Gene or Genome]
  1000   C1518827:PTB [Amino Acid Sequence]

Phrase: "polypyrimidine tract-binding protein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0137872:Polypyrimidine Tract-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1148864:poly-pyrimidine tract binding [Genetic Function]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1185740:Tract [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.420: RT-PCR, reverse transcription-polymerase chain reaction; 

Phrase: "RT-PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "reverse transcription-polymerase chain reaction"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0814037:reverse transcription polymerase chain reaction [Genetic Function]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035380:Reverse Transcription [Genetic Function]
   804   C0040649:Transcription [Genetic Function]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.421: 3'-SS, 3'-splice site; 

Phrase: "3'-SS,"

Phrase: "3'-splice site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0887918:3' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.422: 5'-SS, 5'-splice site; 

Phrase: "5'-SS,"

Phrase: "5'-splice site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0887917:5' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.423: kb, kilobase pairs; 

Phrase: "kb,"

Phrase: "kilobase pairs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0582520:kilobase pairs [Quantitative Concept]
   861   C0582519:kilobase [Quantitative Concept]
   861   C1709450:Pair [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.424: nt, nucleotide; 

Phrase: "nt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332126:NT [Qualitative Concept]
  1000   C1449832:NT [Diagnostic Procedure]

Phrase: "nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.425: DCR, downstream control region; 

Phrase: "DCR,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "downstream control region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883633:Downstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.426: UCR, upstream control region.  

Phrase: "UCR,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "upstream control region."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1883644:Upstream Region [Nucleotide Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.427: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.428: Glenner, G. 

Phrase: "Glenner,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.429: G., and Wong, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Wong,"

Phrase: "C."
Processing 00000000.tx.430: W. 

Phrase: "W."
Processing 00000000.tx.431: (1984) Biochem. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.432: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.433: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.434: Commun. 

Phrase: "Commun."
Processing 00000000.tx.435: 120, 885-890[Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "120,"

Phrase: "885-890"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.436: Masters, C. 

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.437: L., Simms, G., Weinman, N. 

Phrase: "L., Simms,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Weinman,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.438: A., Multhaup, G., McDonald, B. 

Phrase: "A.,"

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "McDonald,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.439: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.440: (1985) Proc. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.441: Natl. 

Phrase: "Natl."
Processing 00000000.tx.442: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.443: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.444: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.445: 82, 4245-4249[Abstract] 3. 

Phrase: "82,"

Phrase: "4245-4249"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.446: Dyrks, T., Weidemann, A., Multhaup, G., Salbaum, J. 

Phrase: "Dyrks,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Weidemann,"

Phrase: "A.,"

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Salbaum,"

Phrase: "J."
Processing 00000000.tx.447: M., Lemaire, H. 

Phrase: "M."

Phrase: ","

Phrase: "Lemaire,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.448: G., Kang, J., Muller, H. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kang,"

Phrase: "J.,"

Phrase: "Muller,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.449: B., Masters, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.450: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.451: (1988) EMBO J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.452: 7, 949-957[Abstract] 4. 

Phrase: "7,"

Phrase: "949-957"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 4."
Processing 00000000.tx.453: Weidemann, A., Konig, G., Bunke, D., Fischer, P., Salbaum, J. 

Phrase: "Weidemann,"

Phrase: "A.,"

Phrase: "Konig,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bunke,"

Phrase: "D."

Phrase: ","

Phrase: "Fischer,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Salbaum,"

Phrase: "J."
Processing 00000000.tx.454: M., Masters, C. 

Phrase: "M."

Phrase: ","

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.455: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.456: (1989) Cell 57, 115-126[Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Cell 57,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "115-126"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.457: Kang, J., Lemaire, H. 

Phrase: "Kang,"

Phrase: "J.,"

Phrase: "Lemaire,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.458: G., Unterbeck, A., Salbaum, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Unterbeck,"

Phrase: "A.,"

Phrase: "Salbaum,"

Phrase: "J."
Processing 00000000.tx.459: M., Masters, C. 

Phrase: "M."

Phrase: ","

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.460: L., Grzeschik, K. 

Phrase: "L., Grzeschik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.461: H., Multhaup, G., Beyreuther, K., and Mueller-Hill, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Mueller-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.462: (1987) Nature 325, 733-736[CrossRef][Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Nature 325,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "733-736"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.463: Tanzi, R. 

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.464: E., Gusella, J. 

Phrase: "E.,"

Phrase: "Gusella,"

Phrase: "J."
Processing 00000000.tx.465: F., Watkins, P. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Watkins,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.466: C., Bruns, G. 

Phrase: "C., Bruns,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.467: A., St George-Hyslop, P. 

Phrase: "A.,"

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.468: H., Van Keuren, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Van Keuren,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.469: L., Patterson, D., Pagan, S., Kurnit, D. 

Phrase: "L., Patterson,"

Phrase: "D."

Phrase: ","

Phrase: "Pagan,"

Phrase: "S."

Phrase: ","

Phrase: "Kurnit,"

Phrase: "D."
Processing 00000000.tx.470: M., and Neve, R. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Neve,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.471: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.472: (1987) Science 235, 880-884[Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Science 235,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "880-884"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.473: Hattori, M., Tsukahara, F., Furuhata, Y., Tanahashi, H., Hirose, M., Saito, M., Tsukuni, S., and Sakaki, Y. 

Phrase: "Hattori,"

Phrase: "M."

Phrase: ","

Phrase: "Tsukahara,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Furuhata,"

Phrase: "Y.,"

Phrase: "Tanahashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hirose,"

Phrase: "M."

Phrase: ","

Phrase: "Saito,"

Phrase: "M."

Phrase: ","

Phrase: "Tsukuni,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Sakaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1207167:sakaki [Plant]

Phrase: "Y."
Processing 00000000.tx.474: (1997) Nucleic Acids Res. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.475: 25, 1802-1808[Abstract/Free FullText] 8. 

Phrase: "25,"

Phrase: "1802-1808"

Phrase: "[Abstract/Free FullText"

Phrase: "] 8."
Processing 00000000.tx.476: Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S., and Ito, H. 

Phrase: "Kitaguchi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "Y.,"

Phrase: "Tokushima,"

Phrase: "Y.,"

Phrase: "Shiojiri,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Ito,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415618:ITO [Gene or Genome]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.477: (1988) Nature 331, 530-532[CrossRef][Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Nature 331,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "530-532"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.478: Ponte, P., Gonzalez, D. 

Phrase: "Ponte,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gonzalez,"

Phrase: "D."
Processing 00000000.tx.479: P., Schilling, J., Miller, J., Hsu, D., Greenberg, B., Davis, K., Wallace, W., Lieberburg, I., and Fuller, F. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schilling,"

Phrase: "J.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "J.,"

Phrase: "Hsu,"

Phrase: "D."

Phrase: ","

Phrase: "Greenberg,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Davis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "W.,"

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Fuller,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.480: (1988) Nature 331, 525-527[CrossRef][Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Nature 331,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "525-527"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.481: Knig, G., Monning, U., Czech, C., Prior, R., Banati, R., Schreiter-Gasser, U., Bauer, J., Masters, C. 

Phrase: "Knig,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Monning,"

Phrase: "U.,"

Phrase: "Czech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337799:czech [Population Group]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Prior,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Prior [Temporal Concept]
  1000   C2826257:PRIOR [Event]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Banati,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Schreiter-Gasser,"

Phrase: "U.,"

Phrase: "Bauer,"

Phrase: "J.,"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.482: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.483: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.484: Biol. 

Phrase: "Biol."
Processing 00000000.tx.485: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.486: 267, 10804-10809[Abstract/Free FullText] 11. 

Phrase: "267,"

Phrase: "10804-10809"

Phrase: "[Abstract/Free FullText"

Phrase: "] 11."
Processing 00000000.tx.487: Sandbrink, R., Masters, C. 

Phrase: "Sandbrink,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.488: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.489: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.490: Biol. 

Phrase: "Biol."
Processing 00000000.tx.491: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.492: 269, 1510-1517[Abstract/Free FullText] 12. 

Phrase: "269,"

Phrase: "1510-1517"

Phrase: "[Abstract/Free FullText"

Phrase: "] 12."
Processing 00000000.tx.493: Pangalos, M. 

Phrase: "Pangalos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.494: N., Efthimiopoulos, S., Shioi, J., and Robakis, N. 

Phrase: "N., Efthimiopoulos,"

Phrase: "S."

Phrase: ","

Phrase: "Shioi,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.495: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.496: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.497: Biol. 

Phrase: "Biol."
Processing 00000000.tx.498: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.499: 270, 10388-10391[Abstract/Free FullText] 13. 

Phrase: "270,"

Phrase: "10388-10391"

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.500: Pangalos, M. 

Phrase: "Pangalos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.501: N., Shioi, J., and Robakis, N. 

Phrase: "N., Shioi,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.502: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.503: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.504: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.505: 65, 762-769[Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "762-769"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.506: Okamoto, M., Mori, S., and Endo, H. 

Phrase: "Okamoto,"

Phrase: "M."

Phrase: ","

Phrase: "Mori,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Endo, H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.507: (1994) Brain Res. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.508: 637, 57-67[Medline] [OrderarticleviaInfotrieve] 15. 

Phrase: "637,"

Phrase: "57-67"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 15."
Processing 00000000.tx.509: Brittis, P. 

Phrase: "Brittis,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.510: A., Canning, D. 

Phrase: "A.,"

Phrase: "Canning,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704712:Can [Manufactured Object]

Phrase: "D."
Processing 00000000.tx.511: R., and Silver, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Silver,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0037125:Silver [Element, Ion, or Isotope]
  1000   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
  1000   C1305285:Silver [Qualitative Concept]
  1000   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   916 E C0079853:Moon [Geographic Area]
   907 E C0003782:Argyria [Injury or Poisoning]
   907 E C3463959:Argyria [Eukaryote]

Phrase: "J."
Processing 00000000.tx.512: (1992) Science 255, 733-736[Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 255,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "733-736"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.513: Margolis, R. 

Phrase: "Margolis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.514: K., and Margolis, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Margolis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.515: U. 

Phrase: "U."
Processing 00000000.tx.516: (1993) Experientia (Basel) 49, 429-446 17. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Experientia"

Phrase: "(Basel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: ")"

Phrase: "49,"

Phrase: "429-446 17."
Processing 00000000.tx.517: Wu, A., Pangalos, M. 

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A.,"

Phrase: "Pangalos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.518: N., Efthimiopoulos, S., Shioi, J., and Robakis, N. 

Phrase: "N., Efthimiopoulos,"

Phrase: "S."

Phrase: ","

Phrase: "Shioi,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.519: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.520: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.521: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.522: 17, 4987-4993[Abstract/Free FullText] 18. 

Phrase: "17,"

Phrase: "4987-4993"

Phrase: "[Abstract/Free FullText"

Phrase: "] 18."
Processing 00000000.tx.523: Hartmann, T., Bergsdorf, C., Sandbrink, R., Tienari, P. 

Phrase: "Hartmann,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bergsdorf,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Sandbrink,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tienari,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.524: J., Multhaup, G., Ida, N., Bieger, S., Dyrks, T., Weidemann, A., Masters, C. 

Phrase: "J.,"

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ida,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020789:IDA [Organic Chemical,Pharmacologic Substance]
  1000   C0063555:IdA [Organic Chemical,Pharmacologic Substance]
  1000   C2275731:Ida [Plant]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bieger,"

Phrase: "S."

Phrase: ","

Phrase: "Dyrks,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Weidemann,"

Phrase: "A.,"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.525: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.526: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.527: Biol. 

Phrase: "Biol."
Processing 00000000.tx.528: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.529: 271, 13208-13214[Abstract/Free FullText] 19. 

Phrase: "271,"

Phrase: "13208-13214"

Phrase: "[Abstract/Free FullText"

Phrase: "] 19."
Processing 00000000.tx.530: Sambrook, J., Fritsch, E. 

Phrase: "Sambrook,"

Phrase: "J.,"

Phrase: "Fritsch,"

Phrase: "E."
Processing 00000000.tx.531: F., and Maniatis, T. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Maniatis,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.532: (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Molecular Cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: ":"

Phrase: "A Laboratory Manual , 2nd Ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3538926:ED [Idea or Concept]
Processing 00000000.tx.533: , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 20. 

Phrase: ", Cold Spring Harbor Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0022877:Laboratory [Manufactured Object,Organization]
   812   C3244292:laboratory [Functional Concept]

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY 20."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]
Processing 00000000.tx.534: Seraphin, B., and Kandels-Lewis, S. 

Phrase: "Seraphin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Kandels-Lewis,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.535: (1996) Nucleic Acids Res. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.536: 24, 3276-3277[Abstract/Free FullText] 21. 

Phrase: "24,"

Phrase: "3276-3277"

Phrase: "[Abstract/Free FullText"

Phrase: "] 21."
Processing 00000000.tx.537: Lou, H., Yang, Y., Cote, G. 

Phrase: "Lou,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Y.,"

Phrase: "Cote,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.538: J., Berget, S. 

Phrase: "J.,"

Phrase: "Berget,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.539: M., and Gagel, R. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Gagel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.540: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.541: (1995) Mol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.542: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.543: Biol. 

Phrase: "Biol."
Processing 00000000.tx.544: 15, 7135-7142[Abstract] 22. 

Phrase: "15,"

Phrase: "7135-7142"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 22."
Processing 00000000.tx.545: Ryan, K. 

Phrase: "Ryan,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.546: J., and Cooper, T. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.547: A. 

Phrase: "A."
Processing 00000000.tx.548: (1996) Mol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.549: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.550: Biol. 

Phrase: "Biol."
Processing 00000000.tx.551: 16, 4014-4023[Abstract] 23. 

Phrase: "16,"

Phrase: "4014-4023"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.552: Sirand-Pugnet, P., Durosay, P., Brody, E., and Marie, J. 

Phrase: "Sirand-Pugnet,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Durosay,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Brody,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Marie,"

Phrase: "J."
Processing 00000000.tx.553: (1995) Nucleic Acids Res. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.554: 23, 3501-3507[Abstract] 24. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "3501-3507"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 24."
Processing 00000000.tx.555: Zhang, L., Ashiya, M., Sherman, T. 

Phrase: "Zhang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ashiya,"

Phrase: "M."

Phrase: ","

Phrase: "Sherman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.556: G., and Grabowski, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Grabowski,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.557: J. 

Phrase: "J."
Processing 00000000.tx.558: (1996) RNA (NY) 2, 682-698[Abstract] 25. 

Phrase: "(1996"

Phrase: ")"

Phrase: "RNA (NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "682-698"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 25."
Processing 00000000.tx.559: Black, D. 

Phrase: "Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "D."
Processing 00000000.tx.560: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.561: (1992) Cell 69, 795-807[Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Cell 69,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007634:Cell [Cell]
   861   C0450388:69 [Intellectual Product]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "795-807"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.562: Min, H., Turck, C. 

Phrase: "Min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0702093:/min [Temporal Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Turck,"

Phrase: "C."
Processing 00000000.tx.563: W., Nikolic, J. 

Phrase: "W., Nikolic,"

Phrase: "J."
Processing 00000000.tx.564: M., and Black, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "D."
Processing 00000000.tx.565: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.566: (1997) Genes Dev. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.567: 11, 1023-1036[Abstract] 27. 

Phrase: "11,"

Phrase: "1023-1036"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 27."
Processing 00000000.tx.568: Modafferi, E. 

Phrase: "Modafferi,"

Phrase: "E."
Processing 00000000.tx.569: F., and Black, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "D."
Processing 00000000.tx.570: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.571: (1997) Mol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.572: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.573: Biol. 

Phrase: "Biol."
Processing 00000000.tx.574: 17, 6537-6545[Abstract] 28. 

Phrase: "17,"

Phrase: "6537-6545"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 28."
Processing 00000000.tx.575: Wasco, W., Bupp, K., Magendantz, M., Gusella, J. 

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Bupp,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Magendantz,"

Phrase: "M."

Phrase: ","

Phrase: "Gusella,"

Phrase: "J."
Processing 00000000.tx.576: F., Tanzi, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.577: E., and Solomon, F. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Solomon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551833:Solomon [Population Group]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.578: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.579: Natl. 

Phrase: "Natl."
Processing 00000000.tx.580: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.581: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.582: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.583: 89, 10758-10762[Abstract] 29. 

Phrase: "89,"

Phrase: "10758-10762"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 29."
Processing 00000000.tx.584: Wasco, W., Brook, J. 

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Brook,"

Phrase: "J."
Processing 00000000.tx.585: D., and Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.586: E. 

Phrase: "E."
Processing 00000000.tx.587: (1993) Genomics 15, 237-239[CrossRef][Medline] [OrderarticleviaInfotrieve] 30. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Genomics 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "237-239"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 30."
Processing 00000000.tx.588: Paliga, K., Peraus, G., Kreger, S., Durrwang, U., Hesse, L., Multhaup, G., Masters, C. 

Phrase: "Paliga,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3284170:Paliga [Eukaryote]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Peraus,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kreger,"

Phrase: "S."

Phrase: ","

Phrase: "Durrwang,"

Phrase: "U.,"

Phrase: "Hesse,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.589: L., Beyreuther, K., and Weidemann, A. 

Phrase: "L., Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Weidemann,"

Phrase: "A."
Processing 00000000.tx.590: (1997) Eur. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.591: J.

Phrase: "J."
Processing 00000000.tx.592: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.593: 250, 354-363[Abstract] 31. 

Phrase: "250,"

Phrase: "354-363"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.594: Rio, D. 

Phrase: "Rio,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445581:Rio [Intellectual Product]

Phrase: "D."
Processing 00000000.tx.595: C. 

Phrase: "C."
Processing 00000000.tx.596: (1993) Curr. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.597: Opin. 

Phrase: "Opin."
Processing 00000000.tx.598: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.599: &Dev. 

Phrase: "&Dev."
Processing 00000000.tx.600: 3, 574-584[Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "574-584"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.601: Lopez, A. 

Phrase: "Lopez,"

Phrase: "A."
Processing 00000000.tx.602: J. 

Phrase: "J."
Processing 00000000.tx.603: (1998) Annu. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.604: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.605: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.606: 32, 279-305[CrossRef][Medline] [OrderarticleviaInfotrieve] 33. 

Phrase: "32,"

Phrase: "279-305"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 33."
Processing 00000000.tx.607: Streuli, M., and Saito, H. 

Phrase: "Streuli,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Saito,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.608: (1989) EMBO J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.609: 8, 787-796[Abstract] 34. 

Phrase: "8,"

Phrase: "787-796"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 34."
Processing 00000000.tx.610: Black, D. 

Phrase: "Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "D."
Processing 00000000.tx.611: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.612: (1991) Genes Dev. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.613: 5, 389-402[Abstract] 35. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "389-402"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 35."
Processing 00000000.tx.614: Tacke, R., and Goridis, C. 

Phrase: "Tacke,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goridis,"

Phrase: "C."
Processing 00000000.tx.615: (1991) Genes Dev. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.616: 5, 1416-1429[Abstract] 36. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "1416-1429"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 36."
Processing 00000000.tx.617: Kawamoto, S. 

Phrase: "Kawamoto,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.618: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.619: Biol. 

Phrase: "Biol."
Processing 00000000.tx.620: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.621: 271, 17613-17616[Abstract/Free FullText] 37. 

Phrase: "271,"

Phrase: "17613-17616"

Phrase: "[Abstract/Free FullText"

Phrase: "] 37."
Processing 00000000.tx.622: Min, H., Chan, R. 

Phrase: "Min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0702093:/min [Temporal Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chan,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.623: C., and Black, D. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "D."
Processing 00000000.tx.624: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.625: (1995) Genes Dev. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.626: 9, 2659-2671[Abstract] 38. 

Phrase: "9,"

Phrase: "2659-2671"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 38."
Processing 00000000.tx.627: Dominski, Z., and Kole, R. 

Phrase: "Dominski,"

Phrase: "Z.,"

Phrase: "and"

Phrase: "Kole,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.628: (1991) Mol. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.629: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.630: Biol. 

Phrase: "Biol."
Processing 00000000.tx.631: 11, 6075-6083[Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "11,"

Phrase: "6075-6083"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.632: Bell, M. 

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.633: V., Cowper, A. 

Phrase: "V., Cowper,"

Phrase: "A."
Processing 00000000.tx.634: E., Lefranc, M. 

Phrase: "E.,"

Phrase: "Lefranc,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.635: P., Bell, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "J."
Processing 00000000.tx.636: I., and Screaton, G. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Screaton,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.637: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.638: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.639: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.640: Biol. 

Phrase: "Biol."
Processing 00000000.tx.641: 18, 5930-5941[Abstract/Free FullText] 40. 

Phrase: "18,"

Phrase: "5930-5941"

Phrase: "[Abstract/Free FullText"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.642: Smith, C. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.643: W., and Nadal-Ginard, B. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Nadal-Ginard,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.644: (1989) Cell 56, 749-758[Medline] [OrderarticleviaInfotrieve] 41. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Cell 56,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "749-758"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 41."
Processing 00000000.tx.645: Mullen, M. 

Phrase: "Mullen,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0885014:MULLEIN [Organic Chemical,Pharmacologic Substance]
  1000   C0936216:Mullein [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.646: P., Smith, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.647: W., Patton, J. 

Phrase: "W., Patton,"

Phrase: "J."
Processing 00000000.tx.648: G., and Nadal-Ginard, B. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Nadal-Ginard,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.649: (1991) Genes Dev. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.650: 5, 642-655[Abstract] 42. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "642-655"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 42."
Processing 00000000.tx.651: Libri, D., Piseri, A., and Fiszman, M. 

Phrase: "Libri,"

Phrase: "D."

Phrase: ","

Phrase: "Piseri,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Fiszman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.652: Y. 

Phrase: "Y."
Processing 00000000.tx.653: (1991) Science 252, 1842-1845[Medline] [OrderarticleviaInfotrieve] 43. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Science 252,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1842-1845"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 43."
Processing 00000000.tx.654: Estes, P. 

Phrase: "Estes,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.655: A., Cooke, N. 

Phrase: "A.,"

Phrase: "Cooke,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.656: E., and Liebhaber, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Liebhaber,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.657: A. 

Phrase: "A."
Processing 00000000.tx.658: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.659: Biol. 

Phrase: "Biol."
Processing 00000000.tx.660: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.661: 267, 14902-14908[Abstract/Free FullText] 44. 

Phrase: "267,"

Phrase: "14902-14908"

Phrase: "[Abstract/Free FullText"

Phrase: "] 44."
Processing 00000000.tx.662: Gooding, C., Roberts, G. 

Phrase: "Gooding,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.663: C., Moreau, G., Nadal-Ginard, B., and Smith, C. 

Phrase: "C., Moreau,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nadal-Ginard,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.664: W. 

Phrase: "W."
Processing 00000000.tx.665: (1994) EMBO J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.666: 13, 3861-3872[Abstract] 45. 

Phrase: "13,"

Phrase: "3861-3872"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 45."
Processing 00000000.tx.667: Lin, C. 

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C."
Processing 00000000.tx.668: H., and Patton, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Patton,"

Phrase: "J."
Processing 00000000.tx.669: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.670: (1995) RNA (NY) 1, 234-245[Abstract] 46. 

Phrase: "(1995"

Phrase: ")"

Phrase: "RNA (NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "234-245"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 46."
Processing 00000000.tx.671: Singh, R., Valcarcel, J., and Green, M. 

Phrase: "Singh,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Valcarcel,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.672: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.673: (1995) Science 268, 1173-1176[Medline] [OrderarticleviaInfotrieve] 47. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 268,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1173-1176"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 47."
Processing 00000000.tx.674: Gooding, C., Roberts, G. 

Phrase: "Gooding,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.675: C., and Smith, C. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.676: W. 

Phrase: "W."
Processing 00000000.tx.677: (1998) RNA (NY) 4, 85-100[Abstract/Free FullText] 48. 

Phrase: "(1998"

Phrase: ")"

Phrase: "RNA (NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "4,"

Phrase: "85-100"

Phrase: "[Abstract/Free FullText"

Phrase: "] 48."
Processing 00000000.tx.678: Chan, R. 

Phrase: "Chan,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.679: C., and Black, D. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "D."
Processing 00000000.tx.680: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.681: (1995) Mol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.682: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.683: Biol. 

Phrase: "Biol."
Processing 00000000.tx.684: 15, 6377-6385[Abstract] 49. 

Phrase: "15,"

Phrase: "6377-6385"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 49."
Processing 00000000.tx.685: Chan, R. 

Phrase: "Chan,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.686: C., and Black, D. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "D."
Processing 00000000.tx.687: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.688: (1997) Mol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.689: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.690: Biol. 

Phrase: "Biol."
Processing 00000000.tx.691: 17, 4667-4676[Abstract] 50. 

Phrase: "17,"

Phrase: "4667-4676"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 50."
Processing 00000000.tx.692: Lenkkeri, U., Kestila, M., Lamerdin, J., McCready, P., Adamson, A., Olsen, A., and Tryggvason, K. 

Phrase: "Lenkkeri,"

Phrase: "U.,"

Phrase: "Kestila,"

Phrase: "M."

Phrase: ","

Phrase: "Lamerdin,"

Phrase: "J.,"

Phrase: "McCready,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Adamson,"

Phrase: "A.,"

Phrase: "Olsen,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Tryggvason,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.693: (1998) Hum. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.694: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.695: 102, 192-196[CrossRef][Medline] [OrderarticleviaInfotrieve] Copyright  2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "102,"

Phrase: "192-196"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2000 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

